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Section 1  Hematopoiesis
1.1 Development and commitment of the hematopoietic stem cell
Hematopoietic stem cells (HSCs) replenish the stem cell compartment, and give rise 
to oligolineage progenitors.  These progenitors expand to maintain the hematopoietic 
compartment and differentiate into various blood lineage progenitors.  Lineage 
positive progenitors are committed for differentiation into mature blood cells.   
Developmentally there are two temporally separate hematopoietic processes. 
Primitive hematopoiesis occurs in the blood islands of the yolk sac around 7.5 days 
post coitum (d.p.c.) in the mouse, giving rise to large, nucleated erythrocytes.  It 
precedes the advent of definitive hematopoiesis with stem cells originating in the 
AGM (aorta, gonads, and mesonephros) during 9.5 to 11.5 d.p.c. in mouse  and 30 
to 37 days of gestation in man (Medvinsky and Dzierzak 1996).   Definitive HSCs 
first expand in the AGM  and then migrate and colonise the foetal liver and spleen 
where they differentiate into their progeny (heterogeneous population of early and 
late hematopoeitic progenitors).  After birth, definitive hematopoiesis is primarily 
confined to bone marrow.
Decisions needed for development and commitment of hematopoietic stem 
cells and their progeny is orchestrated by the transcriptional program.   
1.2 Regulation of Hematopoiesis by transcription factors
Transcription factors have a pivotal role in hematopoiesis and regulate HSC early 
development, survival, proliferation and lineage commitment.  Transcription factors, 
among which Runx1, SCL, Gata-2 and ALL-1 maintain a gene expression program 
unique to HSCs (Phillips et al. 2000).  Also the maintenance of HSC self-renewal 
requires specific transcription factors among which Notch1 (Varnum-Finney et al. 
2000) and Bmi-1 (Park et al. 2003).
HSC commit to either the common myeloid precursor (CMP) or the common 
lymphoid precursor (CLP).  The upregulation of both PU.1 and Gata-1 marks the 
commitment to CMPs (Scott et al. 1994).  The CMPs undergo further lineage 
divergence into megakaryocytic/erythroid progenitors (MEPs) and granulocytic/
monocytic progenitors (GMPs) upon Gata-1 and PU.1 mutual exclusive expression, 
respectively.   Commitment to the erythroid lineage is characterized by the expression 
of erythroid specific transcription factors Gata-1, Eklf and Nfe2 determining the 
erythroid program.  C/EBPα is required for the generation of the GMP compartment 
and its expression also denotes selectivity in differential commitment to monocytic 
lineage (Wang et al. 2006).   In addition to the auto- and cross-regulatory effects of 
these factors at the transcription level, increasing evidence supports the importance 
of expressing different isoforms that modulate lineage commitment in hematopoietic 
cells.  The expression of truncated forms of the transcription factor, Stem Cell 
Leukaemia (Scl) is regulated by differential initiation of translation (Calkhoven et 
al. 2003) and results in erythroid lineage differentiation. Expression of functional 
isoforms due to differential translation has been described for other hematopoietic 
transcription factors (Calligaris et al. 1995; Calkhoven et al. 2000) and disruption of 
isoform ratios are implicated in disease (Pabst et al. 2001; Cleaves et al. 2004).
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1.3 Hematopoietic Signals: the microenvironment
The HSC compartment undergoes self renewal at a constant low rate to maintain the 
HSC population while preventing stem cell exhaustion throughout life.  Proliferation 
of HSCs is orchestrated by Notch (Varnum-Finney et al. 2000), sonic hedgehog 
(Bhardwaj et al. 2001) and Wnt (Reya et al. 2003) signalling.  Wnt-mediated 
maintenance of undifferentiated HSCs requires Notch1 (Reya et al. 2003) and the 
upregulation of HoxB4 by Wnt signalling supports self-renewal of HSCs (Antonchuk 
et al. 2002).  The same pathways are activated in response to mitogenic stimuli to 
induce proliferation of cells.  The production of TGF-β1, within the quiescent micro-
environment, safeguards HSC from exhaustion by downmodulating cell surface 
expression of mitogenic cytokine receptors (cKit, Flt3, IL-6R, Mpl) (Fortunel et al. 
2003).   
Wnt signalling has been implicated in both maintenance of the early progenitor 
compartment and in lineage commitment (Brandon et al. 2000; Reya et al. 2003). 
Upon commitment (section 1.2), lineage specific cytokines and growth factors 
regulate maintenance and differentiation of progenitor cells. Stem Cell Factor (SCF) 
supports proliferation of various hematopoietic compartments.  In erythropoeisis the 
lineage-specific cytokine erythropoietin (Epo) works in concert with SCF to regulate 
the balance between proliferation and differentiation of erythroid progenitors. 
Through different mechanisms, both Epo and SCF protect erythroid progenitors 
fromTRAIL-induced apoptosis (Schmidt et al. 2004; Mirandola et al. 2006), which 
exemplifies the role of signalling mechanisms in regulating cellular sensitivity to the 
microenvironment. 
1.4 Disregulation of Hematopoiesis
The balance between proliferation and differentiation of committed progenitors is 
under tight control, to maintain the progenitor pool and ensure maturation in response 
to physiological demand.  The production of increased numbers of mature blood cells 
during stress, requires higher progenitor proliferation rates.  Concurrently, feedback 
mechanisms must be closely coordinated to repress progenitor proliferation and to 
restore physiological cell numbers when the stress is over (Vattem and Wek 2004). 
Deregulation of this balance will result in disease.  Myelo-Proliferative Disorders 
(MPD) and anaemia originate from hyperproliferative potential that can be sustained 
or can result in bone marrow exhaustion, respectively.  Constitutive active tyrosine 
kinase receptors (FLT-3, cKit), activated Jak2 and mutant PTEN promote proliferation 
and/or survival in committed progenitors that are still capable to differentiate.  This 
results in hyperproliferative phenotype (Vainchenker and Constantinescu 2005; 
Kelly et al. 2002b; Gilliland and Griffin 2002; Zhang et al. 2006).    In addition to 
hyperproliferation, a perturbed program blocking terminal differentiation gives rise to 
leukaemia.  Translocations t(8:21) and  t(15;17) give rise to the fusion proteins AML1/
RUNX1 and PML-RARα, both inhibiting hematopoietic differentiation by recruiting 
repression complexes to target genes of AML1 and RARα respectively (Kelly et al. 
2002a; Tallman et al. 2002).  Expression of these fusion proteins in hematopoietic 
progenitors, confers propagation in serial murine transplantation models (Grisolano 
et al. 1997; Higuchi et al. 2002) but is not sufficient to induce leukaemia.  Cooperation 
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events exemplified by the complementation of Flt3-ITD mutant to PML-RARα 
transgenic bone marrow cells results in 100% penetrance of an APL-like disease 
when transplanted to secondary recipients (Kelly et al. 2002a).  
To study the balance between expansion and differentiation of erythroid progenitors 
we use an in vitro system in which erythroid progenitors can be expanded in the 
presence of Epo, SCF and dexamethasone, while they maintain the capacity to 
differentiate when cultured in Epo alone.  Signals emanating from extrinsic factors 
modulate the gene expression program at various levels, including transcription, 
transcript maturation, stability and translation.  
Section 2 Erythropoiesis
2.1 Regulation of erythropoeisis
The continuous demand of an organism for mature circulating blood cells requires 
a tight balance between maintenance of progenitor compartments versus terminal 
differentiation to satisfy the demand and ensure prevention from exhaustion.   The 
human bone marrow must replace 1011 erythrocytes daily under normal physiological 
erythropoiesis.   The main regulator of erythropoiesis is the glycoprotein hormone 
Erythropoietin (Epo), produced in the kidney in response to oxygen tension in the 
blood.  The function of Epo initiates from the specific interaction to its cell surface 
receptor (EpoR).  The expression of the EpoR is dependent on the transcription 
factor Gata-1 (Zon et al. 1991) and increases on progenitor cells as they mature 
from early BFU-E (Burst-forming unit erythroid) to late CFU-E (Colony-forming 
unit erythroid) (Erslev and Caro 1986; Sawada et al. 1990).   Hence, generation of 
BFU-E and CFU-E progenitors is Epo-independent (Wu et al. 1995), while Epo is 
required for terminal differentiation into erythrocytes.  This is supported by the lack 
of definitive erythropoiesis in Epo knockout mice that die at day 12.5 of gestation 
and the in vitro rescue of Epo-/- foetal liver cells by addition of exogenous Epo (Lin 
et al. 1996).  Interestingly, definitive erythropoiesis is normal in mice expressing  an 
EpoR mutant (EpoRH) capable to recruit Jak2 but lacking signal transducer binding 
sites (Zang et al. 2001), suggesting that the definitive erythroid differentiation is not 
a result of an instructive program by Epo signalling.  
The role of Epo is to sense erythropoietic demand during hypoxia.  In stress 
erythropoiesis, Stem Cell factor (cKit ligand) and glucocorticoids (GR) work in 
concert with Epo to induce expansion of progenitors in the mouse spleen (Broudy et 
al. 1996; Bauer et al. 1999; Wessely et al. 1999).  The requirement for SCF in acute 
erythroid expansion was demonstrated by the observation that antibodies preventing 
c-Kit activation abolished splenic hematopoiesis upon induction of haemolytic 
anaemia in mice, while the antibodies had no effect on steady state erythropoiesis 
(Broudy et al. 1996). 
During terminal differentiation to enucleated, haemoglobinised erythrocytes, 
the cell undergoes drastic changes in the cytoskeleton leading to enucleation, and 
accumulates haeme and globin peptides.  To accomplish these changes, the intrinsic 
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gene expression program is modulated at the level of transcription factor expression 
(section 1.2), alternative mRNA splicing and regulation at translational level. 
Interestingly, the erythroid protein 4.1R isoforms selectively include a cytoskeletal 
membrane binding domain as required during late erythropoiesis (Pinder et al. 
1993).  Alternative 5’ exons that increase complexity within the N-terminal regions 
of transcripts were found in 35% of erythroid genes studied (Tan et al. 2006).  This 
suggests that erythroid specific promoter usage and alternative splicing might offer 
a temporal and cell specific transcriptional modulation of critical genes and their 
products.   
The enormous increase in haeme synthesis during haemoglobinisation of 
erythroblasts, requires tight coordination between iron uptake and storage of iron 
with tight coordination to the production of globins.   This is mainly accomplished 
by translational control that supports the erythroid program by sensing metabolite 
levels and drive quick responses to maintain cellular equilibrium state.  At low iron 
level, iron responsive proteins (IRPs) bind to and stabilize specific RNA structures 
(Iron regulatory elements) found in the 5’UTR of ferritin and 3’UTR of the transferrin 
receptor (TfR1) transcripts (Thomson et al. 1999).  This results in stabilization of 
the TfR1 transcript accompanied by enhanced receptor expression and iron uptake. 
Conversely the IRE/IRP complex in ferritin results in inhibition of translation initiation 
resulting in decreased storage (Cazzola and Skoda 2000).  Collectively, iron is made 
available for enhanced haeme synthesis under tight control of iron.  In addition, 
globin production is attenuated by HRI (kinase of eIF2α) in response to the lack of 
haeme (Han et al. 2001).  During iron deficiency, haeme levels are low, resulting in 
phosphorylation of eIF2α and inhibition of the translation machinery.  
2.2 Role of SCF and Epo signalling in expansion / differentiation of erythroid 
progenitors
Proliferation and differentiation require different signals from the EpoR. The 
EpoR has no intrinsic kinase activity, but is constitutively associated with the 
tyrosine kinase Jak2. The EpoR/Jak2 complex activates a complex signalling 
network including the Stat5 and Map kinase pathways and signalling through 
phosphoinositide-3 kinase (PI3K). Activation of the EpoR results in phosphorylation 
and activation of the tyrosine kinase receptor Ron (Recepteur d’origine Nantese, 
also named Stk: Stem cell tyrosine kinase), which is associated with the adaptor 
protein Gab1 (Grb2 associated binder). Gab1, in turn, is able to activate PI3K and 
the Ras-Map kinase pathway. Interestingly, direct activation of Ron is able to replace 
Epo in renewal but not in differentiation of erythroid progenitors. The observation 
that Stat5 is not phosphorylated upon activation of Ron suggests that Stat5 is not 
involved in proliferation of erythroid progenitors but required for their differentiation 
(van den Akker et al. 2004). One of the targets of Stat5 in differentiation may be 
expression of the anti-apoptotic BclXL protein (Dolznig et al. 2002).   Various attempts 
have been made to study the importance of Stat5 in erythroid differentiation. Mice 
constructed to be Stat5ab-deficient have normal steady state erythropoiesis 
except for a mild anaemia (Teglund et al. 1998), although foetal erythropoiesis is 
compromised (Socolovsky et al. 2001).  These results unexpectedly suggest that 
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Stat5 is not required for steady state erythropoiesis, although it is worth mentioning 
that these mice are Stat5 hypomorph due to the presence of an in frame CUG codon 
giving rise to expression of a truncated Stat5 protein in erythroid progenitors. This 
truncated Stat5 protein fails to form tetramers, required on most promoters, but it 
can function as a dimer. Conversely, Stat5 dominant negative mutants results in loss 
of terminal differentiation in vitro and Stat5ab-/- derived cells showed compensatory 
upregulation of other Stat-family members and underwent apoptosis upon induction 
of terminal differentiation in vitro (Dolznig et al. 2006).  Exogenous Bcl-XL completely 
rescued this phenotype (Dolznig et al. 2002), supporting the central role of Stat5/
BclXL in Epo-induced survival during terminal differentiation.  
Similar to Epo, SCF and glucocorticoid dependent expansion of erythroid 
progenitors in the spleen of hypoxic mice, foetal liver derived primary erythroid 
progenitors or ES-derived erythroblasts can be expanded in the presence of Epo, 
SCF and glucocorticoids, retaining the capacity to differentiate in mature erythrocytes 
in the presence of Epo alone (Figure 1.1) (Dolznig et al. 2001; von Lindern et al. 2001; 
Carotta et al. 2004).   This cellular system has proven extremely powerful to study the 
effect of key players in erythroid progenitor expansion versus differentiation.  
Figure 1.1  In the model system 
we use, the cooperation of Epo, 
SCF and glucocorticoids induces 
renewal of erythroid progenitors, 
whereas the cells undergo terminal 
differentiation in absence of SCF 
and glucocorticoids. Terminal 
differentiation requires Epo and 
insulin as survival factors and is 
characterised by 3-4 cell divisions 
with cell size reduction, haemoglobin 
accumulation and enucleation. 
Expression of transcription 
factors c-myb, Gata-1 and Nfe2 
indicate maturity of terminally 
differentiating erythroid progenitors. 
Adapted from Kolbus et al. (2003). 
(GR;Glucocorticoid receptor)
Epo and SCF transduce signals via multiple cooperating pathways in erythroid 
progenitors (von Lindern et al. 1999; Wessely et al. 1999; Dolznig et al. 2002; von 
Lindern et al. 2004). Activation of PI3K generates PIP3, which serves as an anchor 
for PH-domain containing proteins, both adaptor molecules such as Gab2 and Dok1 
and kinases such as Tec, Btk, PDK1 and PKB (Tang et al. 1994; Stokoe et al. 1997; 
Leevers et al. 1999; Zhao et al. 1999; Saito et al. 2001).  Although both Epo and 
SCF induce activation of PI3K in erythroid progenitors, the efficiency with which 
downstream signalling pathways are activated shows large differences (Bakker et 
al. 2004; Blazquez-Domingo et al. 2005), suggesting differential susceptibility to 
feedback pathways. Particularly the activation of PKB is much more responsive to 
SCF compared to Epo in in vitro cultured erythroid progenitors (von Lindern et al. 
2001). Active PKB phosphorylates Foxo3a, which results in its cytoplasmic retention 
and inhibits transcriptional activation of p27, p130Rb2, Btg1 and cyclin G2 that all 
inhibit cell cycle progression (Bakker et al. 2004).  PKB, also activates the mTOR/
eIF4E pathway (Blazquez-Domingo et al. 2005) resulting in enhanced translation 
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efficiency of structured mRNAs due to increased levels of eIF4F and in increased 
expression of factors involved in ribosome biosynthesis.  PI3K/mTOR activation 
keeps the balance towards proliferation of progenitors and upon downregulation of 
PI3K, Foxo3a signals execution of terminal differentiation.  
Although the requirement for glucocorticoids in vitro is well proven, its role in 
vivo seems restricted to stress erythropoiesis (Bauer et al. 1999).   Glucocorticoids 
upregulate cell cycle inhibitors and proapoptotic genes in erythroid progenitors as 
well as in lymphoid cells where glucocorticoids induce apoptosis. However, most of 
these genes are counterregulated by SCF. Glucocorticoids also induce genes such 
as c-Kit and Jumonji, known to be critical in hematopoiesis (Kitajima et al. 1999). 
To date, however, it is unclear which glucocorticoid target genes could contribute to 
sustained renewal of erythroid progenitors (Kolbus et al. 2003).  
2.3 Growth factor sensitivity in disease
The high demand for erythrocytes in circulation is satisfied by continuous high level 
of erythroid progenitor expansion and differentiation in the bone marrow.  Hence, 
negative feedback of EpoR signalling is required to prevent erythrocytosis.  EpoR 
mutations resulting in truncations in the C-terminal region lack recruitment of the 
phosphatase SHP-1 resulting in constitutive proliferative signals and hypersensitivity 
to Epo (Klingmuller et al. 1995).  These mutants are associated with Primary familial 
polycythemia (Furukawa et al. 1997) with normal cell maturation and increased blood 
cell production.  Hypersensitivity can be a result of loss of negative feedback but also 
be caused by activating mutations resulting in enhanced proliferation and/or survival. 
For instance the V617F JAK2 mutation (James et al. 2005) is found predominantly in 
Polycythemia Vera (PV) patients, a myeloproliferative disorder (MPD) characterized 
by massive erythrocytosis.  The mutation resides in the kinase inhibitory domain, 
resulting in constitutive JAK2 kinase activity.  The role of constitutive active cytokine 
receptor mutants in MPD and cooperative events that lead to leukaemia has been 
described in Section 1.4.  In human disease, constitutive activating mutations in FLT3 
are found in 30 to 35% of adult AML, N-RAS and K-RAS mutations in 20% and cKIT 
mutations account for 5% of cases (Beghini et al. 2000; Gilliland and Griffin 2002), 
supporting that tyrosine kinase receptor mutations represent collaborative events 
in leukaemogenesis following loss or gain of function mutations in hematopoietic 
transcription factors such as fusion proteins,  C/EBPα and PU1.   
Conversely, in myelodysplastic syndrome (MDS) lack of circulating erythrocytes 
occurs due to impaired responsiveness to Epo (Backx et al. 1992; Hoefsloot et al. 1997) 
or aberrant response to inhibitory cytokines.  Epo stimulation of erythroid progenitors 
derived from MDS bone marrow fail to induce Stat5 DNA-binding (Hoefsloot et al. 
1997), suggesting that dysplastic cells result from maturation commitment without the 
capacity to drive the terminal differentiation program.  In addition, genomic instability 
driven scenescence give rise to progenitors with impaired Epo signalling as shown 
in DNA repair deficient mouse models (M. von Lindern, unpublished), suggesting 
another plausible mechanism to impaired responsiveness to cytokines.  Protection to 
inhibitory cytokines, such as tumour necrosis factor α (TNF-α), TNF-β, interferon-α 
(IFN-α), IFN-β, IFN-γ and transforming growth factor-β (TGF-β) (Majka et al. 2000; 
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Giron-Michel et al. 2002; Verma et al. 2002; Chung et al. 2003) (Section 1.3) is 
compromised due to the impaired signalling. This results in increased susceptibility 
to apoptosis (Fontenay-Roupie et al. 1999) resulting in ineffective hematopoiesis.   
Although many signalling pathways have been unravelled, their effect on gene 
expression program is very fragmentary.   We undertook large-scale gene expression 
profiling to examine modulation of gene expression at the level of transcript 
translation in response to  growth factor signalling.  The results are discussed in 
Chapter 3 and 4. 
Section 3 Translation Initiation
3.1 Translation Initiation mechanism
Gene expression is regulated at the transcription level, producing a cell-specific 
mRNA pool, that undergoes fine tuned translation regulation in response to 
environmental and developmental cues.  Regulation of translation (i) permits fast 
cellular responses to growth factors, inducing specific proteins to be expressed, and 
(ii) enables expression of pro-apoptotic proteins when the transcription program 
is inhibited.  Translation Initiation is an important level of translation control. There 
are two limiting steps in the formation of the initiation complex, namely release of 
initiation factor eIF4E to recruit the eIF4F complex to the cap structure and the 
binding of GTP to initiation factor eIF2.
Protein synthesis is controlled by mTOR that is responsive to growth 
factor stimulation, amino acid uptake and ATP levels.  PI3K/PKB activates mTOR 
(mammalian target of rapamycin, also named Frap, Raft1 or Rapt) through 
phosphorylation of the tumour suppressor complex Tsc1/Tsc2 (tuberous sclerosis 
protein).  Tsc1/Tsc2 releases Rheb (RAS-homologue enriched in brain), a small 
GTPase that positively modulates mTOR function (Figure 1.2) (Inoki et al. 2003). 
Amino acid availability is sensed through Tsc1/Tsc2.  The tumour suppressor 
complex Tsc1/Tsc2 also integrates signals from energy levels through the AMP-
kinase.  
Activation of mTOR results in phosphorylation and activation of S6K (Rps6kb1; 
p70S6 kinase) and hierarchical phosphorylation of 4EBP (4E-Binding Protein) 
(Wang et al. 2005).  Since rapamycin and Wortmannin inhibit both phosphorylation of 
S6K and 4EBP, the PI3K/PKB/mTOR pathway is considered to be a direct signalling 
cascade.  However, a rapamycin resistant S6K1 is still sensitive to wortmannin 
indicating that the PI3K and mTOR signals to S6K1 can be disconnected (Cheatham 
et al. 1995; Weng et al. 1995).  Phosphorylation of 4EBP occurs at multiple sites 
primed by phosphorylation at threonine 37 and 46 (Gingras et al. 1999; Gingras et 
al. 2001). The modest mitogen-stimulated phosphorylation of these sites is resistant 
to rapamycin, indicating activity of other mitogen-dependent kinases (Gingras et al. 
2001).  Rapamycin inhibits phosphorylation of serine 65 and threonine 70 (Gingras et 
al. 2001), indicating that mTOR actively maintains these phosphorylated 4EBP sites. 
The kinase responsible for the phosphorylation event that it is modulated by mTOR is 
unknown (Wang et al. 2005).  Inhibiting protein phosphatases type 1 and 2 prevents 
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Figure 1.2  The PI3K/PKB/
mTOR pathway controls 
mRNA translation.  SCF-
receptor activation results 
in recruitment of PI3K to the 
receptor, which generates 
phosphorylates membrane 
lipids (PIP3) that form an 
anchor for the PH-domain 
containing kinases PDK1 and 
PKB. PIP3 is dephosphorylated 
by the tumour suppressor 
PTEN, which silences the PI3K-
pathway. At the membrane 
PDK1 phosphorylates PKB, 
which phosphorylates the 
tuberous sclerosis tumour 
suppressor genes Tsc1 and 
Tsc2. Upon phosphorylation 
these genes release the 
GTPase Rheb to activate 
mTOR. Activation of mTOR 
results in phosphorylation 
of p70S6 kinase (S6K) and 
eIF4E-binding protein (4E-BP). 
Upon phosphorylation, 4E-
BP releases the cap-binding 
translation initiation factor 
4E (eIF4E), which allows for 
association of eIF4E with the 
proteins that form the eIF4F 
scanning complex and with 
the 40S ribosomal subunit (see 
Figure 1.3).
rapamycin-induced dephosphorylation of 4EBP (Peterson et al. 1999), suggesting 
that mTOR inhibition releases a phosphatase to act on its downstream targets. 
Hence, the mechanism by which mTOR controls 4EBP phosphorylation may entail 
both regulation of a 4EBP-kinase and of the serine/threonine phosphatase PP2A 
(Figure 1.2) (Di Como and Arndt 1996; Murata et al. 1997; Inui et al. 1998; Wang et 
al. 2005). PP2A is the main phosphatase acting on S6K and 4EBP1.  PP2A exists in 
various complexes that shift target specificity depending on the binding of regulatory 
components.  Immunoglobulin binding protein 1 (Igbp1, also named α4) binds to and 
sequestrates PP2A, inhibiting dephosphorylation of 4EBP and S6K.  The PP2A-α4 
complex formation is modulated by mTOR, offering release of negative feedback 
from its own downstream targets 4EBP and S6K (Inui et al. 1998; Kong et al. 2004); 
(Chung et al. 1999).
4EBP hyperphosphorylation results in the release of the mRNA cap-binding 
factor eIF4E (eukaryotic Initiation Factor 4E) (Murakami et al. 2004).  Subsequently, 
eIF4E can bind the scaffold protein eIF4G, which enables the formation of an 
eIF4F scanning complex containing eIF4E, eIF4G and the RNA helicase eIF4A. 
eIF4F associates with several other translation factors and the small subunit of the 
ribosome.  This complex scans the 5’UTR for the first AUG codon in an appropriate 
sequence context (Kozak 2005), where the complete ribosome associates with 
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the methionine-tRNA and all translation factors required for protein synthesis 
(Pestova et al. 2001). The cap-binding eIF4E protein is the rate limiting factor in the 
scanning process (Sonenberg and Gingras 1998) and therefore its release upon 
phosphorylation of 4EBP is a crucial control mechanism in polysome recruitment 
of mRNAs. In addition, eIF4E is phosphorylated by MAP-kinase signal-integrating 
kinases Mnk1 and Mnk2 (Flynn and Proud 1995; Joshi et al. 1995) in response to 
insulin and stress (Waskiewicz et al. 1997). The role of eIF4E phosphorylation is still 
controversial.  Studies show contradictory affinity kinetics to the cap structure upon 
eIF4E phosphorylation on Ser209 (Minich et al. 1994; Scheper et al. 2002).  Reduced 
eIF4E affinity to the cap, might implicate modification needed for re-initiation of 
translation, or inhibition of cap-dependent translation (Scheper et al. 2002).    
The eIF2 complex consists of three peptide chaines (eIF2α, β and γ), and 
binds GTP and methionine-loaded tRNA to form the eIF2·GTP/Met-tRNAi
Met ternary 
complex.  Once the proper AUG is selected methionine is delivered to the translation 
start site at the expense of energy and eIF2·GDP is released.  eIF2·GDP is recycled 
by eIF2B.  eIF2α can be phosphorylated at Serine 51, which inhibits the nucleotide 
exchange in eIF2 by eIF2B (Figure 1.3) (Clemens 2001).  
Figure 1.3  When an AUG in an appropriate Kozak-sequence is reached, eIF2:GTP associated with a 
methionine loaded tRNA can position this first amino acid and facilitate recruitment of the 60S ribosomal 
subunit to start protein synthesis. This delivery of methionine requires energy and eIF2:GDP leaves the 
complex to be recharged to eIF2:GTP by eIF2B. When eIF2 is phosphorylated by any of the 4 stress 
eIF2 associated kinases (eIF2ak1-4) such as haem-responsive inhibitor (HRI), P-eIF2 still associates 
with eIF2B, but eIF2B can no longer recharge eIF2:GDP to eIF2:GTP, which precludes loading with 
methionine-tRNA.
Phosphorylation of eIF2α plays an important role in translation regulation 
by various physiological cell stress conditions.  The eIF2α kinases HRI, PKR, PEK 
and GCN2 phosphorylate and inhibit eIF2α in response to haeme levels, viral 
infection, ER stress and low nutrients respectively (Figure 1.4) (Wek et al. 2006). In 
erythrocytes, the haeme-regulated eIF2α kinase (HRI) phosphorylates and inhibits 
eIF2α in response to low haeme levels to prevent production of excess globin 
peptides (Han et al. 2001).  
The regulation of translation initiation complex formation and assembly to 
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RNA transcripts offers a possibility to control translation at a global level and at the 
level of specific transcripts. Whereas global levels are relatively mildly regulated, 
specific transcripts can fully depend on regulatiuon by translation as a function of 
regulatory elements (Figure 1.4) (Graff et al. 1997; Clemens and Bommer 1999; 
Graff and Zimmer 2003).  
Because eIF4E is under direct control of the PI3K/mTOR pathway, we examined the 
role of eIF4E on erythropoiesis (chapter 2).
3.2 Translation Initiation sensitivity to  eIFs
3.2.1 Regulation of eIF4F-sensitive transcripts
Overexpression of the limiting translation initiation factor eIF4E can transform 
fibroblasts (Lazaris-Karatzas et al. 1990). Our results indicated that overexpression 
of eIF4E inhibited erythroid differentiation (Blazquez-Domingo et al. 2005). 
Sequestering eIF4E by overexpressing an mTOR-insensitive 4E-BP1 results in cell 
cycle inhibition (Fingar et al. 2004).  These observations indicate that free, active 
eIF4E attributes to transformation capacity.  Although eIF4E and its associated 
factors are general translation factors, they bind and scan mRNAs with a short 
and simple 5’ Untranslated Region (UTR) much more efficiently than mRNAs with 
a long and structured 5’UTR (De Benedetti and Graff 2004).  Secondary structures 
in the 5’UTRs of transcripts can result in structural hindrance that inhibits ribosomal 
scanning (Manzella and Blackshear 1990).  Translation block can be released by 
removal of the structural elements or by overexpression of eIF4E (Manzella et al. 
1991; Shantz et al. 1996; Koromilas et al. 1992).  eIF4E sensitivity implies a direct 
role of eIF4E in melting complex 5’UTR sequences (Methot et al. 1996).  Interestingly, 
S6K1 phosphorylates eIF4B, which is important for the recruitment of the helicase 
complex to the pre-initiation complex (Holz et al. 2005).  In addition to structures with 
high enthalpy other variables such as the relative distance of hairpin loop structures 
from the 5’ methyl G cap (Babendure et al. 2006) and association of structures with 
specific proteins can dictate translation efficiency.  Structured mRNAs encode for 
growth promoting proteins such as VEGF, ODC, Igbp1 and Uhmk1 (De Benedetti 
and Harris 1999; Graff and Zimmer 2003; Manzella and Blackshear 1990; Godfrey 
Grech submitted).  
A particular type of structured mRNA are TOP-mRNAs. The TOP (terminal 
oligopyrimidine tract) sequence confers selective translation to a given mRNA as 
it renders polysome recruitment dependent on mTOR activation (Jefferies et al. 
1997). TOP sequences are present in mRNAs encoding ribosomal proteins and 
elongation factors (Terada et al. 1994) to render the energy consuming process of 
ribosome biogenesis dependent on the presence of mitogenic factors and nutrients. 
The involvement of S6K as a downstream effector of mTOR in the regulation of TOP 
mRNAs has been challenged by analysis of S6K knockout mice (Barth-Baus et al. 
2002). This strongly suggests that additional factors are involved. One preliminary 
study suggests that a TOP-sequence binds an inhibitory factor that can be depleted 
from cell extracts (Biberman and Meyuhas 1999).   
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3.2.2 eIF2α phosphorylation and AUG selection
Recognition of an AUG codon depends on the sequence context. The better an 
initiation codon resembles the consensus sequence (A/GnnAUGG), the more 
efficiently it will be recognised by the eIF2-ternary complex (Kozak). The initiation 
codon of the protein coding ORF mostly lies in a perfect Kozak sequence.  The 
5’UTR may contain additional upstream AUGs (uAUG) resulting in upstream open 
reading frames (uORF). These usually inhibit translation efficiency. First, ribosome 
dissociation at the end of the uORF may end transcript scanning. Second, the peptide 
encoded by the uORF may actively interfere with the pre-initiation scanning complex. 
Activation of the eIF2 associated kinases e.g. by lack of haeme or amino acids, 
reduces available ternary complex and restricts AUG recognition to codons within 
a Kozak sequence. Phosphorylation and inhibition of eIF2α limits the formation of 
initiation complex at a potential AUG. However, it also alters the relative expression 
of uORF and encoded protein because it alters the efficiency with which different 
Kozak sites are recognised. A particular condition that has been found in several 
transcripts in an uORF out of frame with the protein coding ORF, but overlapping 
the initiation codon of the protein coding ORF. This implies that the uORF has to be 
skipped to allow protein expression, indicated as leaky scanning.  Leaky scanning 
of AUG codons is involved in translation control of GCN4 (Hinnebusch 1993), ATF4 
(Blais et al. 2004; Vattem and Wek 2004), C/EBP (Calkhoven et al. 2000) and Scl/Tal 
(Calkhoven et al. 2003). Interestingly, recovery from translation initiation inhibition 
during low eIf2 availability requires leaky scanning of an inhibitory uORF in activating 
transcription factor 4 (ATF4) transcript (Wek et al. 2006) promoting translation of 
ATF4 and transcription of its target Gadd34.  This results in dephosphorylation of 
eIF2α (Patterson et al. 2006).    
Differential expression of functional isoforms of the hematopoietic transcription 
factors is also under control of selective translation initiation site recognition. An 
alternative AUG in the open reading frame (ORF) of Gata1 is preferred at low 
eIF2 activity, resulting in a truncated protein with similar binding activity to form 
heterodimers, but a different transactivation potential (Calligaris et al. 1995). The 
transcripts of several Ets-family members, Scl/Tal and C/EBPα and β contain an 
uORF that, out of frame, overlaps the AUG start codon of the full length isoform 
of the transcription factor. (Calkhoven et al. 2000; Calkhoven et al. 2003). Because 
the uAUG of the overlapping uORF starts with an uAUG in a suboptimal Kozak 
consensus, it is only at enhanced availability of eIF2α:GTP and eIF4E, that the 
uORF is translated, the initiation codon of the full length protein is skipped and a 
downstream AUG codon is selected. This results in a truncated transcription factor 
protein that acts as a dominant negative isoform.    
The importance of the relative abundance of C/EBPα isoforms is evidenced 
by the occurrence of mutations in acute myeloid leukaemia (AML) cases that inhibit 
translation of the full-length C/EBPα protein (Pabst et al. 2001).  The functional 
30kDa truncated protein expressed in these patients was shown to inhibit G-CSF 
receptor in 32Dcl3 cells induced to differentiate into neutrophils (Cleaves et al. 2004). 
Introducing the full length Scl in mouse bone marrow cells favoured megakaryocytic 
development over erythroid commitment of the megakaryocytic/erythroid progenitor 
(Calkhoven et al. 2003) (Figure 1.5). 
The list of transcripts regulated at the level of alternative AUG usage in 
Chapter 1
22
hematopoietic regulation is increasing (Liu et al. 1999; Liu et al. 2005).  This leaves 
us with the question of what portion of the mRNA pool is controlled at the level of 
translation.  The incomplete information on full length 5’UTR sequences is still a 
hurdle in these types of analysis.  Using oligo-capped cDNA libraries (Suzuki et al. 
2000), 954 full length 5’UTRs were determined and analysed for the occurrence 
of upstream AUGs.  29% of the UTRs contained at least one AUG upstream of the 
proper initiation codon, represented by 569 uAUGs.  These were further classified 
on the basis of being in frame or out of frame with the coding sequence and for 
having (uORF) or not a terminator codon.  41% of uAUGs were defined as uORFs 
potentially regulating translation efficiency and selection of AUG usage to drive 
isoforms, 7% without a termination codon and being in frame suggesting prolonged 
N-termini and 12% without a stop codon and being out of frame. Interestingly 359 
uAUGs in 211 UTRs adequately satisfy Kozak’s consensus.  These percentages 
indicate that translation initiation control by uAUG and uORFs may represent a 
regulatory event that is more common than expected.  Translation initiation inhibition 
of growth regulatory proteins (growth factors, cytokines, oncogenes, repressors of 
tumour suppressor inhibitors and others) is a known phenomenon (Kozak 1991) 
and this may be extended to regulatory proteins that attenuate cellular terminal 
differentiation.
Figure 1.4  Translation Initiation control during Growth Factor stimulation, cellular stress and 
cellular physiology.  Growth factor addition activates the PI3K/PKB/mTOR pathway releasing the 
limiting translation initiation factor 4E (eIF4E) from a repression complex with 4EBP and activating 
S6K resulting in enhanced cap-dependent translation efficiency of structured mRNAs, and ribogenesis. 
Interestingly, the tumour suppressor proteins PTEN, Tsc1/2 and Pp2a are involved in attenuating this 
pathway.  Another limiting initiation factor, eIF2α is involved in providing methionine-tRNA in a complex 
with the 60S ribosome subunit to start peptide synthesis once the proper AUG is recognised. eIF2 is 
phosphorylated by GCN2, PEK, HRI or PRK in response to various stress conditions. Low levels of 
eIF4E and eIF2-GTP as a result of 4EBP repression or stress-induced eIF2 phosphorylation respectively, 
repress cap-dependent translation.  These conditions are optimal for translation initiation from Internal 
Ribosomal Entry Sites (IRES).  The levels of eIFs modulate translation initiation and this depends on 
the codes offered by the transcripts.  Some transcripts are ideal to be translated under stress conditions 
having IRES structures in their 5’UTRs, others have secondary structures that are difficult to melt and 
hence hinder the scanning process.  The presence of uORFs, attenuates translation initiation and also 
have a role in protein isoform formation.  RNA-binding proteins modulate specific mRNAs by stabilising, 
silencing or activating the transcripts.  These RNA/protein complexes (RNPs) have an important role 
in cellular physiology.  Some RNPs respond to oncogenic signals, while others are covalently modified 
and drive translation in response to terminal differentiation signals as in the case of the DICE elements. 
[Translation Initiation factors in bold]
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Figure 1.5 Translation initiation control relays signals to erythroid and granulocytic differentiation. 
SCF binds c-kit, a Receptor Tyrosine Kinases (RTK), activating PI3K/mTOR pathway in the same way as 
constitutive active mutant RTKs and kinase active fusion protein, BCR/ABL.  mTOR downstream effector 
proteins are maintained active by attenuating the phosphatase Pp2a  which is inhibited by SCF-driven 
Igbp1/alpha4 expression and enhanced expression of SET in response to BCR/ABL.  High activity of 
translation initiation factors enhances polysome recruitment of structured mRNAs and delays erythroid 
terminal differentiation.  During erythroid terminal differentiation the balance between globin synthesis and 
haeme biosynthesis is under the tight control of translation initiation.  Iron Responsive Element (IRE) in 
the UTRs of ferritin and transferin modulate iron uptake and storage in accordance to demand of haeme. 
Low cellular iron levels triggers phosphorylation of eIF2α to reduce the production of globin proteins. 
High eIFs levels also regulate commitment to the erythroid or megakaryocytic lineage by selective usage 
of AUGs in the SCL transcript driving different isoform production.  The same mechanism is used to 
produce truncated isoforms of the transcription factor C/EBPα that acts as a dominant negative form of 
the full length and hence inhibits granulocytic terminal differentiation.  Another form of translation control 
is involved in regulation of C/EBPα transcription activity.  Full length C/EBPα enhances transcription 
of micro RNA 223 (mRNA-223), an inhibitor of NFI-A translation.  NFI-A is a competitor for binding 
C/EBPα DNA sites and hence its inhibition results in a positive feedback loop driving granulocytic 
differentiation.  In addition to transcription inhibition of full length C/EBPα driven by selective AUG usage 
or translation silencing of competitors, the role of RNA-binding proteins is important in modulating terminal 
differentiation.  BCR/ABL enhance the expression of hnRNPE2 that binds the UTR of C/EBPα transcript 
and inhibits translation.  
3.2.3  Cap Independent translation
Regulatory elements at the 5’UTR of mature transcripts render translation 
dependent on signalling or other environmental conditions such as iron availability. 
Some transcripts however have a highly structured 5’UTR meant to completely 
block cap-dependent translation initiation.  Translation initiation reverts to internal 
ribosome entry sites (IRES). The structural complexity of IRES elements argue in 
favour of their role as translation inhibitors, although it is more correct to define these 
structures as modulators of translation.  For instance although the 5’UTR of platelet-
derived growth factor (PDGF2) is long (1022bp), structured and contains upstream 
ORFs, it is efficiently translated during megakaryocytic differentiation via binding and 
activation of the IRES by hnRNP C (Figure 1.4) (Bernstein et al. 1995; Sella et al. 
1999).  Hence, specificity of IRES-mediated gene expression is determined by IRES 
trans-acting factors (ITAFs), present in a particular cellular state.   
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Section 4  Control of Translation beyond the Initiation stage
4.1 Translation elongation regulation
Whilst translation initiation can regulate specific transcripts depending on 
transcript structure and the physiological state of the cell, general translation can 
be modulated via regulation of peptide elongation.   The elongation factor, eEF1A 
recruits amino acyl-tRNA at the expense of GTP (Sheu and Traugh 1997) and eEF2 
is required for ribosomal translocation during elongation (Ryazanov and Davydova 
1989).  Interestingly, eEF2-dependent ribosome translocation is inhibited upon 
phosphorylation by eEF2 kinase (Redpath et al. 1993).  S6K phosphorylates and 
inactivates eEF2 kinase enhancing efficiency of general translation elongation in an 
mTOR-dependent manner (Wang et al. 2001).     Response to signals to attenuate 
translation machinery is physiologically relevant to minimize the utilization of energy 
in unnecessary processes and in the case of elongation to retain translational fidelity 
(Carr-Schmid et al. 1999).   
4.2 RNA-binding proteins: transcript stability and translation control 
mRNA translation is regulated by activities of the translation machinery components 
as described above but also via regulation of proteins that bind to specific mRNAs. 
RNA binding protein complexes attenuate expression by modulating stability, 
degradation, cellular localisation and silencing of specific RNAs or subgroups of 
mRNAs.  The most studied RNA-binding proteins present in ribonucleoprotein 
(RNP) particles are the heterogeneous nuclear ribonucleoproteins (hnRNPs) that 
recognize AU-rich elements (ARE) and coordinate expression of mRNAs at the level 
of nuclear-cytoplasmic shuttling (Veyrune et al. 1996), cytoplasmic mRNA turnover 
(Shaw and Kamen 1986) and silencing of cell state- and type-specific mRNAs 
(Ostareck et al. 1997; Notari et al. 2006). The ARE is located in the 3’ untranslated 
region of many short-lived transcripts from cytokines, proto-oncogenes, growth 
factors or cell cycle regulators (Bakheet et al. 2001).  Interestingly, Tristetraprolin 
(TTP) and Butyrate response factor (BRF1) belong to the same protein family and 
both promote ARE-dependent mRNA decay.  Mice lacking TTP suffer from systemic 
inflammatory syndrome as a consequence of enhanced secretion of TNFα and GM-
CSF, the products of two ARE-containing mRNAs (Taylor et al. 1996). Mice lacking 
BRF1 showed embryonic lethality due to chorioallantoic fusion defects (Stumpo et 
al. 2004). This indicates that the proteins have preferential substrates.  Different 
classes of ARE are defined, Class I contains dispersed AU motifs, present in nuclear 
transcription factors and proto-oncogenes; Class II contains tandem AU motifs 
present in inhibitory cytokines, and Class III contains U-rich sequence but lack the 
canonical AUUUA motif. In contrast to TTP and Brf1, members of the ELAV family 
of RNA-binding proteins (eg. HuR), bind and stabilize ARE-containing transcripts 
(Ford et al. 1999).   Interestingly, in the context of a closed loop model of translated 
eukaryotic mRNAs, the recruitment of HuR and other RNA binding proteins to 3’UTR 
elements results in the formation of complexes between HuR and the scanning 
ribosome at the 5’UTR. This stabilises the transcript and may facilitate translation 
initiation at the proper AUG in transcripts with a structured 5’UTR(Mehta et al. 2006) 
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Interactions between RNA-protein complexes at the 3’UTR the pre-initiation scanning 
complex may also allow repositioning of ribosomes across inhibitory structures 
(Figure 1.3). Thus sequences in the 3’UTR may cooperate with translational control 
elements the 5’UTR.  In addition, modification of RNA binding-proteins by signalling 
can be another level of regulating translation efficiency at the proper AUG.  Silencing 
of transcripts by binding of hnRNP K and hnRNP E1 to differentiation control element 
(DICE) in the 3’ UTR of 15-lipoxygenase (LOX) mRNA transcript (Ostareck et al. 
1997), can be released during terminal erythroid differentiation by phosphorylation 
of hnRNP K (Habelhah et al. 2001; Ostareck-Lederer et al. 2002). 
Several other examples show that phosphorylation of RNA-binding proteins 
modulates transcript stability and/or translation, but the exact mechanism is mostly 
unknown. For example: (i) the activity of BRF1 to promote ARE-dependent decay 
is strongly reduced by protein kinase B (PKB) phosphorylation at serine 92 of 
BRF1 (Schmidlin et al. 2004), and (ii) p38 stabilises AU-rich mRNA transcripts 
that are involved in apoptosis (Dean et al. 2004). TPA (12-O-tetradecanoylphorbol-
13-acetate)-induced monocytic differentiation results in enhanced IRES-driven 
translation of p27 (Kip1) suggesting modulation of cell cycle and differentiation 
by internal ribosome recruitment (Cho et al. 2005).  Induction of megakaryocytic 
differentiation in K562 cells, results in PKR-dependent IRES-activation of platelet-
derived growth factor (Gerlitz et al. 2002).  
Interestingly, phosphorylation of ribosomal protein L13a by Interferon-gamma 
results in dissociation of L13a from the 60S ribosome subunit and recruitment 
of an Rpl13-containing protein complex to a structural element in the 3’UTR of 
ceruloplasmin (Mazumder et al. 2003) resulting in translation repression.  This 
mechanism incorporates 2 novel issues.  First, the ribosome is able to present 
signalling sensitive factors that can be released to attenuate translation of specific 
transcripts without affecting global synthesis rates.  Second, regulatory elements 
in the 3’UTR recruit protein complexes within the circular mature transcripts and 
interact with scanning complexes in the 5’UTR, hence modulating translation 
initiation efficiency.  
Organisation of RNAs into functional subgroups that are responsive to extrinsic 
and intrinsic factors (Keene and Lager 2005) underlines a relatively unexplored 
aspect of gene expression modulation that might drive cell fate in the same manner 
as regulation of the transcriptome by transcription factors.  This is exemplified for 
transcripts that contain internal ribosome entry site (IRES) that are modulated by 
IRES trans-acting factors (ITAFs) as described in section 3.2.3.  
The identification of a large number of transcripts subject to growth factor dependent 
translation made it possible to investigate which RNA structures and sequences may 
contribute to this translational control (chapter 5 and discussion).
4.3 Translation silencing by specific miRNAs
MicroRNAs (miRNAs) are endogenous duplexes of 19-22 nucleotides that regulate 
gene expression by targeting repression complexes to selected transcripts, inducing 
either degradation or translation repression (Bartel 2004).  Primary transcripts of 
miRNAs are transcribed by polymerase II as long, capped, polyadenylated and 
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spliced RNAs (Lee et al. 2004).  To produce mature miRNAs, the pre-RNAs are 
processed by nuclear and cytosolic RNaseIII-type endonucleases, namely Drosha 
and Dicer.  The resulting miRNA duplexes are loaded into RNA-induced silencing 
complex (RISC) where one of the strands is engaged in imperfect base pairing with 
selected sequences in target mRNAs (Bartel 2004).  Sufficient complementarity to 
the target mRNA triggers cleavage and degradation of the mRNA, or the transcript 
is translationally repressed if suitable homology permits formation of the complex 
on the mRNA (Zeng and Cullen 2003).  Studies on translation repression of lin-
14 by lin-4 miRNA in the nematode C. elegans showed that polysome loading is 
retained suggesting that repression occurs independently of translation initiation. 
One possible mechanism is to stall or slow ribosome on the transcript, although 
degradation of nascent peptide cannot be ruled out (Olsen and Ambros 1999). In 
mammalian cells premature dissociation of ribosomes accounts for miRNA silencing 
(Petersen et al. 2006). 
miRNAs constitute a new level of gene expression regulation with a role in 
maintenance of multiple cellular functions in a temporal and cell-specific manner. 
miRNAs that are preferentially expressed in murine hematopoietic tissues may 
target specific effectors to modulate normal hematopoiesis.  In fact, miR-181 is 
strongly expressed in the thymus, miR-223 in the bone marrow and miR-142 in 
all hematopoietic compartments (Chen et al. 2004).  In the same study ectopic 
expression of miR-181 in murine multipotent progenitors enhanced B lineage, giving 
evidence of miRNA involvement in hematopoietic lineage commitment. 
Interestingly, retinoic acid-induced granulocytic differentiation results in 
increased expression of miR-223. miR-223 represses the transcription factor NFI-A, 
releasing C/EBPα DNA-binding sites (Figure 1.5).  The presence of C/EBPα binding 
sites in the miRNA-223 promoter region, represents an auto-regulatory circuitry.  A 
2-fold induction in granulocytic commitment was observed upon overexpression 
of miR-223 in NB4 cells (Fazi et al. 2005).   The high expression of miR-221 and 
miR-222 in human cord blood-derived CD34+ progenitor cells decreased during 
unilineage erythroid commitment.  Forced expression of these miRNAs in CD34+ 
derived erythroid culture inhibited cell proliferation concomitant with reduced levels 
of c-kit protein levels (Felli et al. 2005). 
Section 5  Biology of Abnormal Hematopoiesis – the role of 
translation control
Much progress has been made in understanding the role of transcription factors 
(Tenen et al. 1997; Friedman 2002) and dynamic protein complexes that regulate gene 
transcription (Dang et al. 2000; Westman et al. 2002; Suzuki et al. 2003; Rodriguez et 
al. 2005).  Selective recruitment of transcription complexes that specify the repression 
or activation of transcription, does not only require recognition of responsive 
elements in the DNA, but also post-translational modification of transcription factors 
that influences their interaction and activity (Tootle and Rebay 2005). The most 
common modifications are phosphorylation, acetylation, methylation, ubiquitination 
(Yang 2005; Gregoire et al. 2006). In addition, modifications of histones controls not 
only the activity of polymerases, but also the accessibility to chromatin (Freiman 
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and Tjian 2003).  Attention to transcription regulatory complexes in hematopoietic 
progenitors has been accelerated by the observation that transcription factors are 
frequently involved in translocations associated with AML (Tenen 2003).  In addition, 
studies show that the dynamics of transcription factor recruitment to promoter sites 
determines the onset of terminal differentiation as opposed to cell proliferation 
(Goardon et al. 2006).  
Transcription control and protein modification is only part of the molecular 
biology of haematological disease.  It is well accepted that mitogenic factors control 
ribosome biosynthesis and mRNA translation efficiency, which is required to ensure 
that cell growth (i.e. cell mass production) is coupled to cell proliferation  (Alvarez et 
al. 2003).  In addition to this simple view, translation control offers an efficient and 
rapid mechanism to acquire gene expression profiles that promote tumorigenesis 
and cancer progression (Audic and Hartley 2004; De Benedetti and Graff 2004). 
However, standard RNA expression profiles have not given insight into regulation 
at this level of gene expression indicating that the role of translation control in 
haematological disease has been greatly underestimated.  
5.1 Translation attenuation and isoform formation
Molecular lesions associated with disturbed translational control of cytokines 
and disturbance of transcription factor isoforms ratios has been implicated in 
haematological diseases.  Translation attenuation of cytokines is exemplified by 
mutations found in Hereditary thrombocythemia (HT).  Thrombopoeitin (TPO) is a 
potent cytokine driving megakaryopoiesis and platelet production, which is under 
translation initiation repression by the use of seven uAUGs driving five short uORFs 
(Ghilardi et al. 1998).   A G526T transversion in the untranslated region of TPO 
creates a stop codon, shortening the inhibitory uORF and resulting in enhanced 
ribosome re-initiation at the proper AUG (Ghilardi et al. 1999).   A mutation identified 
within the splice donor of intron 3 results in alternative splicing omitting inhibitory 
uORFs from the 5’UTR of TPO (Wiestner et al. 1998).  
As described previously (section 3.2.2), the relative abundance of C/EBPα 
isoforms is perturbed in some AML by the occurrence of mutations that inhibit 
translation of the full-length C/EBPα protein (Pabst et al. 2001). From studies on 
children with trisomy 21, acquired mutations in GATA1 account for the exclusive 
production of a short isoform, Gata1s, as a result of initiation at a downstream AUG 
relative to the proper start codon.  Hence the short isoform lacks the N-terminal 
domain resulting in decreased transactivating potential (Calligaris et al. 1995).  All 
cases develop transient myeloproliferative disorder (TMD) and acute megakaryocytic 
leukaemia (AMKL) (Calligaris et al. 1995; Wechsler et al. 2002; Gurbuxani et al. 
2004). The occurrence of preferential megakaryocytic lineage commitment in 
these disorders suggest that in normal hematopoiesis a non-mutated GATA1 
mRNA can be regulated at the level of alternate AUG usage to express differential 
isoforms (Calligaris et al. 1995) as exemplified by SCL isoform ratio in erythroid vs 
megakaryocytic commitment (Calkhoven et al. 2003).   
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5.2 Signalling deregulation in leukaemia transformation
Mutations that enhance the translation machinery also play a central role in 
enhanced aggressiveness of various human cancers including AML (Longley et 
al. 2001).  The D816V mutation in the kinase domain of cKit activates the PI3K/
PKB/mTOR pathway conferring sensitivity to rapamycin (Gabillot-Carre et al. 2006). 
Interestingly, rapamycin induces cell cycle arrest and apoptosis in patient-derived 
neoplastic mast cells harbouring the D816V cKIT, but not in normal human cord-
blood derived mast cells (Gabillot-Carre et al. 2006).  This implies that inhibitors 
targeting translation initiation regulators are therapeutic candidates in the treatment 
of aggressive systemic mastocytosis (associated with cKIT D816V) and AML 
harbouring the D816V cKIT mutant that is present in 10 to 40% of core-binding factor 
leukaemia (Beghini et al. 2000).  Another line of interest for therapeutic approaches 
is the use of IC87114, a specific inhibitor of PI3K Class 1 p110δ.  p110δ is 
constitutively expressed at high levels in blast cells of AML (Billottet et al. 2006) and 
IC87114 induces death of leukaemic blasts with no affect on normal haematopoietic 
progenitor cells (Sujobert et al. 2005; Billottet et al. 2006).  The frequency of active 
PI3K is higher than the incidence of mutations in RAS or in the receptor tyrosine 
kinases (RTK) FLT3 and cKIT (Cornillet-Lefebvre et al. 2006), suggesting the need 
for targeting PI3K downstream effectors.  Phosphatases that attenuate kinase 
activity are eligible for targeting.  The phosphatases, PTEN and Pp2a attenuate 
the PI3K/mTOR pathway, directly effecting ribosome biosynthesis and translation 
initiation (Podsypanina et al. 2001; Backman et al. 2002; Blazquez-Domingo et al. 
2005).   Pharmacological inactivation of mTOR with rapamycin reduces neoplastic 
proliferation (Podsypanina et al. 2001) in PTEN deficient mice, and reverses tumour 
growth in cancer cells characterised by activated PKB (Neshat et al. 2001). This 
suggests a central role of enhanced protein synthesis in neoplastic transformation. 
In addition, the leukaemic potential of BCR/ABL-expressing cells can be inhibited 
by pharmacological activation of the phosphatase Pp2a (Neviani et al. 2005).  This 
suggests a central role of deregulated PI3K/mTOR/translation machinery in CML (Ly 
et al. 2003; Gingras et al. 2004).  
Interestingly, the expression of RNA-binding proteins that attenuate translation 
of specific subsets of mRNAs (Perrotti et al. 2005), has been implicated in the 
transition from chronic CML to blast crisis events (Perrotti et al. 2003; Perrotti and 
Calabretta 2004) by suppressing differentiation (Perrotti et al. 2002) and increasing 
resistance to apoptosis (Trotta et al. 2003).  For instance, ectopic expression of 
hnRNP E2, an RNA-binding protein upregulated during blast crisis of CML, resulted 
in downregulation of C/EBPα and G-CSFR in myeloid progenitor cells, inhibiting 
granulocytic differentiation (Perrotti et al. 2002).  
In conclusion, modulation of signalling directed to the PI3K/mTOR/eIF4E 
pathway via activating mutants in RTKs and repression of phosphatases predisposes 
to hyperproliferation (Neviani et al. 2005) and block of differentiation (Blazquez-
Domingo et al. 2005). The concomitant modulation of transcription factor isoforms, 
in response to translation initiation factor levels, strengthens the importance of 
translation control as a pharmaceutical target in haematological disease.   
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Scope of the thesis
Erythroid progenitors can be induced to undergo renewal divisions in presence 
of Epo, SCF and glucocorticoids, whereas the same cells mature to erythrocytes 
in presence of Epo. This model has proved to be useful to study how SCF can 
sustain proliferation and inhibit differentiation of progenitor cells. The main objective 
of the study described in this thesis is to understand how Epo/SCF-controlled 
gene expression regulates the balance between proliferation and differentiation of 
erythroid progenitors. To achieve this goal we performed gene expression profiling 
using polysome bound mRNA from cells that are deprived from and re-stimulated 
with Epo plus SCF, and from cells at different stages of differentiation. Interestingly, 
we observed that Stem Cell Factor (SCF) transduced signals are not only capable 
to regulate gene expression at the level of gene transcription, but also at the level 
of polysome recruitment, hence translation initiation. The cap-binding translation 
initiation factor 4E (eIF4E) is an important target of the PI3K/PKB/mTOR signalling 
pathway. Overexpression of eIF4E inhibited differentiation of erythroid progenitors, 
similar to addition of SCF.  This observation prompted us to identify eIF4E sensitive 
transcripts that are recruited to polysomes in response to SCF. Through comparison 
of Epo/SCF-controlled gene expression in polysome bound RNA versus total 
mRNA, we were able to identify a unique list of genes encoding transcripts with 
signalling-dependent polysome loading that are potentially involved in SCF-
repression of erythroid differentiation. Nine genes with a predicted function in signal 
transduction or gene expression regulation were selected to study their expression 
regulation in more detail and to examine their biological role in erythropoiesis. These 
studies revealed that Igbp1 (Immunoglobulin binding factor 1) blocked erythroid 
differentiation. Igbp1 is one of the regulatory subunits of the phosphatase Pp2a (also 
designated α4) and sequestrates the active subunits from dephosphorylating mTOR 
targets, hence maintaining activity resulting in enhanced translation initiation and 
ribogenesis.
Finally, we addressed mechanisms of translation control of these transcripts. 
We screened for regulatory elements within the untranslated regions (UTRs) of 
these transcripts, and initiated functional assays. 
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ABSTRACT
Stem cell factor (SCF) delays differentiation and enhances expansion of erythroid 
progenitors. Previously, we performed expression profiling experiments to link 
signaling pathways to target genes using polysome-bound mRNA. SCF-induced 
phosphoinositide-3-kinase (PI3K) appeared to control polysome recruitment of 
specific mRNAs associated with neoplastic transformation. To evaluate the role of 
mRNA translation in the regulation of expansion versus differentiation of erythroid 
progenitors, we examined the function of the eukaryote initiation factor 4E (eIF4E) 
in these cells. SCF induced a rapid and complete phosphorylation of eIF4E-binding 
protein (4E-BP). Overexpression of eIF4E did not induce factor-independent growth, 
but specifically impaired differentiation into mature erythrocytes. Overexpression of 
eIF4E rendered polysome recruitment of mRNAs with structured 5’-untranslated 
regions largely independent of growth factor and resistant to the PI3K inhibitor 
LY294002. In addition, overexpression of  eIF4E rendered progenitors insensitive 
to the differentiation inducing effect of LY294002, indicating that control of mRNA 
translation is a major pathway downstream of PI3K in the regulation of progenitor 
expansion. 
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INTRODUCTION
Leukemia may arise through mechanisms that enable proliferation and survival 
of normal cells when expansion of the progenitor pool is required. Control of the 
balance between expansion and maturation by cytokines and growth factors is such 
a mechanism. While erythroid progenitors require erythropoietin (Epo) to mature 
into erythrocytes, the progenitor pool can be expanded both in vivo and in vitro in 
response to the cooperative action of Epo, stem cell factor (SCF) and glucocorticoids 
(Broudy et al. 1996; Bauer et al. 1999; Dolznig et al. 2001; von Lindern et al. 2001). 
SCF cooperates with Epo to suppress differentiation and sustain renewal divisions 
of erythroid progenitors. Cooperation of SCF and cytokines is also observed in 
other hematopoietic progenitors (Broxmeyer et al. 1991). A mutated SCF receptor 
(v-Kit) was initially identified as a viral oncogene in a feline leukemia virus (Qiu et 
al. 1988). Mutations in c-Kit that induce constitutive activity are found specifically in 
t(8;21) and inv(16) leukemia, but autocrine loops activating c-Kit are also  reported 
in other types of leukemia (Beghini et al. 2000; Zheng et al. 2004). In an avian model 
system, SCF cooperates with oncogenic MLL fusion genes to transform lympho-
myeloid multipotent progenitors (Schulte et al. 2002). Furthermore, activating c-Kit 
mutations are common in gastrointestinal stromal tumors (GIST; Kim et al. 2004) 
and in bilateral testicular germ-cell tumors (Looijenga et al. 2003). This suggests that 
inhibition of erythroid differentiation by SCF may exemplify a more general role of 
SCF in the regulation of cell growth and differentiation.
The expansion of erythroid progenitors in the presence of SCF is abrogated 
by the phosphatidylinositol 3 kinase (PI3K) inhibitor LY294002 (von Lindern et al. 
2001), resulting in terminal differentiation instead. An important effector of PI3K 
is Protein kinase B (PKB), which controls cellular processes such as cell cycle 
progression, apoptosis and mRNA translation through phosphorylation of e.g. 
Forkhead transcription factors, the proapoptotic protein Bad and the mammalian 
target of rapamycin (mTOR) (Datta et al. 1999; Gingras et al. 2001; Proud 2002; 
Alvarez et al. 2003; Bakker et al. 2004; Fingar et al. 2004). To identify critical pathways 
and targets downstream of SCF-signaling, we performed profiling experiments using 
polysome-bound mRNA to detect those mRNAs that are expressed and translated 
into protein. Expression of the putative oncogene, nucleoside diphosphate kinase 
B (Ndpk-B also known as Nm23-M2 or Nme2), appeared to be regulated by SCF. 
Regulation did not occur at the level of gene transcription, but exclusively through the 
recruitment of its mRNA into polysomes, which was fully dependent on PI3K activity 
(Joosten et al. 2004). As selective recruitment of mRNAs into polysomes appears 
to be an important regulatory mechanism in cell growth control and tumorigenesis 
(Rajasekhar et al. 2003; Bader and Vogt 2004), we examined the role of mRNA 
translation in PI3K-dependent control of expansion and differentiation of erythroid 
progenitors.
The mRNA cap-binding eukaryote Initiation Factor 4E (eIF4E) recruits the 
scaffolding protein eIF4G, which associates among others with the mRNA helicase 
eIF4A and the small subunit of the ribosome. This complex scans the 5’ untranslated 
region (5’UTR) of mRNA until an appropriate AUG is recognized. In binding to the 
limiting factor eIF4E, eIF4G has to compete with the 4E-binding proteins (4E-BP). 
Unphosphorylated 4E-BP binds and inhibits eIF4E, but eIF4E is released upon 
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phosphorylation of 4E-BP by the mTOR kinase (Gingras et al. 1999a). The increased 
availability of eIF4E is associated with cell proliferation (Fingar et al. 2004). Increased 
levels of eIF4E are detected in a number of solid tumors, especially in breast, colon 
and head/neck tumors (De Benedetti and Harris 1999). Interference with translation 
initiation via overexpression of a mTOR-insensitive 4E-BP1 results in the inhibition 
of the cell cycle progression (Fingar et al. 2004). These observations suggest that 
the availability of eIF4E in translation initiation attributes to neoplastic transformation. 
In addition, it has also been suggested that eIF4E enhances nucleocytoplasmic 
transport of specific transcripts. Aberrant regulation of eIF4E-dependent mRNA 
transport contributed to leukemogenesis as it impaired granulocytic and monocytic 
differentiation (Topisirovic et al. 2003).  
Although eIF4E and its associated factors are general translation factors, 
they bind and scan mRNAs with a short and simple 5’UTR much more efficiently 
than mRNAs with a long and structured 5’UTR. The 5’UTR of the Ndpk-B transcript, 
that is strictly dependent on Epo- and SCF-induced PI3K activity, begins with a 
terminal oligopyrimidine (TOP) sequence and contains an inverted repeat (Joosten 
et al. 2004). The TOP sequence confers selective translation to a given mRNA as 
polysome recruitment becomes dependent on mTOR activation (Jefferies et al. 
1997). TOP sequences are present in mRNAs encoding ribosomal proteins and 
elongation factors to render the energy consuming process of ribosome biogenesis 
dependent on the presence of mitogenic factors and nutrients. Additional secondary 
structures within the 5’UTR may also control mRNA translation such as the iron 
response element that renders translation of the transferrin receptor dependent on 
the availability of iron (Thomson et al. 1999).  
In this manuscript we show that control of mRNA translation is an important 
PI3K-dependent pathway regulating progenitor expansion. We demonstrate that SCF 
induces rapid PI3K-dependent phosphorylation of 4E-BP and that overexpression 
of eIF4E in erythroid progenitors delays differentiation and enhances renewal 
divisions in the absence of SCF. We identified mRNAs upregulated by SCF-induced 
polysome recruitment. These mRNAs contain a long and structured 5’UTR (Y-box 
binding protein-1), a short 5’UTR starting with a TOP sequence (the splicing factor 
U2-Snrpb”) or both a TOP sequence and an inverted repeat (Ndpk-B). Polysome 
recruitment of all three mRNAs was strongly enhanced by eIF4E overexpression in 
cells that were factor deprived, while eIF4E overexpression did not affect polysome 
association in the presence of SCF. 
RESULTS
Epo and SCF control eIF4E levels available for mRNA translation.
Since 4E-BP sequester eIF4E in the absence of growth factors, we examined 4E-
BP phosphorylation in erythroid progenitors in response to Epo and SCF. Upon 
factor deprivation only unphosphorylated 4E-BP are detected. Epo induced partial 
phosphorylation of 4E-BP while only SCF induced complete phosphorylation of 
4E-BP (Figure 1A). Comparison of phospho-specific and total 4E-BP staining 
showed that migration of 4E-BP is directly related to its phosphorylation state. 
An unphosphorylated α-isoform, a partially phosphorylated β- and a fully 
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phosphorylated γ-isoform can be discerned in agreement with the proposed two-
step phosphorylation mechanism (Gingras et al. 1999a). Importantly, SCF but not 
Epo is able to induce phosphorylation of Ser64, the last step in a cascade involving 
the sequential phosphorylation of T36/T45, T69 and S64 to release eIF4E (Figure 
1B, Gingras et al. 2001). Epo/SCF-induced phosphorylation of 4E-BP was abrogated 
in the presence of the PI3K-inhibitor LY294002 and the mTOR inhibitor rapamycin 
(Figure 1B). The MEK1-inhibitor U0126 partially inhibited the hyperphosphorylation 
of 4E-BP (Figure 1C), which may indicate that part of the TSC/mTOR pathway is 
controlled through MEK1 (Tee et al. 2003; Naegele and Morley 2004). However, the 
major effect of LY294002 and the minor effect of U0126 are in accordance with the 
observation that inhibition of PI3K but not Mek1 abolished polysome association of 
NDPK-B (Joosten et al. 2004). 
Figure 1 Phosphorylation of 4E-BP 
is controlled by SCF and Epo in 
erythroid progenitors. A/B: I/11 cells 
were factor deprived for 4 h, stimulated 
with Epo (E, 5U/ml), SCF (S, 100 ng/ml) 
or Epo plus SCF (ES) for 10 min, or 
left untreated (NF). C: I/11 cells were 
factor deprived in presence of 10µM 
LY294002 (LY), 10 nM rapamycin (R) or 
20 µM U0126 (U) and stimulated for 10 
min with Epo and SCF (ES) in presence 
of the inhibitors. Western blots with 
total cell lysates (A/C) or with 4E-BP 
immunoprecipitates (B) were stained 
with antibodies recognizing T36/T45 
phosphorylated 4E-BP (α-P(T36/T45)-
4E-BP), S64 phosphorylated 4E-BP 
(α-P(S64)-4E-BP) or total 4E-BP (α-
4E-BP). ERK1/2 staining was used as 
sample loading control (α-ERK1/2). The 
unphosphorylated α-isoform, a partially 
phosphorylated β-isoform and a fully 
phosphorylated γ-isoform of 4E-BP are 
indicated in panel A. D: Samples were 
taken at various time points following 
addition of Epo or SCF (ss, steady 
state, cells not subjected to factor 
deprivation). Western blots were stained 
with antibodies recognizing 4E-BP. E: 
I/11 cells were factor deprived (NF) or 
restimulated as indicated  in panels 
A/B and eIF4E was precipitated with 
m7GTPsepharose. Precipitates were 
stained for eIF4G, 4E-BP and eIF4E on 
Western blots.
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Since only SCF induced full phosphorylation of 4E-BP during 10’ stimulation, we 
examined the kinetics of 4E-BP phosphorylation to exclude that the difference was 
due to different kinetics of induction and feedback modulation. Even after prolonged 
stimulation of erythroid progenitors with Epo, phosphorylation of 4E-BP was partial 
and only low amounts of the fully phosphorylated γ-isoform were detected. In 
contrast, SCF rapidly induced complete phosphorylation of 4E-BP, which was not 
dephosphorylated in continuous presence of the factor (Figure 1D). Subsequently, 
we tested whether phosphorylation of 4E-BP actually resulted in reduced 4E-BP 
binding to eIF4E and increased association of eIF4E with the scaffolding protein 
eIF4G. m7GTP-sepharose was used to precipitate eIF4E from extract of 15x106 
cells that were factor deprived or restimulated with Epo and/or SCF. Surprisingly the 
amount of 4E-BP pulled down from restimulated cells increased, concomitant with 
increased precipitation of eIF4E. However, also eIF4G binding to eIF4E increased 
(Figure 1E). This indicates that 4E-BP is in excess, but that stimulation of erythroid 
progenitors with SCF does induce eIF4F complexes.
The level of eIF4E available for mRNA translation initiation is regulated by 
4E-BP phosphorylation, but we also observed factor-induced upregulation of eIF4E 
expression in mRNA profiling experiments (Kolbus et al. 2003). Real-time quantitative 
PCR showed that eIF4E mRNA increased approximately 2-fold in I/11 erythroblasts 
following a 2h Epo, SCF or Epo/SCF exposure compared to factor-deprivation of 
I/11 cells (Figure 2A). This upregulation was due to an increase in total transcript 
because the relative distribution between subpolysomal and polysomal associated 
mRNA did not change in response to factor-deprivation and restimulation (Figure 2B). 
Increased mRNA expression results in increased protein expression (Figure 2C,D), 
which is in accordance with the data shown in Figure 1E. During terminal erythroid 
differentiation eIF4E mRNA expression was downmodulated approximately 4-fold in 
72 hours (Figure 2E). 
Together, the data show that the level of eIF4E available for mRNA translation 
is controlled by SCF at least at two levels: phosphorylation of 4E-BP allowing 
increased eIF4G binding, and increased expression. 
eIF4E overexpression in I/11 erythroid progenitor cells impairs differentiation 
and enhances cell renewal
If regulation of eIF4E is a major effector of SCF-induced PI3K, overexpression of 
eIF4E is expected to affect the PI3K-dependent balance between expansion and 
differentiation of erythroid progenitors (von Lindern et al. 2001). Using retroviral 
expression vectors, we established multiple clones expressing myc-tagged eIF4E 
(eIF4E-myc; Figure 3A). The eIF4E-myc could efficiently bind 4E-BP, which enabled 
the exogenously expressed eIF4E-myc to titrate the inhibitory function of 4E-BP 
(Figure 3B). Using m7GTP-sepharose we pulled down eIF4E from control and eIF4E 
overexpressing cells that were factor-deprived and restimulated. In contrast to control 
cells, factor-deprived eIF4E overexpressing cells contained eIF4E-eIF4G complexes 
(Figure 3C). More eIF4G was recruited by eIF4E in the eIF4E overexpressing 
erythroid progenitors under all conditions (Figure 3C,D). Since all unphosphorylated 
4E-BP was bound by the excess of eIF4E, induction of 4E-BP phosphorylation upon 
stimulation of the cells with SCF resulted in a more pronounced decrease in 4E-BP 
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Figure 2  eIF4E expression 
is upregulated upon growth 
factor stimulation in I/11 cells. 
A, B: I/11 cells were factor 
deprived for 4 h and stimulated 
with Epo (E), SCF (S) or Epo 
plus SCF (ES) or left untreated 
(NF) for 2 h. Total (A), free and 
polysome associated mRNA (B) 
was isolated and eIF4E mRNA 
was quantified using real-time 
PCR. A: eIF4E expression in 
factor-stimulated cells is given 
as fold-change ratio compared 
to untreated cells. B: The 
percentage of eIF4E mRNA 
present in the polysome-bound 
(pb) fraction is calculated. C: 
I/11 cells were factor deprived 
and restimulated with Epo plus 
SCF for various time intervals 
as indicated. Protein samples 
were analyzed on Western 
blot for eIF4E expression. The 
Western blot was stained with 
α-actin to control for equal 
loading. D: quantification of 
eIF4E intensities. Bars indicate 
the average of 3 independent 
experiments, a representative 
of which is shown in 2C. Error 
bars indicate SD. The insert 
demonstrates the linearity 
of the eIF4E antibody used 
(r2=0.9988). Two-fold dilutions 
of total cell lysate are tested for 
eIF4E expression. Expression 
is given in arbitrary units (a.u.) 
E: I/11 cells were induced to 
differentiate and samples were 
harvested for mRNA isolation 
at the indicated time points. 
Expression of eIF-4E was 
examined by real-time RT-PCR 
and is given as fold-change 
ratio compared to expression in 
expanding I/11 cells (t0).
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binding than observed in control cells (compare Figures 1E and 3D). In conclusion, 
although the level of myc-eIF4E overexpression detected in Figure 3A is modest 
compared to endogenous eIF4E, the increase in eIF4G-association indicates that 
the expression of myc-eIF4E significantly enhances the level of free eIF4E (not 
bound to 4E-BP).
Using immunofluorescence we analyzed the subcellular localization of 
endogenous eIF4E and of eIF4E-myc. Previously it has been shown that eIF4E 
may accumulate in nuclear bodies to prevent cytoplasmic translocation of specific 
mRNAs (Topisirovic et al. 2003). A small fraction of endogenous eIF4E appeared in 
nuclear bodies, but eIF4E-myc appeared to be exclusively cytoplasmic (Figure 3E). 
Thus, it is not likely that eIF4E-myc in erythroid progenitors functions through a non-
translational mechanism such as retaining specific mRNAs in the nucleus.  Finally, 
we also expressed an eIF4E mutant in which tryptophan-73 was mutated to alanine 
(W73A mutant) in I/11 cells. The W73A mutant is unable to bind the scaffolding 
protein eIF4G or 4E-BP. A low level of eIF4E(W73A) expression was detected in 
mass cultures within a week after transduction, but expression of this mutant was 
rapidly lost and we were unable to establish single cell derived clones expressing the 
W73A mutant (data not shown). This suggests that eIF4E may not only bind 4E-BP 
or the scaffold eIF4G, but that positive factors can also be competed for by eIF4E-
myc overexpression.
To examine the effect of eIF4E overexpression on the balance between 
expansion and differentiation of erythroid progenitors, we exposed vector control 
cells and eIF4E-myc expressing clones to conditions inducing expansion (Epo, 
SCF, Dex), delayed differentiation (Epo, SCF), differentiation (Epo) or apoptosis 
(no factor). Both control and eIF4E-myc expressing cells fail to proliferate or mature 
in absence of growth factors (Figure 4A,E). Under differentiation conditions, i.e. in 
presence of Epo only, control cells undergo prompt differentiation, characterized by 
transient proliferation, decrease in cell size and accumulation of hemoglobin (Figure 
4A-C). Notably, this differentiation is markedly delayed in eIF4E-myc expressing cells 
indicated by prolonged expansion, maintenance of a blast-like cell size and lack of 
hemoglobin accumulation (Figure 4E-G). In presence of Epo plus SCF, control cells 
were delayed in differentiation, but e.g. cell size reduction starts almost as rapidly 
as in the presence of Epo only. Under these conditions, differentiation of eIF4E-myc 
expressing cells was essentially absent. The delay of differentiation in eIF4E-myc 
expressing cells is also evident from the cell morphology of the distinct cultures after 
4 days exposure to Epo (Figure 4D,H). 
The effect of eIF4E-myc expression on Epo-dependent differentiation was 
analyzed for multiple independent clones, which showed consistent inhibition of 
differentiation (Figure 5).
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Figure 3  Ectopic myc-eIF4E protein is able to interact and titrate out endogenous 4E-BP and is 
mainly localized in the cytoplasm of I/11 cells. A: Lysates of an empty vector transduced clone (eV) 
and various myc-eIF4E transduced clones were tested for eIF4E expression on Western blots using 
antibodies recognizing eIF4E (top panel) or the myc-tag (lower panel). The myc-eIF4E and endogenous 
eIF4E proteins have different mobility and are indicated by arrows. B: myc-eIF4E expressing I/11 cells 
expanding in presence of Epo, SCF and Dex (ss) or factor deprived for 4 h (NF) were lysed and myc-
eIF4E was immunoprecipitated with anti-myc antibody (α-myc, + lanes). Mock immunoprecipitations using 
sepharose beads without antibody (- lanes) served as controls. Western blots were stained for 4E-BP 
(top) or the c-myc tag (bottom). Unphosphorylated and hypophosphorylated 4E-BP  (α- and β-form) were 
co-immunoprecipitated with myc-eIF4E.  The myc-tagged eIF4E could efficiently bind to endogenous 
4E-BP. C/D: eIF4E was precipitated by m7GTPsepharose and tested for eIF4G and 4E-BP association on 
Western blots. Endogenous eIF4E was detected by specific antibody, myc-eIF4E was detected by anti-
myc antibody. Lysates were prepared from myc-eIF4E expressing and control I/11 cells that were steady 
state expanding (ss) or factor deprived (NF) (C) or factor-deprived (NF) and restimulated with Epo (E; 5U/
ml, 60’), SCF (S; 100ng/ml; 60’) or Epo plus SCF (ES) (D).  E: Cytospins of empty vector (upper panel) and 
myc-eIF4E (middle/lower panel) expressing I/11 cells are fixed and stained for eIF4E (upper, middle left 
panel) or the c-myc tag (lower left panel) using FITC- and TRITC labeled second antibodies respectively. 
In addition nuclei of all cells are stained by DAPI (middle panels). The right panels represent the overlay 
of eIF4E or c-myc with DAPI. A small fraction of endogenous eIF4E appeared in nuclear bodies, whereas 
myc-eIF4E seems to be exclusively cytoplasmic.
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Figure 4  Overexpression of eIF4E impairs differentiation of I/11 erythroid progenitors. I/11 cells 
transduced with an empty control vector (A-D) or with an eIF4E expression vector (E-H) were seeded in 
medium without factor (-), or supplemented with Epo (E, 2U/ml), Epo plus SCF (ES, 100ng/ml SCF) or 
Epo, SCF and dexamethasone (ESD, 10-6M dexamethasone). (A, E) Cumulative cell number, (B, F) cell 
size and (C, G) and hemoglobin content per cell volume (arbitrary unites; a.u.) were analyzed at regular 
intervals for 7 days. At day 4, cells seeded in Epo were harvested for cytospins and stained for hemoglobin 
and histological dyes (D, H). Hemoglobinised and enucleated erythrocytes are present in control cells, 
while eIF4E expressing cells contain mainly blasts.
Figure 5  Overexpression of 
eIF4E consistently impairs 
differentiation of I/11 erythroid 
progenitors. A, B: Vector and 
myc-eIF4E transduced clones 
were subjected to differentiation 
as described for Figure 4. The 
average cell volume (A) and 
hemoglobin content (B) as 
measured 3 and 4 days following 
induction of differentiation is 
shown for 6 clones each. Error 
bars represent standard deviation.
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Figure 6  eIF4E overexpression in I/11 cells impairs differentiation but fails to prolong renewal in 
presence of Epo. A, B: Empty vector (EV) control clones and myc-eIF4E expressing cells (eIF4E) were 
fixed and permeabilized, stained with propidium-iodine (PI) and analyzed by flow cytometry.  A: Three days 
following reseeding of the cells in differentiation medium (supplemented with Epo only), the EV control 
cells were predominantly arrested in the G1 phase of the cell cycle, the G2 peak is absent. The PI-staining 
is relatively low because the nuclei are condensed and bind less PI. A prominent peak representing 
the G2 phase of the cell cycle is present in eIF4E overexpressing cells. B: At day 6 and day 7 following 
seeding in differentiation medium, the eIF4E overexpressing cells are still in cycle as demonstrated by the 
G2 peak, but in time the number of cells with a sub-G1 DNA content (indicating dead cells) accumulates. 
C: Protein lysates of empty vector (EV) control clones and myc-eIF4E expressing cells (eIF4E) were 
harvested at increasing intervals following reseeding of the cells in differentiation medium. Western blots 
were stained with antibodies recognizing endogenous eIF4E, 4E-BP or ERK1/2 as indicated. Erk served 
as a loading control.
Measuring the DNA content by flow cytometry at day 3 following reseeding in 
differentiation medium confirmed that control cells arrest in the G1-phase of the cell 
cycle, while eIF4E-myc cells can be detected in all phases of the cell cycle (Figure 
6A; the G1-peak of control cells is shifted to the left because the highly condensed 
DNA of late erythroblasts binds less propidium iodine; no significant number of 
apoptotic cells is detected by annexin staining or Tunnel assay). However, eIF4E-
myc expressing cells are not transformed and fail to undergo prolonged renewal 
in presence of Epo. Seven days following reseeding in differentiation conditions 
the cultures of eIF4E-myc expressing cells accumulate cells with a sub-G1 DNA-
content and annexin positive staining (Figure 6B and data not shown), suggesting 
increased apoptosis. In the control cultures all cells have enucleated. These results 
were confirmed in 4 control clones and 6 eIF4E-myc expressing clones. The failure to 
undergo differentiation could be due to the failure to downregulate eIF4E (Figure 2C). 
Indeed, expression of eIF4E protein decreased during differentiation of control cells, 
followed by decreased expression of 4E-BP. However, expression of endogenous 
eIF4E remained high in eIF4E-myc progenitors (Figure 6C).
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PI3kinase inhibition does not abrogate cell expansion of I/11 eIF4E-
overexpressing cells.
We showed that PI3K-activity rather than MEK1/ERK-activation is essential to 
maintain cell renewal divisions in erythroid progenitors (von Lindern et al. 2001). 
Since phosphorylation of 4E-BP and release of eIF4E is one of the PI3K effectors, 
we analyzed whether constitutive expression of eIF4E maintains cell renewal in 
presence of the PI3K-inhibitor LY294002. Addition of LY294002 to renewal conditions 
decreased expansion of control cultures and accelerated cell differentiation 
evidenced by increased hemoglobinization. In contrast, eIF4E-myc expressing cells 
did not alter cellular renewal or differentiation in response to LY294002 (Figure 7). 
This indicates that control of translation initiation is a major target of PI3kinase in 
erythroid development.
Figure 7  Overexpression 
of eIF4E renders cells 
insensitive to the PI3K 
inhibitor LY294002. Two 
empty vector control clones 
and two eIF4E overexpressing 
clones (black and white 
symbols indicate separate 
clones) were seeded in 
medium supplemented with 
Epo and SCF (ES) in absence 
(diamantes) or presence 
(circles) of LY294002 (LY; 10 
µM). (A) Total cell number and 
(B) hemoglobin (Hb) content 
per cell volume (in arbitrary 
units; a.u.) were monitored 
daily.
Polysome association of Ndpk-B, U2-Snrpb” and YB-1 transcripts depends on 
PI3K activation or eIF4E expression.
Recently we screened for Epo- and SCF-induced genes in a profiling assay using 
polysome bound mRNA. Expression of Nucleoside diphosphate kinase-B (Ndpk-
B) appeared to be controlled specifically at the level of polysome recruitment by 
a mechanism involving SCF-activated PI3K activity (Joosten et al. 2004). Since 
other targets upregulated by SCF may be regulated by the same mechanism, the 
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Figure 8  eIF4E overexpression increases polysome association of structured mRNAs in absence 
of growth factors or in presence of growth factors and the PI3K inhibitor LY294002. I/11 control cells 
(black bars) and eIF4E overexpressing cells (white bars) were factor deprived in absence or presence 
of LY294002 (LY; 10 µM) or rapamycin (R; 10nM) and restimulated for 2 h with Epo (E, 5U/ml), SCF (S, 
100 ng/ml), Epo plus SCF (ES). In addition, cells were left untreated (NF) or were harvested from steady 
state proliferating cultures (ss). Free and polysome bound mRNA was isolated and assayed for the 
expression of (A) NdpkB, (B) YB-1, (C) U2-Snrpb”, (D) eIF1β2, (E) ODC and (F) Fli-1. The percentage of 
mRNA associated with polysomes (pb-mRNA) was calculated for the different genes under the different 
conditions.
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expression of Epo- and SCF-upregulated genes was examined by quantitative RT-
PCR in total, free and polysome-associated mRNA fractions (supplemental data). In 
addition to Ndpk-B, we found expression of the splicing factor U2-Snrpb” and the Y-
box binding protein-1 (YB-1) to be regulated by polysome association (supplemental 
data and Figure 8). In absence of growth factor, less than 10, 5 and 25% of Ndpk-B, 
YB-1 and U2-Snrpb” mRNAs, respectively, were detected in the polysomal fractions. 
Upon stimulation with Epo and SCF, 75% of the Ndpk-B, 80% of the U2-Snrpb” and 
50% of the YB-1 messengers were found in the polysomal fractions and polysome 
association was dependent on PI3K activation (Figure 8A, B, C, black bars).
Whereas the 5’UTR of Ndpk-B starts with a TOP tract and contains an 
inverted repeat, the 5’UTR of U2-Snrpb” is short and contains a TOP sequence 
(AA146248), whereas the 5’UTR of YB-1 is long, highly structured and lacks a TOP 
sequence (Fukuda et al. 2004; X57621). Thus, these three genes represent different 
types of mRNAs and may be a representative panel to study the pathways involved 
in gene-specific mRNA recruitment to polysomes. We examined the effect of eIF4E 
overexpression on factor-dependent polysome association of Ndpk-B, U2-Snrpb” 
and YB-1 mRNA. Polysome recruitment of Fli-1 mRNA was analyzed as a negative 
control to assess the general effect of LY294002 and rapamycin on polysome 
formation. Polysome association of eukaryote elongation factor 1β (eEF1β) and 
ornithine decarboxylase (ODC) was examined as a positive control. They contain 
a TOP-sequence and a highly structured 5’UTR, respectively. Enhanced eIF4E 
expression increased polysome association of Ndpk-B, YB-1 and U2-Snrpb” mRNA 
in factor deprived cells and it rendered factor-induced polysome association resistant 
to the PI3K-inhibitor LY294002 (Figure 8, white bars). The polysome association of 
the mRNAs in Epo or SCF stimulated cells was not different between control and 
eIF4E overexpressing cells. 
Both control mRNAs, eEF1β and ODC, known to be regulated by polysome 
association showed the same level of regulation as Ndpk-B, YB-1 and U2-Snrpb”. 
In contrast, at least half of all Fli-1 mRNA remained associated with polysomes 
independent of PI3K activity. Upon factor deprivation and inhibition of PI3K, 20 - 25% 
of the Fli-1 mRNA was lost from polysomes. This can be considered the general 
effect of growth factor stimulation on mRNA translation initiation, which is much lower 
than the effect observed for structured mRNAs.
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DISCUSSION
Control of expansion versus maturation of hematopoietic progenitors requires a tight 
regulation of the gene expression program. It becomes increasingly evident that the 
expression of genes critical for progenitor renewal and tumorigenesis is not only 
regulated at the level of gene transcription, but also by control of mRNA translation 
(De Benedetti and Graff 2004). Expansion of erythroid progenitors is critically 
dependent on SCF-induced PI3K activity. SCF-induced PI3K/PKB activity controls 
the level of eIF4E available for translation initiation and we show that overexpression 
of eIF4E in erythroid progenitors impairs their differentiation and enhances renewal 
divisions in absence of SCF. Notably, inhibition of PI3K did not lead to differentiation of 
eIF4E overexpressing erythroid progenitors as it does in control cells indicating that 
control of eIF4E is a pathway of major importance downstream of PI3K in expanding 
erythroid progenitors. We observed that either SCF-induced signal transduction or 
eIF4E overexpression resulted in a significant increase in the polysome recruitment 
of a specific set of mRNAs with a structured 5’UTR such as Ndpk-B, YB-1 and U2-
Snrpb”. This supports the notion that the expression of not only ribosomal proteins 
and translation factors but also of other proteins with an important role in cellular 
metabolism and proliferation are controlled at the level of polysome recruitment. 
Therefore, we suggest that gene-specific recruitment of mRNAs into polysomes 
by SCF-induced PI3K/PKB activity may contribute to the control of expansion and 
maturation of erythroid progenitors.
Release of eIF4E is a major pathway downstream PI3K in erythroid 
progenitors
Overexpression of eIF4E specifically inhibits differentiation. Notably, induction of 
erythroid maturation does not require inhibition of cell cycle progression, but involves 
3-4 cell divisions with loss of cell size control, resulting in 8-16 erythrocytes (4µm in 
mice) from a single proerythroblast (12µm) (Dolznig et al. 2001; von Lindern et al. 
2001). In consequence, maintenance of cell size is crucial in renewal divisions, which 
requires a proper balance between protein synthesis and G1 progression through 
the restriction point in the cell cycle (Zetterberg et al. 1995; Dolznig et al. 2004). This 
indicates an important role for protein synthesis, and for a limiting factor in mRNA 
translation such as eIF4E in particular, in the control of expansion and differentiation 
of erythroid progenitors. 
We previously showed that inhibition of PI3K abrogates the ability of erythroid 
progenitors to maintain a renewal program (von Lindern et al. 2001). Because 
overexpression of eIF4E rendered expansion of erythroid progenitors insensitive 
to the PI3K inhibitor LY294002, selective protein synthesis appears to be a major 
pathway downstream of SCF-induced progenitor expansion. However, we also 
demonstrated that SCF-induced activation of the PI3K/PKB pathway results in 
phosphorylation of Foxo3, which results in its cytoplasmic retention and inhibition 
of its transcriptional activity (Bakker et al. 2004). Among the Foxo3 targets are p27, 
p130Rb2, Btg1 and cyclin G2 that all inhibit cell cycle progression (Bakker et al. 2004; 
Bakker submitted). These genes are upregulated when PI3K activity is inhibited 
in control cells. Yet, erythroid progenitors overexpressing eIF4E undergo normal 
renewal divisions in absence of PI3K activity. This seeming contradiction may 
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have two explanations. First, expression of Foxo-family members is low in erythroid 
progenitors and Foxo3 expression is markedly increased during differentiation, 
resulting in Foxo3 activity 48 h after induction of differentiation when cells arrest in 
G1. The low levels of Foxo3 protein in erythroid progenitors may result in insufficient 
expression of the cell cycle inhibitors to arrest cells when all other signals are 
activated. Second, preliminary analysis of translationally controlled genes suggests 
that increased eIF4E expression results in the enhanced expression of proteins 
that inhibit the cell cycle inhibitors such as kinase interacting with stathmin (Kis, 
unpublished data). Thus, control of eIF4E availability is a major pathway downstream 
of PI3K to maintain renewal divisions of erythroid progenitors. Upon downregulation 
of PI3K other pathways such as Foxo3 activation are activated to execute the 
differentiation program.
Constitutive eIF4E expression does not render erythroid progenitors 
independent of growth factors
It has been shown that the PI3K/PKB/mTOR pathway is required for the tumorigenic 
phenotype of various tumors and sufficient for oncogenic transformation of chicken 
embryo fibroblasts (De Benedetti and Harris 1999; Aoki et al. 2001; Avdulov et al. 
2004). In breast tumor-derived cell lines and eIF4E-transformed fibroblasts, increased 
expression of eIF4E and phosphorylation of 4E-BP prevent apoptosis upon factor 
deprivation. Erythroid progenitors overexpressing eIF4E are not factor-independent 
for either renewal or differentiation and are not prevented from apoptosis in absence 
of growth factors. Moreover, eIF4E expression impairs differentiation, but is not able 
to sustain long-term renewal. Upon moderate overexpression the cells undergo 
delayed differentiation but high levels of eIF4E eventually induce erythroid progenitors 
to die under differentiation conditions. Whereas eIF4E availability may be the crucial 
pathway downstream of PI3K signaling, it is not sufficient for sustained expansion or 
differentiation of erythroid progenitors. The distinct effects of eIF4E overexpression 
in different cell types, i.e. control of apoptosis versus control of differentiation, is 
in accordance with the different function of PI3K and Foxo transcription factors in 
these cells. Whereas PI3K is mainly known as a survival factor in fibroblastoid cells 
(Franke et al. 1997), it controls the balance between expansion and differentiation 
of erythroid progenitors (Bakker et al. 2004; van den Akker et al. 2004). The tyrosine 
kinase receptor RON/Stk is a downstream target of the EpoR (van den Akker et al. 
2004). Direct activation of RON, using a NGF-inducible TrkA-RON fusion induced 
phosphorylation of Gab1 and Gab2 and strong PI3K activation but it was not able 
to induce renewal divisions in absence of SCF, or differentiation in absence of 
Epo. Thus, expansion requires additional signaling pathways initiated by the SCF-
receptor cKit and differentiation requires Epo-induced Stat5 activation (Dolznig et 
al. 2002; van den Akker et al. 2004). Whether the biological effect of eIF4E is rescue 
from apoptosis or impaired differentiation, in both cases it contributes to enhanced 
expansion of progenitors and to neoplastic transformation.
Increased eIF4E expression recruits specific RNA transcripts to polysomes
Although eIF4E is predominantly a translation initiation factor, overexpression 
of eIF4E in myeloid progenitors was suggested to contribute to leukemogenesis 
by increased nuclear export of cyclinD1 (Topisirovic et al. 2003). The proline-rich 
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homeodomain protein, PRH/Hex, disrupts eIF4E nuclear bodies and reduces export 
of D-cyclins (Topisirovic et al. 2003). We did observe nuclear bodies in control cells 
using antibodies against endogenous eIF4E, but upon overexpression of eIF4E these 
nuclear bodies disappeared. Interestingly, we found that PRH/Hex is upregulated 
in response to SCF. This involved both transcriptional and translational control 
as the 28bp long 5’UTR of the PRH transcript contains a TOP sequence (Grech, 
unpublished results). Possibly, the increased expression of PRH/Hex suppressed 
nuclear localization of eIF4E. 
In consequence, delayed differentiation of erythroid progenitors upon 
overexpression of eIF4E must be due to the effects of eIF4E on mRNA translation. 
Increased availability of eIF4E allows more eIF4F, harboring the eIF4A helicase, 
to bind and scan structured mRNAs, i.e. to recruit the structured mRNAs into 
polysomes (Gingras et al. 1999b). Until recently, PI3K/PKB/mTOR-dependent 
polysome recruitment was mainly described for mRNAs containing a TOP sequence 
and encoding ribosomal proteins and translation factors (Meyuhas 2000; Stolovich 
et al. 2002). Few other structured mRNAs were shown to be regulated at the 
level of translation initiation such as c-Myc and ornithine decarboxylase (ODC; 
(De Benedetti and Graff 2004)). In this manuscript we describe PI3K and eIF4E-
dependent polysome recruitment of Ndpk-B, YB-1 and U2-Snrpb”. Notably, both 
Ndpk-B and YB-1 are suggested to be involved in tumor progression (Postel 1998; 
Janz et al. 2002). Ndpk-B 5’-UTR contains a TOP-tract and an inverted repeat 
predicted to form a stem-loop structure (Joosten et al. 2004). Removal of the Ndpk-B 
5’-UTR caused loss of Ndpk-B translational control. YB-1 mRNA contains a highly 
structured 5’UTR and lacks a TOP tract, whereas U2-Snrpb” has a short 5’UTR 
starting with a TOP sequence. All three mRNAs as well as the controls EF1β (TOP 
mRNA) and ODC (structured mRNA) were hardly or not associated with polysomes 
in the absence of growth factors. Of unstructured mRNAs, such as Fli-1 mRNA, at 
least 50% of the mRNA remains associated with polysomes in absence of growth 
factors. Overexpression of eIF4E increased polysome association of Ndpk-B, YB-
1 and U2-Snrpb” in the absence of growth factors, but did not completely rescue 
polysome association compared to SCF-induced polysome association. This 
suggests that additional signaling still plays a role in mRNA translation, possibly by 
phosphorylation of proteins that stabilize structures in the mRNAs.
Besides increased recruitment of structured mRNAs to polysomes, increased 
expression of eIF4E may act via other mechanisms as well and such additional 
mechanisms may contribute to the observed phenotype of eIF4E overexpressing 
erythroid progenitors. In conjunction with other initiation factors (eIF2 and eIF3) 
eIF4E affects selection of the ATG-initiation codon. Under conditions of suboptimal 
growth factors, protein synthesis will start at the first ATG start codon that is 
embedded in an optimal Kozak sequence (Kozak 1989). However, when translation 
initiation factors are abundantly available, less optimal ATG codons can be selected 
to start protein synthesis while it concurrently enables initiation factors to continue 
mRNA scanning beyond a first open reading frame (ORF) to re-initiate at the next 
ATG. Short ORFs in the 5’UTR can serve to attenuate translation of the functional 
ORF (e.g. thrombopoietin; Ghilardi et al. 1998), but upstream ORFs can also affect 
the choice of the start codon for the functional protein and thereby the translation of 
antagonistic proteins from the same mRNA (e.g. cEBPβ, SCL; Calkhoven et al. 2000; 
Calkhoven et al. 2003). 
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MATERIALS AND METHODS
Cells
I/11 cells were cultivated in StemPro-34TM medium (Life Technologies) as described 
(von Lindern et al. 2001). For expansion, the medium was supplemented with 
0.5U/ml Epo, (kind gift from Ortho-Biotech, Tilburg, The Netherlands), 100ng/
ml SCF (supernatant of CHO producer cells) and 10-6M dexametasone (Dex, 
Sigma-Aldrich). To induce differentiation, cells were cultivated in StemPro-34TM 
medium supplemented with 5U/ml Epo and 0.5mg/ml iron-loaded transferring 
(Intergene). Cell numbers and cell size distribution were determined using 
an electronic cell counter (CASY-1, Schärfe-System, Reutlingen, Germany). 
LY294002 and rapamycin were obtained from Alexis (Schwitzerland).
Hemoglobin content determination and cell morphology
Small aliquots of the cultures were removed and analyzed for hemoglobin content by 
photometry as described earlier (Kowenz et al. 1987; Bakker et al. 2004). The values 
obtained were the average of triplicate measurements after normalization for cell 
number and mean single cell volume. Cell morphology was analyzed in cytospins 
stained with histological dyes and neutral benzidine (Beug et al. 1982), using an 
OlympusBx40 microscope (40x objective, NA 0.65), an OlympusDp50 CCD camera 
and Viewfinder Lite 1.0 acquisition software. Images were cropped using Adobe 
photoshop 6.0.
SDS-PAGE, western blotting, immunoprecipitation and antibodies
For acute stimulation with growth factors, proliferating I/11 cells were washed twice 
with phosphate-buffered saline (PBS) and seeded at 4 x 106 cells/ml in plain Iscove’s 
modified Dulbecco’s medium (IMDM, Life Technology). After 4 h factor deprivation, 
cells were stimulated at 37°C with SCF (100ng/ml) or Epo (5U/ml). Cells were 
harvested after the indicated time points by addition of ice-cold PBS. 
Cell lysates, SDS-PAGE, immunoprecipitation and Western blotting were 
performed as described previously (van Dijk et al. 2000). To analyze eIF4E and 4E-
BP, 10 µl of protein extract (≈1x106 cells) was loaded onto a 15% polyacrylamide 
gel. The antibodies used were: α-eIF4E, α-4E-BP1, α-Phospho-4E-BP1(Thr37/46), 
α-Phospho-4E-BP1(Ser65) (Cell Signaling Technology, Inc.), α-ERK1(K-23) and 
α- Myc (Santa Cruz Biotechnology, Inc.). For immunoprecipitation, Myc-eIF4E was 
immunoprecipitated from the lysate of 15x106 cells by an overnight incubation at 4°C 
with the monoclonal α-myc antibodies (1 µg antibody/15x106 cells), followed by an 
hour incubation at 4°C with 15 µl of a 50% solution of protein G-Sepharose beads 
(Pharmacia LKB). 
m7GTP-Sepharose affinity chromatography
For the isolation of eIF4E and associated proteins, 15x106 cells were lysed in buffer 
C (50mM MOPS/KOH (pH7,2); 0.5mM EDTA; 0.5mM EGTA; 100mM KCl; 14mM 
2-mercaptoethanol; 50mM NaF; 100mM GTP and protease inhibitor cocktail) 
and subjected to m7GTP-Sepharose chromatography as described previously 
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(Morley and Pain 1995).   Briefly, the lysed cells were incubated at 4oC with 25ml of 
equilibrated sepharose resin (7-Methyl GTP-Separose 4B;  Amersham Biosciences) 
for 1 hour.  The resin  was washed three times with buffer C and recovered proteins 
eluted directly into sample buffer for SDS/PAGE analysis.   
Generation of myc-eIF4E expressing I/11 clones
The myc-eIF4E cDNA (NCBI accession number M61731) containing six myc-tags 
at the 5’ start of the coding sequence was isolated from the pCS3MT vector and 
inserted into the eukaryotic retroviral expression vector pBabe using EcoRI and 
BamHI restriction sites. Retroviral transduction was performed as described (Bakker 
et al. 2004). Briefly, 0.5x106 ecotropic Phoenix cells were transfected with 12 µg 
plasmid DNA (myc-eIF4E-pBabe) using calcium-phosphate coprecipitation assay. 
After 40 h, cells were treated with 10µg/ml mitomycin C (Kyowa Hakko Kogyo, Tokyo, 
Japan) for 1 h and washed 3 times with PBS. 2x106 I/11 cells were added in 4ml 
StemPro-34TM medium supplemented with Epo, SCF and Dex and co-cultured for 
24 h. Subsequently, I/11 cells were removed from the Phoenix cells and cultured in 
semisolid medium (Methocel-containing StemPro-34TM, supplemented with factors) 
containing 2 µg/ml puromycin (Sigma). After 7 days well-separated colonies were 
picked, expanded and analyzed for myc-eIF4E expression.
Immunofluorescence microscopy
Cells (eIF4E overexpressing and empty vector clones) were spun onto a microscope 
slide.  The cells were fixed in 4% paraformaldehyde and permeabilized for 30 min 
with 0.2% TritonX.  After blocking for 1h in PBS containing 1% BSA and 0.05% 
Tween, the fixed cells were incubated for 1 h at rt with anti-eIF4E antibody (Cell 
Signaling Technology; #9742), and with anti-myc-antibodies (Santa Cruz; 9E10) for 
the eIF4E-overexpressing cells.  The slides were washed and incubated for 1h at rt 
with FITC anti-rabbit or TRITC anti-mouse secondary antibody (DakoCytomation), 
respectively.  Cover slips were mounted with a drop Vector Shield (Vector laboratories 
Inc; H-1000), including DAPI (0.3ng/µl).  Imaging of the cells was done with 543nm, 
488nm, 405nm excitation provided by an argon laser and a 63 x 1.4 NA apochromat 
objective lense (Carl Zeiss MicroImaging) for FITC, TRITC and DAPA respectively. 
Zeiss AIM  software version 3.2 was used for merging the images. 
Flow cytometry
To distinguish between live and dead cells, the DNA content was determined. 0.5 
to 1.0x106 cells were fixed and permeabilized with ice-cold methanol (0.5ml; 30’) 
washed 2 times with PBS and incubated for 30’ with 0.5% w/v RNAse A in PBS under 
constant shaking. DNA was stained with propidium iodide (50mg/ml in PBS) and 
fluorescence was measured by flow cytometry.
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RNA isolation and cDNA synthesis
Total RNA was isolated using the Trizol reagent (Life Technologies) as recommended 
in the manufacturer’s protocol. Isolation of polysomal RNA by sucrose gradient 
fractionation was performed as described (Mullner 1997; Joosten et al. 2004). Cell 
extracts were layered on a 4ml linear sucrose gradient (15–40% sucrose [w/v]) and 
8 fractions were collected. Northern blotting indicated that fractions 1-4 contain 
nonpolysomal and subpolysomal mRNA, while fractions 5-8 consisted of polysome-
bound RNA. These fractions were pooled to generate subpolysomal and polysomal 
mRNA of each sample. RNA was quantified by UV-absorbance. Poly(A)+ mRNA was 
purified and cDNA was generated as described (Joosten et al. 2004) 
Real-time PCR 
The real-time PCR assay involved TaqMan technology (PE Applied Biosystems Model 
7700 sequence detector), using the double stranded DNA-specific fluorescence dye 
SYBR green I to detect PCR product as previously described (Kolbus et al. 2003). 
The amplification program consisted of 1 cycle of 50°C with 2’ hold (AmpErase UNG 
incubation), 1 cycle of 95°C with 10’ hold (AmpliTaq Gold Activation), followed by 
40 cycles of denaturation at 95°C for 15”, annealing at 62°C for 30” and extension 
at 72°C for 30”. All the different primer pairs had similar optimal PCR annealing 
temperatures. Acquisition of the fluorescence signal from the samples was carried 
out at the end of the elongation step. To confirm amplification specificity, the PCR 
products from each primer pair were subjected to agarose gel electrophoresis and 
the dissociation curve was checked at the end of each run. Gene-specific primers 
corresponding to nucleoside diphosphate kinase B (Ndpk-B, X68193), eukaryotic 
translation elongation factor eEF-1β2 (MGC:6763), eukaryotic translation initiation 
factor eIF-4E (M61731), Fli-1 (X59421), ornithine decarboxylase (ODC, M12330), 
mammalian ribonuclease inhibitor (IMAGE:1366946), U2 splicing factor Snrpb” 
(AA146248) and Y-box binding protein 1 (YB-1, X57621) were obtained from 
Invitrogen Life Technologies or Sigma-Genosys Ltd. The sequences of the primers 
used for the amplification are listed in Table I.
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Table I. Primer sequences used for real-time PCR amplification.
Name Forward Primer Sequence Reverse Primer Sequence
Ndpk-B 5’ATG GGA TTC GGA GAC CTG AA3’ 5’TCA GCA GGT GGT GGA CCA GA3’
eEF-1b2 5’ATG GGA TTC GGA GAC CTG AA3’ 5’TCA GCA GGT GGT GGA CCA GA3’
eIF4E 5’TCT AAT CAG GAG GTT GCT AAC3’ 5’TAG ACA ACT GGA TAT GGT TGTA3’
Fli-1 5’TGC AGC CAC ATC CAA CAG AG3’ 5’TGA AGG CAC GTG GGT GTT AG3’
ODC 5’TG ACG TCA TTG GTG TGA GC3’ 5’TAT CAA GCA GAT GCA TGC TGT3’
RI 5’TCC AGT GTG AGC AGC TGA G3’ 5’TGC AGG CAC TGA AGC ACC A3’
U2 Snrpb” 5’TCA GTT TGG ACA CGT GGT AG3’ 5’TCC TTG TCA GCG AAA GTA CCA3’
YB-1 5’TGC AGG AGA GCA AGG TAG AC3’ 5’TGG TGG ATC GGC TGC TTT TG3’
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ABSTRACT 
SCF-induced activation of phosphoinositide-3-kinase is required for erythroid 
progenitors to undergo renewal. The activation of mTOR (Target of Rapamycin) 
and subsequent release of the cap-binding translation initiation factor eIF4E plays 
an important role in the regulation of proliferation versus maturation of erythroid 
progenitors. To study the contribution of selective polysome recruitment of mRNAs, 
we compared SCF-dependent gene expression between total and polysome bound 
mRNA. This yielded a list of 115 genes subject to major regulation by translation 
initiation. Detailed analysis showed that SCF-induced polysome recruitment 
exceeded 5-fold regulation, and was PI3K-dependent and eIF4F-sensitive for 9 out 
of 10 genes. One of the targets, Igbp1/α4, binds and inhibits the serine/threonine 
phosphatase Pp2a that functions as an mTOR antagonist in translation initiation. 
Constitutive expression of Igbp1/α4 strongly impaired erythroid differentiation, 
maintained 4EBP and p70Sk phosphorylation and enhanced polysome recruitment 
of structured mRNAs. This showed that PI3K-dependent polysome recruitment of 
Igbp1/α4 acts as a strong positive feedback mechanism on translation initiation 
and underscores the important regulatory role of selective polysome recruitment.
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INTRODUCTION 
The balance between expansion and differentiation of hematopoietic progenitor 
cells is controlled by cytokines and growth factors. In erythropoiesis, stem cell 
factor (SCF), the ligand for cKit, cooperates with glucocorticoids and erythropoietin 
(Epo) to suppress differentiation and sustain renewal divisions of erythroid 
progenitors in vitro (Dolznig et al., 2001; von Lindern et al., 2001) as well as in vivo 
in response to hypoxia (Bauer et al., 1999; Broudy et al., 1996). Activation of PI3K 
(phosphotidylinositol-3 kinase) is required for proliferation of erythroid progenitors 
(Haseyama et al., 1999; Klingmuller et al., 1997; Nishigaki et al., 2000; Sui et al., 
2000; von Lindern et al., 2001). Activation of PI3K generates PIP3, which serves 
as an anchor for PH-domain containing proteins, of which protein kinase B (PKB) 
is a major PI3K effector. Although both Epo and SCF induce activation of PI3K in 
erythroid progenitors, the efficiency with which downstream signalling pathways 
are activated shows large differences (Bakker et al., 2004; Blazquez-Domingo et 
al., 2005). In in vitro cultured erythroid progenitors the activation of PKB is much 
more responsive to SCF compared to Epo (von Lindern et al., 2001, Bakker et al., 
2004). PKB activates mTOR (mammalian target of rapamycin, also named Frap1) 
through phosphorylation of the tumour suppressor complex Tsc1/Tsc2 (tuberous 
sclerosis protein), which releases Rheb (RAS-homolog enriched in brain) to 
phosphorylate mTOR (Inoki et al., 2003; Tee et al., 2003). Activation of mTOR results 
in phosphorylation and activation of p70S6 kinase (Rps6kb1; Dufner and Thomas, 
1999), and hierarchical phosphorylation of 4EBP (4E-Binding Protein; Gingras et 
al., 1999a) resulting in release of the mRNA cap-binding factor eIF4E (eukaryotic 
Initiation Factor 4E; Gingras et al., 2001). Subsequently, eIF4E can bind the scaffold 
protein eIF4G to the site otherwise occupied by 4EBP, which enables the formation 
of a eIF4F scanning complex containing eIF4E, eIF4G and the RNA helicase eIF4A 
(Gingras et al., 1999b). eIF4F associates with several other translation factors and the 
small subunit of the ribosome. This complex scans the 5’UTR for the first AUG codon 
in an appropriate sequence context (Kozak, 2005), where the complete ribosome 
recruits methionine-tRNA and all translation factors required for protein synthesis 
(Pestova et al., 2001). The cap-binding eIF4E protein is the rate-limiting factor in 
the scanning process (Duncan et al., 1987; Sonenberg and Gingras, 1998) and 
therefore its release upon phosphorylation of 4EBP is a crucial control mechanism 
in polysome recruitment of mRNAs. Importantly, transcripts with a short and simple 
5’UTR show a limited sensitivity to 4EBP phosphorylation, whereas transcripts with 
a long and structured 5’UTR or with a terminal oligopyrimidine tract (TOP) are highly 
sensitive to the concentration of eIF4F complexes in the cell (Jefferies et al., 1997; 
Koromilas et al., 1992; Kozak, 2005). 
The mechanism by which mTOR controls 4EBP phosphorylation may entail 
both regulation of a 4EBP-kinase and of the serine/threonine phosphatase Pp2a 
(Di Como and Arndt, 1996; Inui et al., 1998; Murata et al., 1997; Wang et al., 2005). 
Pp2a is the main phosphatase acting on p70S6K and 4EBP1, thereby suppressing 
translation initiation. Pp2a exists in various complexes that shift target specificity 
depending on the binding of regulatory components. mTOR modulates the formation 
of the Pp2a-α4 complex sequestrating the phosphatase activity away from its own 
downstream targets 4EBP and p70S6 kinase (Inui et al., 1998; Kong et al., 2004).  
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We showed previously that 4EBP is rapidly and strongly phosphorylated 
by SCF (Blazquez-Domingo et al., 2005), and identified transcripts that require 
SCF-induced PI3K/mTOR activation to be recruited to polysomes, while their 
transcript levels in the cells are unchanged (Blazquez-Domingo et al., 2005). The 5’ 
untranslated regions (UTR) of Nm23, Ybx1 and Snrpb” include stable hairpin loops, 
long complex sequences and TOP structures respectively, structures that impose 
gene expression control at the translation level. 
Overexpression of eIF4E increased the levels of eIF4F complexes and 
suppressed erythroid differentiation in the absence of SCF, indicating an important 
role for mechanisms that control eIF4F formation in regulating the balance between 
expansion and differentiation in erythropoiesis (Blazquez-Domingo et al., 2005). This 
is in line with reports stating that increased expression of eIF4E in tumour samples 
is associated with increased malignancy (Bader and Vogt, 2004; De Benedetti and 
Graff, 2004; De Benedetti and Harris, 1999; Topisirovic et al., 2003). It suggests a 
major role for selective translation of specific mRNAs, but an overview of mRNAs 
subject to factor-dependent polysome recruitment is missing. 
In this study we compared factor-dependent mRNA expression in total and 
polysome bound mRNA and identified a list of 115 transcripts that require PI3K or 
increased eIF4F levels for polysome recruitment. From these we selected 9 genes 
suspected to be involved in signal transduction or gene expression and analysed their 
expression regulation and biological function in erythroid progenitors. Except for one 
gene, Grwd1, that was regulated by gene transcription and mRNA translation, the 
selected genes were strictly regulated by SCF-induced activation of PI3K and eIF4F. 
Strikingly, we identified the Pp2a-associated protein Igbp1/α4 as a target of SCF-
dependent polysome recruitment. Constitutive expression of Igbp1/α4 in erythroid 
progenitors enhanced the mTOR-dependent phosphorylation of S6K and 4EBP, 
releasing eIF4E. This resulted in impaired differentiation of erythroid progenitors, 
and enhanced polysome recruitment of other targets identified in this screen. 
RESULTS 
Transcripts dependent on Epo/SCF-induced polysome recruitment
To identify mRNA transcripts that are selectively recruited to polysomes upon 
growth factor stimulation of erythroid progenitors, we compared factor-induced gene 
expression at the level of total and polysome bound (pb) RNA using mRNA profiling. 
Erythroid progenitors were factor deprived (4h) and restimulated (2h) with Epo plus 
SCF, or left unstimulated. Four biologically independent replicates were prepared 
using two established p53-/- erythroblast cultures with different genetic background 
(I/11 and R10; Schmidt et al., 2004; von Lindern et al., 2001). Total and pb RNA 
were isolated twice from each culture, cRNA was generated and hybridized to 
Affymetrix oligonucleotide arrays. Rosetta Resolver software was used to normalize 
and analyse the intensity data. The ratio of gene expression in Epo/SCF stimulated 
samples (ES) versus factor-deprived cells (NF) was calculated for total and pb 
mRNA by Rosetta Resolver software. To identify genes differentially regulated in 
total versus polysome bound RNA, we applied a two step selection (for strategy see 
supplemental Figure S1). First, the variance between the ES/NF ratio’s for total and 
pb RNA was derived by ‘Analysis of Variance’ (ANOVA; p=0.01). Second, selected 
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genes had to be differentially expressed in presence or absence of Epo/SCF in 
total or polysome bound mRNA in both I/11 or both R10 hybridisations (p=0,0012) 
This resulted in 115 probe sets, representing 111 transcripts, subject to Epo/SCF-
controlled polysome recruitment (supplementary Table S-II). To relate differential 
polysome recruitment to gene expression during differentiation, we derived pb mRNA 
from steady state expanding and differentiating progenitors (48 and 60 h following 
differentiation induction). Following hybridization of oligonucleotide arrays we used 
Rosetta Resolver to calculate the gene expression ratio of differentiation over steady 
state renewal. Subsequent cluster analysis of the gene expression ratio’s resulted 
in a matrix that groups the selected probe sets into 5 separate clusters (Figure 1; 
supplementary Table S-II). 
To gain insight into regulation of gene expression in the various clusters, 
we plotted the normalized intensity data obtained from the array hybridisation with 
total and pb RNA, from factor-deprived and Epo/SCF-restimulated cells (weighted 
average of the 4 hybridisations; Supplementary Figure S2). Genes in cluster 1, 3 
and 5 are subject to Epo/SCF-enhanced polysome recruitment, and decreased 
expression during differentiation. Cluster 1 represents constitutive expression in 
total RNA and Epo/SCF-dependent polysome recruitment, cluster 3 represents 
factor-dependent increased transcript level, but a much larger stronger increase 
of Epo/SCF-induced polysome recruitment, cluster 5 represents Epo/SCF-induced 
repression of expression in total mRNA with maintained, constant levels in pb RNA, 
which, in effect, indicates increased Epo/SCF-induced polysome recruitment from 
a smaller transcript pool. In contrast, genes present in cluster 2 and 4 are subject 
to enhanced polysome recruitment following factor deprivation, which is abrogated 
by Epo/SCF restimulation (supplementary Figure S2). Only genes represented in 
cluster 4 are upregulated during differentiation. 
Polysome recruitment of selected transcripts depends on the PI3K/mTOR/
eIF4E pathway
Next, 9 genes were selected that (i) require Epo/SCF for polysome recruitment, 
(ii) are downregulated in differentiation, and (iii) are suggested to function in signal 
transduction or gene expression (Table I). Quantitative RT-PCR (Q-PCR) was used 
to analyse whether polysome recruitment was always dependent on PI3K and 
mTOR, and on eIF4E expression. 
First, we examined how signalling-dependent expression in total and pb 
RNA correlates between array-data and Q-PCR. We determined transcript levels 
in subpolysomal and pb RNA by Q-PCR and calculated the percentage polysome 
recruitment. Nm23-M2 and Ybx1 were tested as positive controls. A control gene, Fli-
1 (Blazquez-Domingo et al., 2005), that is not regulated at the level of RNA-specific 
polysome recruitment, showed at most 2-fold difference in polysome recruitment in 
response to Epo or SCF (Table I, Figure 2C,F). In contrast, 8 out of 9 of the selected 
genes showed at least a 5-fold increase in polysome recruitment in response to Epo 
or SCF (Table I, Figure 2A,B,D,E). As shown previously for Nm23-M2 and Ybx1, 
SCF-induced increase in polysome recruitment exceeded Epo-induced poysome 
recruitment (Joosten et al., 2004). Cluster 1 genes (Igbp1, mEd2, Rnf138, Nap1l1, 
Cnih, Nubp1) were almost exclusively upregulated in pb but not in total mRNA; cluster 
5 genes (Uhmk1, Hnrpa1) were downregulated in total mRNA in accordance with the 
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Figure 2  Polysome recruitment of Igbp1 and mEd2 is PI3K and eIF4E sensitive. I/11 cells were 
factor-deprived for 4h and subsequently restimulated with Epo (E, 2U/ml), SCF (S, 100 ng/ml) or both 
for 2h. Total and pb mRNA were isolated and relative amounts of Igbp1 (A), mEd2 (B) and Fli1 (C) 
mRNA measured by semi-quantitative RT-PCR. Expression ratio’s in restimulated versus factor deprived 
cells is calculated and shown in panels A-C. In addition, free and polysome bound mRNA were isolated 
from I/11 cells that were factor deprived and restimulated in absence or presence of LY294002 (LY; 10 
µM) or rapamycin (R; 10nM) and restimulated for 2 h with Epo (E, 2U/ml) or SCF (S, 100 ng/ml).  The 
percentage of mRNA associated with polysomes (pb-mRNA) was calculated for the different genes under 
the different conditions (D-F). I/11 cells transduced with an empty control vector (black bars) or with an 
eIF4E expression vector (eIF4E overexpressing cells; white bars) were factor deprived in absence or 
presence of LY294002 (LY; 10 µM) and restimulated for 2 h with SCF (S, 100 ng/ml). In addition, cells 
were left untreated (NF).  Free and polysome bound mRNA was isolated and assayed for the expression 
of (G) Igbp1 (H) mEd2, and (I) Fli-1. The percentage of mRNA associated with polysomes (pb-mRNA) was 
calculated for the different genes under the different conditions.  I11 cells were induced to differentiate and 
total RNA isolated from time point 0hours, 24hours (t24), 48hours (t48) and 72 hours (t72).  The relative 
amount to time point 0 is plotted (J-L; fold change 2 log value).  The error bars represent 3 replicates each 
from 2 different RNA batches. 
Figure 1 Cluster analysis of genes subject to regulation by Epo/SCF-controlled mRNA polysome 
recruitment and their regulation during differentiation. I/11 cells and R10 cells were factor deprived for 
4h and stimulated with Epo plus SCF (ES), or left untreated (NF) for 2h. Total RNA and polysome bound 
(pb) mRNA was isolated and used for RNA profiling on MG_U74Av2 Affymetrix oligonucleotide arrays. For 
each of two biologically independent experiments (I/11a and I/11b; R10a and R10b) the ES/NF ratio of 
intensity data was calculated. Significant variance between ES/NF ratios obtained with total and pb RNA 
was calculated using ANOVA (pvalue 0.01), and differential expression in at least 2 single experiments 
had to be significant (p=0.0012). This yielded the 115 genes plotted in this heat map. In two independent 
experiments I/11 and R10 cells were differentiated for 48h and 60h to generate pb RNA that was profiled 
on the same Affymetrix oligonucleotide arrays. Expression ratios were clustered using Rosetta software 
and Pearson correlation. A bar in the left upper corner indicates how up- and down-regulation correlate 
with the intensity of red and blue respectively on a 10log-scale. 
array data (Table I). In presence of the PI3K-inhibitor LY294002 or the mTOR inhibitor 
rapamycin, polysome recruitment of the control gene Fli-1 was approximately 2-fold 
decreased, but all genes that require Epo/SCF for polysome recruitment, dissociate 
from polysomes in presence of PI3K and mTOR inhibitors (Table I; Figure 2D-F). 
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Because the PI3K/mTOR pathway controls phosphorylation of 4EBP, which releases 
eIF4E and increases the availability of the eIF4F scanning complex, overexpression 
of eIF4E is expected to render the selected transcripts less sensitive to Epo/SCF-
induced PI3K activity (Blazquez-Domingo et al., 2005). Indeed, PI3K-dependent 
polysome recruitment of all transcripts became constitutive in cells overexpressing 
eIF4E (Table I, Figure 2G,H). The effect on the Fli-1 control is again 2-fold maximum 
(Figure 2I).
We previously showed that PI3K activity is required for the expansion 
of erythroblast cultures, and overexpression of eIF4E impaired differentiation 
(Blazquez-Domingo et al., 2005; von Lindern et al., 2001). Therefore, proteins 
whose expression is controlled by PI3K-dependent mRNA polysome recruitment 
may be mainly required during erythroblast proliferation. Pb mRNA was isolated 
from I/11 cells induced to differentiate and Q-PCR showed that the selected genes 
were all downregulated during differentiation (Table I, Figure 2J,K). The erythroid 
transcription factor Nfe2 is known to be upregulated during differentiation and is 
shown as a control (Figure 2L). 
Epo/SCF-dependent protein expression of Igbp1 and Uhmk1
To examine whether protein expression of selected genes is faithfully represented 
by polysome recruitment, we analysed protein expression of Igbp1 and Uhmk1 
on Western blot and compared factor-dependent expression with Fli-1. To verify 
that expression of Igbp1 and Uhmk1 is primarily controlled at the level of mRNA 
translation, we analysed protein expression during steady state proliferation, 
following inhibition of gene transcription by Actinomycin D (ActD) and upon inhibition 
of mRNA translation by cycloheximide (CHX). In contrast to Fli-1, expression of Igbp1 
and Uhmk1 was more sensitive to inhibition of translation compared to inhibition of 
transcription (Figure 3A). Factor-deprivation decreased Igbp1, but not Uhmk1 protein 
levels (Figure 3B), which is in accordance with differential polysome recruitment, 
because Igbp1 showed constant transcript levels and strict factor-dependent 
polysome recruitment, whereas Uhmk1 showed decreased transcript levels with 
sustained polysome recruitment upon factor-deprivation (Supplemental Figure 
S2H). Restimulation rapidly increased Igbp1 and Uhmk1 protein expression which 
was inhibited by rapamycin as much as with CHX. Fli-1 expression, however, was 
inhibited by CHX, but not by rapamycin (Figure 5B). Thus, factor-dependent Igbp1 
and Uhmk1 protein expression was appropriately reflected by polysome-bound RNA 
levels, and not by total mRNA levels. 
Functional analysis of target genes
Since SCF-induced, PI3K-dependent pathways sustain expansion and delay 
differentiation of erythroid progenitor cultures, we next investigated whether the 
proteins that require SCF-induced signalling to be synthesised have a major role in 
this process. Selective polysome recruitment, in general, depends on the 5’ structured 
UTR of the transcripts. From the 9 selected genes, 8 showed PI3K-dependent 
polysome recruitment and 7 of these 8 genes could be expressed from retroviral 
expression vectors in which we cloned the ORF downstream of sequences encoding 
the myc-epitope (for unclear reasons Nubp1 resisted cloning in pBabe). Expression of 
selected genes in the Phoenix cells was analysed on Western Blots (data not shown) 
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Figure 3  Signalling dependent expression 
of Igbp1 and Uhmk1 protein.  A: Inhibitors 
of translation (cycloheximide 50µg/ml; 
ChX) and transcription (Actinomycin D 
10µg/ml; ActinoD) were added for 2, 4, 
6 and  8 h to proliferating I/11 cells.  The 
insert shows the linearity of Igbp1 detection 
in subsequent 2-fold dilutions of total cell 
lysate (r2=0.9939). Bars for ChX (black) 
and ActinoD (white) indicate fold change 
(fc) expression compared to ActinoD 2hr 
expression. Compared to Fli-I, expression 
of Igbp1 and Uhmk1 is more sensitive to 
translation inhibition.  B: I/11 cells were 
factor deprived for 4 h and restimulated 
with Epo plus SCF for 2 h (stimulation) or 
left untreated (starvation).  A steady state 
(ss) sample is also included. Inhibitors 
of mTOR (rapamycin 40ng/ml; rapa) and 
translation elongation (ChX) were added 
during factor deprivation and subsequent 
restimulation. Bars indicate fold change of 
protein expression compared to expression 
after factor deprivation.
and its cellular distribution assessed by Immunofluorescence (Supplementary 
Figure S3). The expression vectors were transduced into I/11 cells and single cell-
derived clones were established. In every experiment aimed to establish clones 
expressing selected genes, empty vector control clones were established as well. 
Four of the eight genes, Uhmk1/Kis, Cnih, Rnf138, and Nap1l1 could be 
expressed transiently in Phoenix cells (Supplementary data Figure S3), but we 
failed to establish I/11 clones stably expressing these genes. Hnrpa1, Igbp1 and 
mEd2 (2010315L10Rik) were expressed in Phoenix and in I/11 cells and several 
I/11, single cell-derived clones were established. To analyse how individual target 
genes contribute to SCF-induced suppression of differentiation, these clones were 
subjected to differentiation conditions. Differentiation parameters including cell 
number, mean cell volume (Figure 4A), haemoglobin per cell volume (Figure 4B) and 
cell morphology at various time points (Figure 4C) were analysed. Upon induction 
of differentiation, empty vector transduced control cells rapidly became smaller and 
accumulated haemoglobin (Figure 4A,B). After 72 hours they mostly showed a mature 
morphology (Figure 4C). Constitutive expression of Hnrp1 showed essentially the 
same differentiation kinetics. Constitutive expression of Igbp1 and mEd2, however, 
clearly impaired differentiation. Erythroblasts constitutively expressing Igbp1 
remained large, failed to accumulate haemoglobin and kept a blast like morphology 
(Figure 4A-C). Erythroblasts constitutively expressing mEd2 were partially impaired 
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in differentiation. The cells became smaller, but did not accumulate haemoglobin and 
showed a partially differentiated morphology (Figure 4A-C). In these experiments 
we used the mEd2 ORF published to enhance an ERK-dependent reporter 
construct (Matsuda et al., 2003). In a later stage longer cDNAs became available 
that express the ORF recently described to encode a novel Q-SNARE protein D12 
(Okumura et al., 2006). Similar to Uhmk1, Rnf138 and Cnih, we could express D12 
in Phoenix cells, but we failed to establish stable expression in I/11. Thus, constitutive 
expression of a full length protein seems incompatible with proliferation of erythroid 
progenitors while expression of a truncated protein inhibits differentiation.  
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Figure 4  Overexpression 
of Igbp1 and mEd2 impairs 
differentiation of I/11 erythroid 
progenitors. I/11 cells 
transduced with an empty control 
vector or with an Igbp1, mEd2 
and Hnrpa1 expression vectors 
were seeded in differentiation 
medium supplemented with Epo 
(E, 20U/ml). A: Mean Cell volume 
(fl) and B: hemoglobin content 
per cell volume (arbitrary unites; 
a.u.) were analyzed at regular 
intervals for 4 days. C: At the 
start of the assay and at day 3, 
cells were harvested for cytospins 
and stained for hemoglobin 
(brown color) and histological 
dyes. Hemoglobinised and 
enucleated erythrocytes are 
present in control cells and cells 
constitutively expressing Hnrpa1, 
while Igbp1 and mEd2 expressing 
cells contain mainly blasts.
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Figure 4  Overexpression of Igbp1 and mEd2 impairs differentiation of I/11 erythroid progenitors. 
I/11 cells transduced with an empty control vector or with an Igbp1, mEd2 and Hnrpa1 expression vectors 
were seeded in differentiation medium supplemented with Epo (E, 20U/ml). A: Mean Cell volume (fl) and 
B: hemoglobin content per cell volume (arbitrary unites; a.u.) were analyzed at regular intervals for 4 days. 
C: At the start of the assay and at day 3, cells were harvested for cytospins and stained for hemoglobin 
(brown color) and histological dyes. Hemoglobinised and enucleated erythrocytes are present in control 
cells and cells constitutively expressing Hnrpa1, while Igbp1 and mEd2 expressing cells contain mainly 
blasts.
Igbp1 affects 4EBP and p70S6k phosphorylation
Igbp1 is able to associate with the serine/threonine phosphatase Pp2a and modifies 
Pp2a phosphatase activity (Inui et al., 1998; Kong et al., 2004). Interestingly, Pp2a 
is the major phosphatase of 4EBP and p70S6k and Igbp1 inhibits Pp2a-activity on 
these targets. Therefore we analysed Epo- and SCF-dependent 4EBP and p70S6k 
phosphorylation in control and Igbp1 expressing erythroblasts. As we have shown 
previously, SCF but not Epo is able to induce full phosphorylation of 4EBP in control 
cells (Blazquez-Domingo et al., 2005). Upon constitutive expression of Igbp1, however, 
stimulation of erythroblasts by Epo is sufficient to induce hyperphosphorylation of 
4EBP (Figure 5A). Similarly, constitutive expression of Igbp1 increased Epo-induced 
p70S6k to levels only obtained with Epo plus SCF in control cells (Figure 5B). 
Constitutive expression of alpha4 enhances polysome recruitment of 
structured mRNAs
Because phosphorylation levels of 4EBP and p70S6k affect translation of structured 
mRNAs, we tested polysome recruitment of mRNAs in steady state expanding cells, 
in factor-deprived and Epo-restimulated cells. Expression levels of various genes 
were measured by Q-PCR in subpolysomal and polysome-bound mRNA fractions 
isolated from empty vector-transduced control erythroblasts and erythroblasts 
constitutively expressing Igbp1. Igbp1 itself showed increased polysome recruitment 
upon factor-deprivation and Epo restimulation (Figure 5D), which is not surprising 
as the expressed construct lacks the regulatory sequences responsible for factor-
dependent translation. Polysome recruitment of Fli-1, which is not subject to 
factor-dependent translation, is also not affected by Igbp1 expression (Figure 5C). 
However, two transcripts with a terminal oligopyrimidine tract, eIF1β and Rps4 as 
well as two transcripts with a highly structured 5’UTR, mEd2 and Nm23-M2, show 
increased polysome recruitment (Figure 5E-H). Together these data indicate that 
translational control of Igbp1 is an important positive feedback signal to enhance 
polysome recruitment of structured mRNAs.
DISCUSSION  
Overexpression of eIF4E rendered proliferation of erythroid progenitors independent 
of SCF-induced PI3K activation and indicated that activation of the PI3K-mTOR-eIF4E 
pathway is an important mechanism by which SCF delays differentiation and sustains 
proliferation of erythroid progenitors (Blazquez-Domingo et al., 2005). This suggests 
that selective polysome recruitment of structured mRNAs is crucial to erythropoiesis. 
However, only few such transcripts are known. In this study we identified a unique 
set of genes that are hardly regulated at the level of gene transcription and are 
recruited to polysomes by an SCF-induced, PI3K-dependent, increase in eIF4F 
complexes. Functional analysis revealed that constitutive expression of one of these 
genes, Immunoglobulin binding protein 1 (Igbp1, also named α4 subunit of Pp2a), 
strongly inhibited terminal differentiation of erythroid progenitors. Whereas Pp2a 
dephosphorylates the mTOR targets 4EBP and p70S6K, constitutive expression of 
Igbp1/α4 maintained phosphorylation of 4EBP and p70S6K, particularly in presence 
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Figure 5 Constitutive Igbp1 expression 
increases phosphorylation of 4EBP 
and S6K and enhances Epo induced 
polysome recruitment of structured 
transcripts. A-B: I/11 cells transduced 
with an empty control vector (ev) or 
with an Igbp1 expression vector were 
factor deprived for 4 h, stimulated with 
Epo (E, 5U/ml) or SCF (S, 100 ng/ml) 
or Epo plus SCF (ES), as indicated or 
left untreated (NF).  Expanding I/11 
cells in the presence of Epo, SCF and 
dexamethasone are denoted as ss 
(steady state).   A: Western blots with 
total cell lysates were stained with 
antibodies recognizing total 4EBP 
(4EBP Ab). The non-phosphorylated, 
hypo and hyper-phosphorylated 
proteins can be discriminated by their 
distinct electrophoretic mobility as α, β 
and γ-isoforms respectively. B: Western 
blots with samples stimulated for 10 
minutes were stained with a phospho-
specific antibody against p70S6K 
(P-S6K) and counterstained for total 
S6K to control for equal loading. C-H: 
I/11 empty vector control (black bars) 
or constitutive Igbp1 expressing cells 
(white bars) were factor deprived and 
restimulated for 2 h with Erythropoietin 
(Epo, 2U/ml). In addition, cells were left 
untreated (NF).  Free and polysome 
bound mRNA was isolated and assayed 
for the expression of Fli-1 (C), Igbp1 
(D), eEF1β  (E), rps4 (F), Nm23 (G), 
and mEd2 (H). The percentage of 
mRNA associated with polysomes (pb-
mRNA) was calculated for the different 
genes under the different conditions. 
Constiutive Igbp1 expression enhances 
polysome recruitment of translationally 
controlled transcripts under Epo 
conditions alone.
of Epo and absence of SCF. Igbp1/α4 appeared to function in a positive feed-back 
loop of mTOR regulated polysome recruitment of structured mRNAs. The complete 
inhibition of differentiation induced by constitutive Igbp1/α4 expression emphasises 
the important role of selective polysome recruitment in control of gene expression 
and cell fate determination.
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Specific transcripts recruited to polysomes by SCF signalling 
It is well recognised that transcript levels determined by total mRNA profiling differ 
from protein expression levels. Polysome bound mRNA profiling integrates control at 
the level of transcription, mRNA nuclear export and polysome recruitment, getting 
results closer to proteomics (Pradet-Balade et al., 2001). Recently, Rajasekhar 
and collegues demonstrated PI3K- and Mek1-dependent, selective polysome 
recruitment of mRNA in v-Ras/v-Akt transformed glioblastoma cells (Rajasekhar 
et al., 2003). We found little overlap between our studies, which may be due to the 
use of a different cell type and a different experimental approach addressing quick 
responses to stimuli in our study as opposed to the effect of genetically perturbed 
pathways. 
Both studies indicate that gene expression profiling using polysome bound 
mRNA (pb RNA) will reveal differentially expressed genes that would not be detected 
at the level of total RNA. However, the advantage of using pb mRNA may depend 
on the conditions and samples used. Conventional profiling with total mRNA may 
be preferred to find targets of transcription factors, or when structural, noncoding 
RNAs have to be included in the targets. In conclusion, the distribution of Epo/
SCF-controlled gene expression detected using total and pb mRNA indicates that 
polysome recruitment is an important level at which signalling-dependent gene 
expression is regulated and that the use of pb RNA in RNA profiling studies can 
increase the sensitivity with which alterations in gene expression can be detected.
Selective polysome recruitment depends on structured UTRs
SCF signalling stimulates cap-dependent translation and is expected to identify 
transcripts that require increased levels of the eIF4F complex and enhanced p70S6K 
activation. It is broadly accepted that these transcripts are characterized by structured 
5’UTRs (Koromilas et al., 1992, De Benedetti et al, 2004). Our list of translationally 
regulated genes contained ribosomal proteins and some translation factors known to 
contain a TOP sequence (Levy et al., 1991) (mainly present in clusters 1 and 5; Table 
S-I). The difference between factor-induced expression (array data) in total versus 
pb RNA of these genes, however, was mostly less than 1,5-fold. The genes selected 
for functional analysis showed a more extensive control of expression at the level 
of mRNA polysome recruitment. None of them contained a TOP sequence, but the 
structures that contribute to control of translation initiation are not easily discernable. 
Cross-species comparisons and comparisons between genomic and coding 
sequences present in genome databases suggest that most of these structured 
5’UTRs are incompletely represented. However, even when the 5’UTR is known, the 
structural configuration that controls polysome recruitment occurs in combination 
with short sequences that are on their own not discriminative as is shown by the 
limited recognition site of the iron response element stem-loop element (Thomson 
et al., 1999) or the consensus pseudoknot structure bound by Fragile-X mental 
retardation protein (Frm1; Darnell et al., 2005). In addition to hairpin and pseudoknot 
structures, upstream AUGs (uAUG) may affect polysome recruitment. Translation of 
upstream open reading frames (uORF) can attenuate translation of the proper ORF 
as a result of premature dissociation of ribosomes (Child et al., 1999; Kozak, 1987) 
and/or stalling of the scanning complex by interaction of the nascent peptide with 
components of the complex (Ruan et al., 1996). Although the transcription start site 
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of Igbp1/α4 and mEd2 is not yet fully known, both seem to contain potential hairpin 
structures and uAUGs.
Signalling mRNA translation; role of Pp2a
The activity of the central regulator of protein synthesis, mTOR, is modulated by a 
variety of signals (Gingras et al., 1999b; Gingras et al., 2001; Inoki et al., 2003). Thus, 
polysome recruitment of transcripts that require activation of the PI3K/mTOR/eIF4E 
pathway is expected to be sensitive to amino acid starvation and lack of cAMP as well 
(Hara et al., 1998; Lawrence et al., 1997). However, activation of mTOR may not be 
sufficient to induce polysome recruitment, additional PI3K-dependent kinases may 
also be involved (Dennis et al., 1996; Peterson et al., 2000; Wang et al., 2005; Weng 
et al., 1995). The possible requirement for additional kinases may also explain why 
erythroblasts are only dependent on PI3K activation, while the glioblastoma model 
requires cooperation between v-Ras/Mek1 and PI3K/mTOR signalling (Rajasekhar 
et al., 2003).
The major antagonist of mTOR and/or cooperating kinases is the serine/
threonine phosphatase Pp2a (Kloeker et al., 2003). Functional Pp2a consists of 
a catalytic subunit, a structural subunit (Pp2aA) and a variable regulatory subunit 
(Pp2aB; Kloeker et al., 2003). Among the regulatory subunits is Igbp1/α4. Pp2a 
was already implied in mTOR regulated polysome recruitment as addition of 
rapamycin disrupts the complex of Pp2a and Igbp1 (Inui et al., 1998) sequestering 
Pp2a to other functions (Kamibayashi et al., 1994). Most of these studies employed 
ectopic expression studies, or factor-independent cell lines which precluded 
analysis of factor-dependent expression of Igbp1/α4. Constitutive expression of 
Igbp1/α4 potently inhibited differentiation of erythroblasts in presence of Epo. The 
interaction of Igbp1/α4 with Pp2a controls more cellular processes in addition to 
phosphorylation of 4EBP and p70 S6K (Liu et al., 2001). However, the observation 
that (i) Igbp1/α4 expression enhances phosphorylation of 4EBP and p70S6K in 
presence of Epo to levels normally reached by Epo plus SCF, plus (ii) the finding that 
polysome recruitment of previously identified genes is rendered independent of SCF 
by constitutive Igbp1/α4 expression (similar to eIF4E overexpression; Blazquez-
Domingo et al., 2005), suggests that positive feedback in the polysome recruitment 
of structured mRNAs is a major role of SCF-induced expression of Igbp1/α4 in 
erythroid progenitors.
Interestingly, another inhibitor of Pp2a, the putative oncogene SET (von 
Lindern et al., 1992) is induced in CML (Neviani et al., 2005).  Therapeutic activation 
and ectopic expression of Pp2a, inhibits SET activation by BCR/ABL and resulted in 
reduced proliferation and leukemogenic capacity in transplantation murine models 
(Neviani et al., 2005).
Genes regulated by selective polysome recruitment and their tumorogenic 
potential
Both polysome recruitment as a function of UTR structure and the release of 
mRNAs silenced in Ribonuclear protein (RNP)-complexes offer the possibility of 
rapid alteration of predisposed gene expression patterns in response to mitogen 
and constitute a target for tumorigenic deregulation (Audic and Hartley, 2004; De 
Benedetti and Harris, 1999).  
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It is of interest that we do not find many transcription factors to be regulated 
at the level of polysome recruitment, which confirms that this level of regulation may 
be specifically targeted to pre-disposed expression profiles for quick responses. 
This is consistent with data showing that transcripts for kinases, phosphatases and 
transcription factors are not shifted from polysomes upon rapamycin treatment. In the 
same study, the transcripts of RNA-binding proteins that are part of RNP-complexes 
were identified as transcripts dissociated from polysomes upon rapamycin treatment 
(Grolleau et al., 2002). Similarly, we also detected several RNA binding proteins 
that associated with polysomes upon growth factor addition such as Hnrpa1. From 
all targets tested, Hnrpa1 was the only gene that could be constitutively expressed 
at abundant levels. It is known to be involved in the generation of correct splice 
variants encoding the erythrocyte membrane protein Band4.1 (Hou et al., 2002; Yang 
et al., 2005) and incorrect splicing has major consequences in vivo (Caceres and 
Kornblihtt, 2002). 
For functional studies, we selected genes that were recruited to polysomes 
by growth factors addition and downmodulated in differentiation.  We assumed that 
these could be constantly expressed during expansion of progenitors.  However, 
most of the genes we tested could not be constitutively expressed.  There may be a 
need to express these proteins only during a specific phase of the cell cycle.  Notably, 
these genes included Uhmk1/Kis and Cnih which associate with and control stability 
of tubulins during mitosis (Maucuer et al., 1997; Roth et al., 1995).  Igbp1/α4 has also 
been implicated in tubulin stability (Liu et al., 2001), possibly  contributing to the slow 
growth and low expression of α4 in erythroid progenitors. Rnf138 contains protein 
domains for nuclear localisation (confirmed by immunofluorescence) and ubiquitin 
ligase function. Constitutive expression may result in degradation of nuclear proteins 
that otherwise need to be controlled as a response to a particular cellular state. 
mEd2 is also known as MAPK activating protein PM26 (Matsuda et al., 2003) and its 
human homologue is ‘uncharacterised hematopoietic stem/progenitor cells protein 
MDS032’. Recently, mEd2 was shown to be a Q-SNARE protein, termed D12, 
involved in ER-trafficking (Okumura et al., 2006). Interestingly, reduced expression 
of D12 resulted in increased phosphorylation of eIF2a. This opens the interesting 
possibility that translational control of mEd2/D12, by surveillance of protein quality in 
the ER, also functions in a feed-back mechanism; a feedback from eIF4E activation 
to protection of eIF2a from inactivation by phosphorylation.
Finally, the strong inhibition of erythroid differentiation by overexpression of 
eIF4E or by constitutive expression of IGBP1/α4, the high levels of eIF4E found 
in several cancer types (De Benedetti and Graff, 2004) and the promising results 
of rapamycin as an anticancer drug (Bjornsti and Houghton, 2004; Hidalgo and 
Rowinsky, 2000) indicate that many translationally controlled genes await further 
characterisation with respect to function and regulation and that control of translation 
is not simply control of cell growth to reach ‘start’ in the cell cycle, but that it is an 
important and selective level of regulation of gene expression.
Constitutive activation of PI3K has frequently been found in both solid tumours 
and leukemia (Grandage et al., 2005; Luo et al., 2003; Min et al., 2003; Neshat et 
al., 2001; Sujobert et al., 2005; Vivanco and Sawyers, 2002). Currently, rapamycin 
homologues are tested as anticancer drugs in a large variety of tumours, yielding 
promising results (Bjornsti and Houghton, 2004; Hidalgo and Rowinsky, 2000; 
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Panwalkar et al., 2004). Although it is assumed that the anticancer effect of rapamycin 
and its analogues is due to a general inhibition of protein synthesis in proliferating 
cells, it is more likely that inhibition of mTOR specifically targets structured mRNAs. 
The promising antitumour effects of rapamycin and the finding that constitutive 
expression of IGBP1/α4 inhibited maturation and sustained expansion of progenitor 
cells, underline the importance to understand mechanisms of translation initiation. 
The genes identified in this study are a good starting point for such studies.
MATERIALS AND METHODS
Cells
I/11 cells were cultivated in StemPro-34TM medium (Life Technologies) as described 
(von Lindern et al., 2001). For expansion, the medium was supplemented with 
0.5U/ml Epo, (kind gift from Ortho-Biotech, Tilburg, The Netherlands), 100ng/ml 
SCF (supernatant of CHO producer cells) and 10-6M dexametasone (Dex, Sigma-
Aldrich). To induce differentiation, cells were cultivated in StemPro-34TM medium 
supplemented with 5U/ml Epo and 0.5mg/ml iron-loaded transferrin (Intergene). Cell 
numbers and cell size distribution were determined using an electronic cell counter 
(CASY-1, Schärfe-System, Reutlingen, Germany). LY294002 (10µM in final volume) 
and rapamycin (40ng/ml) were obtained from Alexis (Schwitzerland), Actinomycin D 
(10µg/ml) and Cycloheximide (50µg/ml) from Sigma-Aldrich.
Haemoglobin content determination and cell morphology
Small aliquots of the cultures were removed and analyzed for hemoglobin content 
by photometry as described earlier (Bakker et al., 2004; Kowenz et al., 1987). The 
values obtained were the average of triplicate measurements after normalization 
for cell number and mean single cell volume. Cell morphology was analyzed in 
cytospins stained with histological dyes and neutral benzidine (Beug et al., 1982), 
using an OlympusBx40 microscope (40x objective, NA 0.65), an OlympusDp50 CCD 
camera and Viewfinder Lite 1.0 acquisition software. Images were cropped using 
Adobe photoshop 6.0.
Microarray hybridization and analysis
A MIAME compatible description of sample preparation and hybridization protocols 
is given in supplementary data. The data extraction strategy is described in 
supplementary Figure S1.  Microarray data were normalised using the Rosetta 
Resolver ® system, as described in (Weng et al., 2006).  Weighted averages were 
calculated using log error data extracted for each probe set.  The error weight was 
calculated (log error / total log error of 4 hybridisations) and the average calculated 
integrating the error weight.  
SDS-PAGE, western blotting and antibodies
For acute stimulation with growth factors, proliferating I/11 cells were washed twice 
with phosphate-buffered saline (PBS) and seeded at 4 x 106 cells/ml in plain Iscove’s 
modified Dulbecco’s medium (IMDM, Life Technology). After 4h factor deprivation, 
cells were stimulated at 37°C with SCF (100ng/ml) or Epo (5U/ml). Cells were 
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harvested after the indicated time points by addition of ice-cold PBS. Cell lysates, 
SDS-PAGE, immunoprecipitation and Western blotting were performed as described 
previously (van Dijk et al., 2000).  10 µl of protein extract (≈1x106 cells) was loaded 
onto a 15% polyacrylamide gel.  The antibodies used were: α-4EBP1 (Cell Signaling 
Technology, Inc.), α-Uhmk1 (Gift from M Boehm NIH/NHLBI), α-alpha4 (Gift from D 
L Brautigan, Center for Cell Signaling, University of Virginia), S6K-P (Cell Signaling) 
α-Fli1 and α- Myc (Santa Cruz Biotechnology, Inc.).
Transduction of I/11 clones 
The coding sequences (NCBI accession number NM_008784; NM_029768; 
NM_010447; NM_207623; NM_015781; NM_010633; NM_009919; NM_153419) 
were amplified with Pfu polymerase (Promega M7741) using primers designed to 
insert an EcoRI at the 5’end and a ClaI site at the 3’ end of the PCR product. The 
PCR product was inserted in TA vector (Invitrogen KNM2040-01). The EcoRI/ClaI 
digestion product was inserted into the same sites of a pBlueScript vector. The 
PCR primer was designed to abolish the Kozak sequence and insert the ATG of 
the coding sequence in frame to a six myc-tag sequence at the EcoRI site of the 
pBlueScript vector. A BamHI/SalI digestion product containing the N-terminal myc-
tag and the coding sequence was inserted into the eukaryotic retroviral expression 
vector pBabe. Retroviral transduction was performed as described (Bakker et al., 
2004). Briefly, 0.5x106 ecotropic Phoenix cells were transfected with 12 µg plasmid 
DNA using calcium-phosphate coprecipitation assay. After 40 h, cells were treated 
with 10µg/ml mitomycin C (Kyowa Hakko Kogyo, Tokyo, Japan) for 1 h and washed 
3 times with PBS. 2x106 I/11 cells were added in 4ml StemPro-34TM medium 
supplemented with Epo, SCF and Dex and co-cultured for 24 h. Subsequently, 
I/11 cells were removed from the Phoenix cells and cultured in semisolid medium 
(Methocel-containing StemPro-34TM, supplemented with factors) containing 2 µg/ml 
puromycin (Sigma). After 7 days well-separated colonies were picked, expanded and 
analyzed for myc-coding sequence expression.
Immunofluorescence microscopy
Phoenix cells were grown on microscope cover slips, placed at the bottom on 
5ml pedri dishes. The cells were transfected with myc-tagged constructs used for 
the transductions (see above).  The cells were fixed in 4% paraformaldehyde and 
permeabilized for 30 min with 0.2% TritonX.  After blocking for 1h in PBS containing 
1% BSA and 0.05% Tween, the fixed cells were incubated for 1 h at rt with anti-myc-
antibodies (Santa Cruz; 9E10).  The slides were washed and incubated for 1h at rt 
with TRITC anti-mouse secondary antibody (DakoCytomation).  The Cover slips were 
mounted with a drop Vector Shield (Vector laboratories Inc; H-1000), including DAPI 
(0.3ng/µl).  Imaging of the cells was done with 543nm, 488nm, 405nm excitation 
provided by an argon laser and a 63 x 1.4 NA apochromat objective lense (Carl Zeiss 
MicroImaging) for FITC, TRITC and DAPI respectively.  Zeiss AIM  software version 
3.2 was used for merging the images. 
RNA isolation and cDNA synthesis
Total RNA was isolated using the Trizol reagent (Life Technologies) as recommended 
in the manufacturer’s protocol. Isolation of polysomal RNA by sucrose gradient 
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fractionation was performed as described (Joosten et al., 2004; Mullner, 1997). 
Cell extracts were layered on a 4ml linear sucrose gradient (15–40% sucrose [w/v]) 
and 8 fractions were collected. Northern blotting indicated that fractions 1-4 contain 
nonpolysomal and subpolysomal mRNA, while fractions 5-8 consisted of polysome-
bound RNA. These fractions were pooled to generate subpolysomal and polysomal 
mRNA of each sample. RNA was quantified by UV-absorbance. Poly(A)+ mRNA was 
purified and cDNA was generated as described (Joosten et al., 2004). 
Real-time PCR 
The real-time PCR assay involved TaqMan technology (PE Applied Biosystems Model 
7700 sequence detector), using the double stranded DNA-specific fluorescence dye 
SYBR green I to detect PCR product as previously described (Kolbus et al., 2003). 
The amplification program consisted of 1 cycle of 50°C with 2’ hold (AmpErase UNG 
incubation), 1 cycle of 95°C with 10’ hold (AmpliTaq Gold Activation), followed by 
40 cycles of denaturation at 95°C for 15”, annealing at 62°C for 30” and extension 
at 72°C for 30”. All the different primer pairs had similar optimal PCR annealing 
temperatures. Acquisition of the fluorescence signal from the samples was carried 
out at the end of the elongation step. To confirm amplification specificity, the PCR 
products from each primer pair were subjected to agarose gel electrophoresis and 
the dissociation curve was checked at the end of each run. Gene-specific primers 
corresponding to Igbp1 (NM_008784); mEd2 (NM_029768); Hnrpa1 (NM_010447); 
Rnf138 (NM_207623); Nap1l1 (NM_015781); Uhmk1 (NM_010633); Cnih (NM_
009919); Nubp1 (NM_153419), Grwd1 (NM_153419), Pscd3 (NM_011182), Txnip 
(NM_023719), nucleoside diphosphate kinase B (Ndpk-B, 008705), eukaryotic 
translation elongation factor eEF-1β2 (NM_018796), ribosomal protein S4 (rps4, 
M73436), Fli-1 (NM_008026), mammalian ribonuclease inhibitor (IMAGE:1366946), 
Y-box binding protein 1 (YB-1, X57621), Nfe2 (NM_008685) were obtained from 
Invitrogen Life Technologies or Sigma-Genosys Ltd. Sequences are available 
in supplementary Table S-5. 
Supplementary data
Supplementary figures 1 to 3 are found below, pages 88 and 89.
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Igbp1/α4 inhibits erythroid differentiation
Supplementary Figure 1
The array data analysis strategy 
to identify the translationally 
controlled genes is depicted 
here and has been extensively 
explained in the text and referred 
to in Figure 1.  I/11 cells and R10 
cells were factor deprived for 4 
hours and stimulated with ES, 
or left untreated (NF).  For each 
condition 2 of each erythroid 
progenitor cell line were treated 
(I/11 denoted as I/11-a and I/11-b, 
while R10 denoted as R10-a and 
R10-b).  This diagram gives an 
overview of the gene lists that have 
been extracted during the analysis 
and the statistical thresholds used. 
Supplementary Figure 2.  
Intensity data profiles of representative 
genes of various clusters show different 
polysome recruitment regulation upon 
stimulation as compared to total RNA. 
The bars represent the weighted average 
of Intensity data calculated from the 4 
biological replicas for each condition. 
The error bars represent the standard 
error between the 4 intensity values.  The 
intensity values plotted is the normalized 
geometric mean calculated by the Rosetta 
Resolver software.  Heat Map cluster 1 
represented by Nap1l1 and Cnih (A,B), 
cluster 3 by Actg1 (C); cluster 2 and 4 by 
Pscd3, Ndst2 and Txnip (D-F); and cluster 
5 by Hnrpa1 and Uhmk1 (G, H).
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Supplementary Figure 3
Phoenix cells were grown on microscope slides and myc-tagged coding sequences of  transiently 
transfected.  The cells were fixed and stained for myc tag FITC- labeled second antibodies. The 
expression of Uhmk1, Cnih, Igbp1, mEd2, Hnrpa1, Rnf138 and Nap1l1 is localized at microtubule active 
centers, endoplasmic reticulum associated with nuclear membrane, cytoplasmic, possible associated 
with reticulum, nuclear with higher concentrations at the nuclear circumference, nuclear and in discrete 
speckles through the cytoplasm and nucleus, respectively.  
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ABSTRACT  
SCF and glucocorticoids cooperate with Epo to induce renewal divisions of 
erythroid progenitors, whereas Epo is required for survival of erythroblasts 
during differentiation.  Renewal is dependent on PKB activation, which enhances 
translation initiation efficiency and retains Foxo3a in an inactive state. To study the 
impact of signalling-controlled gene expression on the balance between renewal 
and differentiation of erythroid progenitors, we set up mRNA profiling experiments 
to identify genes sensitive to Epo, SCF and/or Dex, and regulated during erythroid 
differentiation.  Most of the Epo-controlled genes were similarly regulated by Epo 
and SCF and counter regulated during differentiation. This underscores the role 
of Epo signalling in induction of progenitor renewal. In addition, we identified a 
small group of genes that are upregulated specifically by Epo and upregulated 
during differentiation. All known Stat5 target genes are comprised in this set of 
genes. The mRNA profiles were generated using polysome bound (pb) mRNA. 
Comparison of Epo/SCF-controlled gene expression between profiles of total and 
pb mRNA demonstrate a prominent effect of signalling on polysome recruitment. 
The prominent, and so far underestimated effect of signalling on mRNA translation 
prompted us to evaluate signalling dependent expression of translation factors and 
proteins involved in ribosome biosynthesis. Together, ribosome synthesis regulation 
and polysome recruitment ensure enhanced translation efficiency in presence of 
mitogenic factors.
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INTRODUCTION
The number of circulating erythrocytes in the blood is tightly controlled, which 
requires a robust balance between expansion, survival and maturation of the 
erythroid progenitor population. Insight into mechanisms regulating this balance 
has been obtained from in vivo studies using genetically modified mice and from 
in vitro cultures of erythroid progenitors, that can be established in serum free 
medium supplemented with Epo, stem cell factor (SCF) and glucocorticoids (i.e. 
the artificial glucocorticoid dexamethasone; Dex).  These studies showed that SCF 
and glucocorticoids cooperate with Epo to induce renewal divisions of erythroid 
progenitors both in vitro and in vivo (Broudy et al. 1996; Bauer et al. 1999; Wessely 
et al. 1999; von Lindern et al. 2001; Dolznig et al. 2006), whereas Epo is required for 
survival of erythroblasts during differentiation (Wu et al. 1995; Lin et al. 1996; Dolznig 
et al. 2002). Renewal or differentiation of erythroid progenitors requires the activation 
of distinct gene expression programs. Several erythroid specific transcription factors 
are known to control erythropoiesis such as Gata-1, Eklf and Nfe-2 (Scott et al. 
1994). However, these transcription factors have mainly been studied in the context 
of haemoglobin regulation and very little is known about genes involved in the growth 
factor-controlled balance between renewal and differentiation. This study aims to get 
insight into gene expression programs controlled by Epo, SCF and glucocorticoids.  
Mice lacking Epo or the Epo-receptor (EpoR) die at embryonic day 13,5 with a lack 
of mature definitive erythrocytes (Wu et al. 1995; Lin et al. 1996). Although Epo can 
induce a multitude of signalling pathways (for review see Richmond et al. 2005), the 
phosphorylation and transcriptional activation of Stat5 appeared to be crucial for 
Epo-dependent differentiation of erythroblasts (Socolovsky et al. 2001; Dolznig et al. 
2002; Dolznig et al. 2006). Epo-induced Stat5 activation controls BclXL upregulation 
during erythroid differentiation, which appeared to be sufficient for survival and 
differentiation of erythroblasts in vitro  (Dolznig et al. 2002; Dolznig et al. 2006). 
However, upregulation of BclXL is delayed compared to Stat5 phosphorylation and 
most likely involves intermediates. Notably, the enhancer involved in the massive 
upregulation of BCLX gene expression during erythroid differentiation does not 
contain STAT5 binding sites (Tian et al. 2003). Therefore, it remains unclear which 
genes activated by Stat5 are crucial in erythroid differentiation.
Whereas Epo-induced Stat5 activation is crucial for survival during differentiation 
(Dolznig et al. 2002), other Epo-induced pathways are required to induce renewal 
divisions (van den Akker et al. 2004) in cooperation with signals emanating from 
the SCF-receptor cKit. Activation of phosphoinositide 3-kinase (PI3K) appeared 
to be particularly important for Epo/SCF-induced renewal divisions of erythroid 
progenitors as inhibition of PI3K abrogates renewal and induces differentiation 
instead (von Lindern et al. 2001). Activation of PI3K generates PIP3, which serves as 
an anchor for PH-domain containing proteins, both adaptor molecules such as Gab2 
and Dok1 and kinases such as Tec, Btk, PDK1 and PKB (Tang et al. 1994; Stokoe et 
al. 1997; Leevers et al. 1999; Zhao et al. 1999; Saito et al. 2001). Although both Epo 
and SCF induce activation of PI3K in erythroid progenitors, the efficiency with which 
downstream signalling pathways are activated shows large differences (Bakker et al. 
2004; Blazquez-Domingo et al. 2005). In cultured erythroid progenitors the activation 
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of PKB is more responsive to SCF compared to Epo (von Lindern et al. 2001; Bakker 
et al. 2004). We found that two major pathways downstream of PKB control renewal 
versus differentiation of erythroid progenitors. First, PKB phosphorylates the class 
O Forkhead transcription factor 3a (Foxo3a), which retains Foxo3a in an inactive 
state in the cytoplasm. Foxo3a translocates to the nucleus upon factor-deprivation 
to activate genes involved in apoptosis and stress-responses (Greer and Brunet). 
Foxo3a is transcriptionally upregulated during erythroid differentiation, while PKB 
activation decreases, resulting in increased Foxo3a activity late in differentiation 
(Bakker et al. 2004). Thus, Epo/SCF-induced activation of PKB silences genes that 
are upregulated following factor-deprivation and differentiation induction. Second, 
PKB activates mTOR (mammalian target of rapamycin) (Inoki et al. 2003; Tee et al. 
2003) modulating phosphorylation and activation of p70S6 kinase (Rps6kb1) (Dufner 
and Thomas 1999) and hierarchical phosphorylation of 4EBP (4E-Binding Protein) 
(Gingras et al. 1999), resulting in activation of the translation machinery (Wang et 
al. 2001; Raught et al. 2004) and release of the mRNA cap-binding factor eIF4E 
(eukaryotic Initiation Factor 4E) (Gingras et al. 2001), respectively. The cap-binding 
eIF4E protein is the rate limiting factor in the mRNA scanning process (Duncan et 
al. 1987; Sonenberg and Gingras 1998), particularly for structured mRNAs that are 
only translated at increased eIF4E levels. Overexpression of eIF4E increased the 
levels of eIF4F complexes and suppressed erythroid differentiation in the absence 
of SCF, indicating an important role for recruitment of structured mRNAs, potentially 
responsive to SCF in regulating the balance between expansion and differentiation 
in erythropoiesis (Blazquez-Domingo et al. 2005). 
The aim of this study is to get insight into the impact of signalling-controlled 
gene expression on the balance between renewal and differentiation of erythroid 
progenitors. We set up profiling experiments to identify (i) how Epo, SCF and Dex 
control erythroid gene expression independent of each other, (ii) how they mutually 
affect regulation of gene expression under renewal conditions, and (iii) how and 
to what extent genes regulated during differentiation are controlled by signal 
transduction.
Increasingly, discrepancies between the transcriptome and the proteome are 
uncovered, indicating the importance of post-transcriptional regulation particularly 
in the incidence and progression of disease (Rajasekhar et al. 2003; Perrotti and 
Calabretta 2004). Our own results also indicate an important role for PI3K/mTOR 
controlled polysome recruitment of specific mRNAs (Blazquez-Domingo et al. 2005). 
Therefore we used polysome-bound mRNA to screen for growth factor-controlled 
gene expression on oligonucleotide arrays. For short-term stimulation by Epo, SCF 
and/or Dex we also used total RNA to generate the opportunity to identify transcripts 
selectively recruited to polysomes. Analysis of the data shows that growth factor 
induced polysome loading is an important level at which signalling-dependent 
gene expression is regulated and that the use of pb RNA in RNA profiling studies 
can increase the sensitivity with which alterations in gene expression can be 
detected. The prominent effect of polysome recruitment on signalling-induced gene 
expression profiles prompted us to evaluate signalling- and differentiation-dependent 
expression of genes involved in protein synthesis. Ribosome synthesis is generally 
known to be under control of mitogenic factors supposedly by selective translation of 
ribosomal proteins. However, we found only a modest regulation of the expression 
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of ribosomal proteins and a much more pronounced regulation of a large number of 
factors involved in expression and maturation of rRNA, in association of rRNA and 
ribosomal proteins to ribosomal subunits, and in export and trafficking of ribosomal 
subunits.    
 
RESULTS and DISCUSSION
Establishing gene expression profiles 
For the profiling studies we used four biologically independent replicates derived 
from two established p53-/- erythroblast cultures with different genetic background (I/
11 and R10, Figure 1) (von Lindern et al. 2001; Schmidt et al. 2004). Two independent 
experiments were performed for each background. To assess factor dependent gene 
regulation, erythroid progenitors were factor deprived (4h) and restimulated (2h, 6hr 
and 18hr) with Epo, SCF or dex, with a combination thereof, or left unstimulated 
(NF). The combinations we tested represented delayed differentiation (Epo plus 
SCF) or sustained renewal (Epo, SCF, Dex Figure 1) (Dolznig et al. 2001; von 
Lindern et al. 2001). Because it has been reported that growth factor signalling may 
activate nuclear hormone receptors in absence of ligand (Weigel and Zhang 1998; 
Labriola et al. 2003), we included the glucocorticoid receptor antagonist ZK112,993 
(ZK) in combination with Epo and SCF to address glucocorticoid-specific gene 
regulation. Polysome-bound RNA was isolated cRNA was generated and hybridized 
to Affymetrix oligonucleotide arrays. At 2h following factor stimulation, we also 
isolated cytoplasmic RNA, which was similarly processed to cRNA and hybridised to 
oligonucleotide arrays. Rosetta Resolver software was used to normalize and analyse 
the intensity data. The ratio of gene expression in growth factor stimulated samples 
versus factor-deprived cells (NF) was calculated by Rosetta Resolver software. 
Concurrently, erythroid progenitors were induced to undergo terminal differentiation 
by switching renewal conditions (Epo, SCF, Dex) to differentiation conditions 
(increased concentration of Epo plus iron-saturated transferrin). Polysome-bound 
RNA was generated from steady state growing progenitors and progenitors induced 
to differentiate for 6, 22, 48 or 60 hours (Figure 1), processed to cRNA and used to 
hybridise oligonucleotide arrays. Rosetta resolver was used to calculate the gene 
expression ratio of differentiated cells over steady state growing cells. 
Gene expression regulated by Epo and SCF
To assess Epo and SCF dependent gene expression and the potential effects of these 
genes on the balance between renewal and differentiation of erythroid progenitors, 
we first identified genes regulated by Epo, SCF or Epo plus SCF by ‘Analysis of 
Variance’ (ANOVA, p=0.01). The ANOVA analysis was performed with a relatively 
low stringency. Concurrent quantitative PCR analysis of random targets indicated 
that increasing the probability (p-value) of the ANOVA comparison did not improve 
the selection procedure and excluded too many valid candidates (data not shown). 
Analysis of selected data showed that gene probes that are unjustly excluded at 
increased p-value, show a variation between the 4 biological replicates that exceeds 
the differential expression that consistently occurred within every single experiment. 
Therefore we decided to retain low stringency ANOVA (p=0.01) as a first step, 
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Figure 1  The gene expression profiling strategy to identify genes differentially regulated by growth 
factor signalling and during erythroid differentiation.  I/11 cells and R10 cells were factor deprived for 
4 hours and Epo, SCF, ES, ESD, ESZK or Dex were added for 2 hours, 6 hours or 18 hours or cells were 
left untreated (NF).  For each condition we performed duplicate experiments for both erythroid progenitor 
cell lines (I/11 denoted as I11-a and I11-b; R10 denoted as R10-a and R10-b).  For the 2 hour time points 
both Total and polysome bound (pb) mRNA were isolated, while for all the other conditions pb RNA was 
isolated.  Cells (4 replicas as above) were induced to differentiate under Epo conditions.  Cells were 
harvested at 6, 22, 48 and 60 hours and pb RNA isolated.  
followed by more stringent selection of differential expression in response to Epo 
and/or SCF in at least both I/11 or both R10 samples (p=0.001 in two experiments, 
indicated as p=0.0012). Comparisons were made between polysome-bound RNA 
profiles corresponding to factor-deprived cells and cells stimulated for 2h and 6h 
either with Epo, with SCF or with Epo plus SCF. These lists were combined to form 
the “signalling signature”. Next the signalling-induced and differentiation-induced 
expression ratio’s were clustered for these ‘signalling signature’ genes (K-means, 
Pearson; Figure 2, supplemental data Table S-II).
As observed before using total RNA, essentially all genes upregulated in response 
to SCF are also upregulated in response to Epo (cluster 4 and 5)(Kolbus et al. 2003). 
The vast majority of these genes is downregulated during differentiation, suggesting 
that among those genes we may find important regulators of progenitor renewal. 
Conversely, not all genes upregulated in response to Epo are also upregulated by 
SCF. Cluster 1 represents genes upregulated by Epo, not regulated by SCF and 
upregulated during differentiation (Figure 2). This cluster contains all known Stat5 
target genes including Cish, Pim1, Cdkn1a/p21WAF, and TGFβ2. Cluster 1 is the 
only cluster containing genes that are upregulated in response to Epo and during 
differentiation (Figure 2). From previous studies on Foxo3a target genes we expected 
genes that are inversely regulated by Epo and SCF such as Cited2 (Bakker et al, 
submitted). Cited2  was also identified in cluster 1. 
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6 h treatment with Epo, SCF and Dex (ESD) with profiles obtained 2 or 6 h following 
Epo, SCF, and Zk112,993 (ESZk) treatment, and (ii) polysome-bound RNA profiles 
of factor deprived cells and profiles obtained following 2 and 6 h treatment with Dex. 
These selected genes were combined and used to cluster Dex-induced, signalling-
induced and differentiation-induced expression ratio’s (Figure 3, supplemental Table 
S-III). Interestingly, gene regulation by Dex and by Epo plus SCF occurred in all 
possible combinations: (i) Genes in cluster D1 were upregulated in response to Dex 
both in absence and in presence of Epo plus SCF (cluster D1, Figure 3); (ii) some 
genes were only regulated by Dex in presence of Epo plus SCF (cluster D2) or Epo/
SCF signalling enhanced Dex-induced gene expression (cluster D3), whereas (iii) 
other genes were upregulated in response to Dex, but repressed upon addition of 
Epo plus SCF to Dex (cluster D5 and D6, Figure 3), subsequent these genes could 
be upregulated (D2, D5) or repressed (D1, D3, D6) during differentiation.  
The Epo-controlled gene expression profile is in accordance with previous 
observations that most Epo-induced signalling pathways are required for 
expansion of the progenitor pool under conditions of hypoxic stress and not for 
erythroid differentiation. Only the activation of Stat5 is required for Epo dependent 
maturation of erythroid progenitors (Dolznig et al. 2002; van den Akker et al. 2004). 
Concordantly, it is only 1 small gene cluster containing Stat5 target genes that is 
upregulated by Epo and during differentiation.  In contrast, the majority of Epo-
induced genes is downregulated during differentiation, and many Epo-repressed 
genes are upregulated during differentiation.  Although it remains to be shown which 
pathways drive expression of genes in cluster 1 versus clusters 4 and 5, the genes 
present in cluster 1 are strong candidates for Stat5 targets that may proof informative 
for erythroid differentiation induction and control of target genes during differentiation 
(eg BclXL). Conversely, clusters 4 and 5 may harbour genes inhibiting differentiation 
in response to the cooperative signal of Epo and SCF.
Gene expression regulated by dexamethasone
To identify genes regulated by glucocorticoids, i.e. by dexamethasone, we used 
the same selection procedure (ANOVA between groups with a threshold of p=0.01, 
differential expression in at least both I/11 or both R10 experiments with a threshold 
of p=0.0012) for comparisons of (i) polysome-bound RNA profiles obtained after 2 or 
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Figure 3  Cluster analysis of genes that respond to Dexamethasone (Dex) and their regulation 
during renewal and differentiation conditions.  Probe sets (Affymetrix MG_U74Av2) that are 
differentially expressed upon addition of Dex  were obtained by ANOVA, comparing intensity data of 
hybridisations representing ESD and ESZk conditions, combined with a comparison between Dex and 
NF (see text).  The selected probe sets were clustered for regulation by Dex and differentiation conditions 
according to gene expression ratios as indicated (differentiation time point/steady state; diff/ss).  Rosetta 
resolver software was used for clustering (K-means, Pearson correlation). A bar in the left upper corner 
indicates how up- and down-regulation correlate with the intensity of red and blue respectively on a 10log-
scale.
Figure 2  Cluster analysis of genes that respond to growth factor stimulation and their regulation 
during differentiation. Probe sets (Affymetrix MG_U74Av2) that are differentially expressed in response 
to growth factor stimulation were obtained by ANOVA comparing intensity data of hybridisations 
representing factor-deprived and restimulated cells (see text).  These selected probe sets were 
clustered by gene expression ratios representing the effect of signal transduction and differentiation 
as indicated(differentiation time point/steady state; diff/ss).  Rosetta resolver software was used for 
clustering (K-means and Pearson correlation). A bar in the left upper corner indicates how up- and down-
regulation correlate with the intensity of red and blue respectively on a 10log-scale.
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Figure 4  Cluster analysis of genes that are regulated during differentiation and their expression 
during growth factor stimulation and deprivation conditions.  Probe sets (Affymetrix MG_U74Av2) 
that are differentially expressed upon differentiation induction were obtained by ANOVA, comparing 
intensity data of hybridisations representing differentiation time points and steady state cells.    The 
selected probe sets were clustered for gene expression during differentiation, in response to growth 
factors and upon factor deprivation using gene expression ratios as indicated.  Rosetta resolver software 
was used for clustering (K-means, Pearson correlation). A bar in the left upper corner indicates how up- 
and down-regulation correlate with the intensity of red and blue respectively on a 10log-scale.
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Figure 5  Classification of selected genes 
according to regulation and function.  A: To 
analyse gene expression regulation in response 
to Epo/SCF  ANOVA was used to compare 
intensity data of Epo/SCF treated (ES) versus 
untreated (NF) cells (see text). This yielded a 
selection of 458 probe sets that are regulated 
in pb RNA profiles (Anova pb) and 148 probe 
sets in total RNA profiles (Anova total) To select 
genes genes specifically regulated by polysome 
recruitment ANOVA was used to compare ES/NF 
ratios between pb and total RNA which selected 
for 115 probe sets (Anova pb/total)(see text). 
The Venn diagram  shows the overlap of the 
ANOVA lists (Supplementary Table V, VI, VII).  B, 
C: Signalling-controlled genes were classified 
according to function and according to regulation 
at at the level of transcription (total RNA level 
only [29 genes] or polysome association 
following transcription [113 genes] (B), or at the 
level of polysome recruitment (significant ratio 
pb/total and not transcriptionally regulated [109 
genes])(C).
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The different expression patterns are partly associated with the different nature 
of Dex target genes. They include genes known to be involved in glucocorticoid-
induced apoptosis such as Gpcr25 (G-protein coupled receptor 25; also known as T-
cell death associated gene 8 – Tdag8) (Malone et al. 2004) and Txnip (Thioredoxin-
interacting protein)  (Wang et al. 2006), but they also include genes known to be 
essential in hematopoietic development such as jumonji, Jarid2 (AT rich interactive 
domain 2) (Kitajima et al. 1999) and cKit (Broudy et al. 1996), or involved in cell 
cycle progression such as Per1 (Period homolog 1) (Walisser and Bradfield 2006), 
Nek2 and Nek7 (NIMA (never in mitosis gene a)-related expressed kinase 2 and 7) 
(Quarmby and Mahjoub 2005), whereas induction of Hpgd (hydroxyprostaglandin 
dehydrogenase) suppresses prostaglandin-induced cAMP activity, which signals 
erythroid differentiation (Bakker et al, submitted). Notably Dex-induced expression 
of genes associated with apoptosis induction, such as Gpcr25 (Tdag8), can also 
be further enhanced by SCF, which suggests that a G-protein coupled receptor that 
induces cell death in one cell type, may have a positive effect in another cell type. In 
addition, several Dex-induced genes are repressed by SCF, suggesting a protective 
effect of growth factor signalling on glucocorticoid-induced apoptosis and/or cell 
cycle inhibition. The expression of Dex-controlled genes in absence and presence 
of growth factors, during renewal and differentiation erythroid progenitors, may shed 
light not only on important processes in erythropoiesis, but also on the multifaceted 
role of glucocorticoids in lymphopoiesis, where glucocorticoids are mostly known as 
potent apoptosis inducers (Webb et al. 2003). 
Gene expression regulated during erythroid differentiation
Finally, we identified the genes that are up- or downregulated during differentiation 
to assess to what extent these genes are controlled by combinations of renewal 
or differentiation factors. Because the cluster analysis of the “signalling signature” 
genes indicated that the major changes in gene expression occur in samples taken 
late in differentiation, we compared polysome-bound RNA profiles of steady state 
growing erythroid progenitors with profiles of cells induced to differentiate for 48 
and 60 h (p=0.01 for ANOVA between groups; p=0.0012 for differential regulation 
in at least both I/11 or both R10 experiments). The selected genes are indicated as 
the “differentiation signature”. To asses the relation between gene regulation during 
differentiation and upon factor-deprivation and restimulation we clustered differential 
expression in differentiating compared to steady state growing progenitors with 
differential expression in factor-deprived compared to steady state growing, and 
in restimulated progenitors compared to factor-deprived progenitors. Restimulation 
involved renewal (Epo, SCF, Dex) or differentiation (Epo) factors. (Figure 4, 
supplemental Table S-IV). The first striking observation is the lack of discrimination 
between gene expression patterns induced upon restimulation of erythroid 
progenitors by differentiation (Epo) or renewal (Epo, SCF, Dex) factors for 2 or 6h. 
One third of genes downregulated during differentiation is upregulated by Epo- and 
Epo,SCF,Dex-induced signalling. This underlines again the ambiguous role of Epo, 
acting as a differentiation factor but most of all as a proliferation factor to increase the 
number of erythroid progenitors in response to hypoxia.
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Epo/SCF-induced polysome recruitment
It is well recognised that transcript levels determined by total mRNA profiling differ 
from protein expression levels. Polysome bound mRNA profiling integrates control at 
the level of transcription, mRNA nuclear export and polysome recruitment, getting 
results closer to proteomics (Pradet-Balade et al. 2001). One of the factors controlling 
polysome recruitment in response to PI3K-activation is the cap-binding, eukaryotic 
translation initiation factor 4E (eIF4E) that is the limiting factor in the eIF4F pre-
initiation scanning complex. We previously showed that overexpression of eIF4E 
blocked Epo-induced differentiation (Blazquez-Domingo et al. 2005), which indicates 
that translation initiation has a critical role in erythroid differentiation.
To estimate to what extent polysome recruitment contributes to Epo/SCF-controlled 
gene expression as a whole, we identified differential expression in response to 
Epo/SCF in total and pb RNA separately. First, we performed ANOVA (p=0.01) 
between the intensity data obtained with RNA from factor-deprived and Epo/SCF-
restimulated cells. This yielded 470 probe sets for total RNA and 1051 for pb RNA. 
Further selection of differential expression in at least both I/11 or both R10 samples 
(p=0.0012) reduced the number of probe sets to 148 for total RNA and to 458 for pb 
RNA (Figure 5A, supplemental Tables S-V, S-VI). The overlap between these sets 
(differential gene expression measured in total and pb RNA) is 118 probe sets (111 
genes). This leaves 340 probe sets as being ‘exclusively’ regulated in polysome-
bound mRNA. 
     To identify transcripts specifically subject to Epo/SCF-controlled polysome 
recruitment, we took another approach and directly compared ES/NF ratio’s for total 
and pb RNA by ANOVA (p=0.01) plus differential expression in absence or presence 
of Epo/SCF in at least both I/11 or both R10 samples (p=0.0012). To retain selective 
polysome recruitment with constant RNA expression as well as reduced RNA 
expression with maintenance of polysome binding, differential expression had to occur 
either in total or in pb RNA hybridisations . This reduced the number of differentially 
regulated genes between total and pb mRNA to 115 probe sets representing 111 
genes (Grech, submitted, Table S-VII). Comparison of both methods indicates that 
only 62 of the 340 probe sets exclusively regulated by Epo/SCF in pb mRNA had 
been selected as differentially regulated in response to Epo/SCF between total and 
pb mRNA. The discrepancy is due to the fact that many genes are regulated at the 
level of total mRNA just below the probability threshold we set, while their regulation 
surpasses the threshold in pb mRNA (supplemental Table S-VI). In other words, 
transcription and translation initiation cooperate to enhance or reduce expression in 
response to Epo/SCF, but these genes are not specifically regulated by polysome 
recruitment. This phenomenon was also observed when higher or lower threshold 
were used.  Importantly, however, approximately 20% of Epo/SCF-regulated genes 
was subject to major regulation at the level of polysome recruitment. This indicates 
that the use of pb mRNA to study differential gene expression in response to Epo, 
SCF and Dex or during differentiation (Figures 2-4) increased the sensitivity of our 
profiling study.
Cellular processes regulated by gene transcription or mRNA translation
To examine whether genes regulated specifically by polysome recruitment or 
regulated at the transcriptional level control different cellular processes, we classified 
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the genes controlled by Epo/SCF stimulation in total, or only in pb mRNA according 
to function (Figure 5B,C). The mRNAs encoding ribosomal proteins and some 
translation factors start with a terminal oligopyrimidine tract (TOP) that renders 
polysome recruitment sensitive to mTOR activation (Meyuhas 2000). These genes 
were mainly regulated in the pb mRNA fraction (Figure 3C), which validates our 
selection. Strikingly, also Epo/SCF-controlled expression of genes involved in protein 
modification and protein stability are mostly regulated by polysome recruitment. In 
contrast, genes involved in ribogenesis are mainly transcriptionally controlled and also 
Epo/SCF-controlled regulation of the cell cycle and gene transcription occurs mostly 
at the transcriptional level. Genes involved in metabolism are either translationally 
or transcriptionally controlled. Interestingly, this group contains 8 genes involved in 
lipid biosynthesis that are all regulated by gene transcription, and 6 genes involved 
in glucose metabolism that are all controlled by polysome recruitment. 
       Thus, certain cellular mechanisms are controlled by signalling-induced gene 
transcription, whereas other mechanisms are largely regulated at the level of 
translation initiation. The profiles established in this study enable us to analyse the 
expression of translation factors, including proteins involved in ribosome synthesis, 
that may drive translational control in the signalling- and differentiation signatures.
Regulation of translation factors:eIF2
Translation initiation is tightly regulated in response to cellular conditions. The two 
limiting translation factors regulated by environmental signals are (i) the cap-binding 
factor eIF4E that recruits all subunits of the pre-initiation scanning complex and (ii) 
eIF2, the prime factor of the eIF2·GTP/Met-tRNAi
Met ternary complex responsible for 
selection of the AUG start-codon (Clemens 2001; Pestova and Kolupaeva 2002). We 
have previously shown that activation of the PI3K/PKB/mTOR pathway and release 
of eIF4E is important for polysome recruitment of structured mRNAs (Blazquez-
Domingo et al. 2005; chapter 3). Whereas eIF4E is regulated by mitogenic factors, 
eIF2 is phosphorylated and inhibited by 4 kinases that are activated in response 
to various stress conditions (Proud 2005; Wek et al. 2006). Interestingly, our data 
indicate that eIF2 function is positively regulated at the transcriptional level in 
response to growth factors (Table-I). This is of direct relevance to the profiles 
obtained with pb mRNA, because analyses of the 5’UTR of translationally regulated 
genes commonly revealed one or more uORF (chapter 6). The eIF2 level is the 
main determinant of uORF translation and its potential consequences for polysome 
recruitment (Morris and Geballe 2000).
The eIF2 is a trimeric complex existing of an α, β and γ chain (eIF2s1, eIF2s2 and 
eIF2s4). When the eIF2·GTP/Met-tRNAi
Met ternary complex (TC) has delivered 
methionine at the AUG start codon, eIF2·GTP is reduced to eIF2·GDP that is 
recycled to eIF2·GTP by eIF2B, consisting of 5 subunits. The eIF2α subunit can 
be phosphorylated on serine115. Phosphorylation does not affect the association 
of eIF2 with eIF2B, but it disables the reloading of eIF2 with GTP. The major eIF2 
kinase in erythroid cells is eIF2ak1or haem-regulated kinase (HRI) (Han et al. 2001). 
The profiling results show that the α and β subunits of eIF2 and the b1 subunit 
of eIF2B are upregulated in response to Epo/SCF signalling and downregulated 
during differentiation. In contrast, HRI is downregulated in response to Epo/SCF 
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and upregulated in differentiation (Table-I). Thus, Epo/SCF signalling increases the 
eIF2·GTP/Met-tRNAi
Met TC.  This TC subsequently associates with the 40S ribosomal 
subunit which is mediated by a complex of translation initiation factors eIF1, eIF3 and 
eIF5 (Singh et al. 2005). These factors are involved in conformational changes of the 
complex when the AUG start codon is recognised. In addition, eIF5 binds eIF2·GDP, 
which may serve as a eIF2 reservoir or may compete for eIF2B/eIF2·GDP interaction 
and recovery of stable ternary complex (Singh et al. 2006). We observed that eIF1 
is upregulated by Epo/SCF and downregulated during differentiation, which is in 
agreement with increased availability of the TC. Surprisingly, eIF5 is downregulated 
by signalling and clearly upregulated during differentiation (Table-I), suggesting that 
eIF5 may have a competitive role, rather than a supporting role in the function of the 
TC (Singh et al. 2006).
Regulation of translation factors: elongation and termination
Control of protein elongation and translation termination has a general effect on 
protein synthesis, but it may also affect the regulatory role of uORFs. Interestingly, 
we find downregulation of elongation factor 1d (eEf1d) and upregulation of its close 
homologue Gtpbp2 during differentiation (Table-I), which is in accordance with the 
observation that these antagonistic factors have been found as a putative oncogene 
and tumorsuppressor gene respectively (De Bortoli et al. 2006; Mulholland et al. 
2006). Micro-RNAs inhibit translation by inducing premature ribosome dissociation 
(Petersen et al., 2006). Both Argonaut2/eIF2c2 and Rck/Ddx6, involved in 
translational repression via miRNAs (Chu and Rana 2006), are downregulated by 
Epo/SCF signalling (Table-I), indicating that growth factor signalling may repress 
miRNA function and increase the stability of translation elongation complexes. 
Finally, the translation termination factor eTf1 is upregulated by Epo/SCF signalling, 
but its function in regulation of gene expression is unknown.
Proteins binding AU-rich elements
Proteins binding AU-rich elements (ARE) in the 3’UTR of transcripts recruit poly(A)-
specific ribonuclease (Parn) and complete deadenylation results in degradation 
of the mRNA. But the length of the poly-A tail is also important for the amount of 
polyA binding protein (PABP) that can bind. PABP directly associates with the eIF4F 
complex and stabilizes pre-initiation scanning complexes (Mangus et al. 2003). In 
addition, ARE-binding proteins can directly recruit PABP to interact with the pre-
initiation complexes. The ARE are present in the 3’ untranslated region of many 
short-lived transcripts from cytokines, proto-oncogenes, growth factors or cell cycle 
regulators (Bakheet et al. 2001).  Interestingly, the Tristetraprolin family members Brf1 
(Butyrate responsive factor 1 or Znf36-like 1) and Brf2 (Znf36l2) known to promote 
ARE-dependent decay, are regulated by SCF signalling and during differentiation in 
an opposing way. Whereas Brf1 is active in late, almost mature erythroid cells, Brf2 
expression is induced by renewal conditions (Table-I). Notably, Brf2 is also strongly 
induced by glucocorticoids. Mice lacking Brf1 or Brf2 have different phenotypes 
(Ramos et al. 2004, Ciais et al., 2004), suggesting that these homologues have 
distinct targets; one of which is VEGF repressed by Brf1, which is accordance 
with VEGF upregulation in renewing erythroid progenitors and downregulation in 
Chapter 4
104
Table 1  Genes involved in mRNA translation, regulated by signal transduction and/or during differentiation. 
Expression data shown are weighted averages if fold changes; Epo/NF (E), SCF/NF (S), Epo+SCF/NF (ES), 
Epo+SCF+Dex (ESD), Dex/NF (D) and differentiation/steadystate (Diff). The number indicates hours of exposure.
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Control of mRNA translation: ribosome biosynthesis
Growth factor signalling limits the energy consuming protein synthesis to growth 
and proliferation of cells. Mitogenic signals are required to induce rRNA synthesis 
(Stefanovsky et al. 2001; James and Zomerdijk 2004) and to recruit transcripts 
encoding proto-oncoproteins (De Benedetti and Graff 2004), ribogenesis 
components (Jefferies et al. 1994) and translation factors (Terada et al. 1994) 
to polysomes. Mitogenic factors were assumed to control ribosome biosynthesis 
through factor-dependent translation of ribosomal proteins. The terminal 
oligopyrimidine (TOP) sequence immediately following the mRNA cap is supposed 
to render translation dependent on mTOR activation. However, we found that 
Epo/SCF-controlled translation of ribosomal proteins is modest (at most 1.5 fold). 
Instead, control of other key regulators may contribute to control of ribogenesis. 
Knowledge on ribosome biosynthesis has rapidly increased as ribosomes or protein 
complexes containing specific ribosomal proteins have been isolated from yeast 
to be analysed by mass spectroscopy (Fromont-Racine et al. 2003). Subsequent 
domain analysis in combination with genetic experiments has indicated that the 
generation of ribosomes requires a very complex biosynthesis machinery in which 
at least 170 nucleolar proteins are found to participate. Whereas the analysis of 
ribosome biosynthesis has revealed control mechanisms in yeast, to date little is 
know about the regulation in higher eukaryotes. Nevertheless, defects in ribosomal 
and nucleolar proteins underlie diseases such as Diamond Blackfan Anemia (DBA) 
and Swachman-Bodian-Diamond syndrome (SBDS)(Liu and Ellis 2006). 
The initial step in the nucleolus is the generation of noncoding ribosomal  RNA. The 
35S pre-rRNA is transcribed by RNA polymerase I, a 5S rRNA is transcribed by 
RNA polymerase III. Expression of several proteins in both polymerase complexes 
(Rpo1-3, Rpo1-1, Rrn3, Polr3k) is upregulated in response to Epo/SCF (Table-I), 
but the major regulation is on Polr1e (polymerase I polypeptide E; at least 4-fold 
up by Epo/SCF and downregulated during differentiation), a transcription factor that 
associates with Ubtf (upstream binding transcription factor) to activate Polymerase 
I activity (Voit and Grummt 2001). Notably, this interaction requires PI3K-dependent 
phosphorylation of Ubtf  (Drakas et al. 2004), which places activation of Pol-I by the 
Polr1e/Ubtf complex under tight control of Epo/SCF.
          Next, the 35S pre-rRNA is processed in the 90S preribosome to produce the 
18S rRNA integrated in the 40S ribosomal subunit, and 25 plus 5.8 rRNAs integrated 
in the 60S ribosomal subunit. The processing complex harbours Bop1 (block of 
proliferation 1) and Pes1 (pescadillo homolog 1) (Gratenstein et al. 2005).  Bop1 
is strongly upregulated by Epo/SCF, and both Bop1 and Pes1 are downregulated 
during differentiation.
Following cleavage of the pre-RNA, the subunits are trimmed to their mature size. 
For the 25 and 5.8 rRNAs of the 60S ribosomal subunit, this requires brix-domain 
differentiation (Table-SII). Also members of the ELAV family of RNA-binding proteins 
bind and stabilize ARE-containing transcripts, and promote their translation (Ford et 
al. 1999). Elavl1 (human antigen R; HuR) is moderately upregulated under renewal 
conditions (Table-I). In contrast, the expression of Trove-2 (Sjogren syndrome 
antigen B, Ssb) is upregulated during differentiation. Trove-2 was identified as an 
auto-antigen in Lupus erythromatosis, and the protein was found to control polysome 
recruitment of specific mRNAs (Horton et al. 2001).
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containing proteins Bxdc1 and Bxdc2, and Ppan (Peter pan homologue) (Eisenhaber 
et al. 2001). Maturation of the 18S rRNA of the 40S subunit requires Imp3 and Imp4 
associated with Mphosph10 in the U3-snoRNP complex (Granneman et al. 2003). 
Several Brix domain-containing proteins are upregulated 1,5 to 2-fold in response 
to Epo/SCF. In addition, various U3-snoRNP associated proteins are upregulated in 
response to Epo/SCF and downregulated in differentiation (Table-I), the exact role 
of which is not clear.
     Maturation of the rRNA subunits also requires extensive modification of 
nucleotides, which mainly occurs in regions that do not associate with proteins 
and which may stabilize the conformation of the rRNA subunit. Nsun2 (Nol1/Nop2/
Sun domain family 2), Nol1 (nucleolar protein 1), Nol5a and ftsj3 (FtsJ homolog 
E.coli) are all involved in rRNA methylation. Nol1 and Nol5a are most prominently 
upregulated in response to Epo/SCF, whereas Nol5a and Ftsj3 are downregulated 
during differentiation. Notably, expression of Nol1 has been associated with many 
types of cancer (Busch et al. 1991; Husson et al. 2002). In addition, Nola1 and Nolc1 
are involved in pseudo-uridinylation of rRNA and particularly Nolc1 is significantly 
upregulated in response to Epo/SCF (Table-I). 
          Proper folding of rRNAs and interaction with ribosomal proteins is promoted by 
RNA helicases of the Ddx-family (DEAD (Asp-Glu-Ala-Asp) box polypeptides). We 
found Ddx18, Ddx21, Ddx51 and Ddx54 that are all involved in assembly of the 60S 
preribosomeal subunit to be upregulated in response to Epo/SCF and downregulated 
during differentiation. 
        Finally the import of all proteins into the nucleolus and the export of the 60S 
ribosomal subunit to the cytoplasm also needs to be controlled. Among the genes 
induced in response to Epo/SCF is Nip7 (nucleolar import 7) and the export factors 
Rrs1 (ribosome biogenesis regulator homolog) and Nmd3 that both interact with 
Rpl11 and control trafficking of the large ribosomal subunit within the cell. Both 
factors are similarly upregulated in response to Epo/SCF (3-fold) but Rrs1 is 
prominently downregulated in differentiation. Export of the 60S subunit requires 
several GTPases. Gtpbp4 (Nog1), which binds the trafficking factor Nmd3, is strongly 
upregulated by Epo/SCF, and known to be regulated by mTOR (Honma et al. 2006).
Thus, cooperative signals emanating from the EpoR and cKit enhance ribosome 
biosynthesis at the level of rRNA synthesis, processing and modification, and by 
facilitating the interaction of mature rRNA with ribosomal proteins, and the export of 
ribosomal subunits. 
          Genetic experiments have predominantly been performed in yeast and deletion 
of most of the proteins mentioned above is lethal. In contrast, overexpression may 
contribute to tumorigenesis. However, disruption of normal expression may have 
cell type specific effects. For example, enhanced expression of pes1 or UBF in 32D 
cells did not render cells factor-independent nor did it interfere with differentiation, 
whereas both factors efficiently transformed mouse embryo fibroblasts (Prisco et al. 
2004). Interestingly, the nuclear import factor Nip7 (KD93) was identified as a novel 
protein expressed in human hematopoietic stem/progenitor cells (Liu et al. 2004).
Together, the regulation of so many factors involved in ribosome synthesis strongly 
suggests that the number of ribosomes is tightly regulated. The question is what 
for? It is mostly assumed that proliferative signals have to enhance global and 
specific protein synthesis, which is repressed during terminal differentiation when 
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cell division stops (Hensold et al. 1996; Krichevsky et al. 1999; Kroll et al. 2001). 
However, signalling via mTOR is able to repress erythroid progenitor differentiation 
(Blazquez-Domingo et al. 2005; chapter 3). Just as the availability of translation 
factors specifically controls translation of structured transcripts, this may also be true 
for the availability of ribosomal subunits. Moreover, it becomes increasingly clear that 
ribosomal proteins may interact with specific structural elements in transcripts to act 
as a translational regulator (Remacha et al. 1995; Jefferies et al. 1997; Mazumder 
et al. 2003).  The finding that the composition of ribosomes is cell- and cell state-
specific with altered affinity for specific mRNAs supports that the ribosome is not only 
a general protein synthesis machine, but involved in selective transcript translation 
(Mauro and Edelman 2002). Therefore, this analysis of signalling-controlled ribosome 
synthesis is not only the analysis a random set of signalling targets, but should help 
to explain the difference between a signalling dependent gene expression profile 
obtained with total or polysome bound mRNA. We need to understand how signalling 
controls the protein synthesis machinery, to be able to unravel the mechanisms that 
regulate translation of specific transcripts.
 
MATERIALS AND METHODS
Cells
I/11 cells were cultivated in StemPro-34TM medium (Life Technologies) as described 
(von Lindern et al. 2001). For expansion, the medium was supplemented with 
0.5U/ml Epo, (kind gift from Ortho-Biotech, Tilburg, The Netherlands), 100ng/ml 
SCF (supernatant of CHO producer cells) and 10-6M dexametasone (Dex, Sigma-
Aldrich). To induce differentiation, cells were cultivated in StemPro-34TM medium 
supplemented with 5U/ml Epo and 0.5mg/ml iron-loaded transferrin (Intergene). 
For factor deprivation and restimulation, cells were washed twice in Hank’s buffered 
saline solution (HBSS; Life technologies) and seeded in IMDM supplemented with 
0.2% purified BSA (Life Technologies). After 4h Epo (5U/ml), SCF (500ng/ml), Dex 
(10-6M), ZK112,993 (10-6M) were added as indicated for 2h, 6h or 18h. Cell numbers 
and cell size distribution were determined using an electronic cell counter (CASY-1, 
Schärfe-System, Reutlingen, Germany).
Microarray hybridization and analysis
A MIAME compatible description of sample preparation and hybridization protocols 
is given in supplementary data. The data extraction strategy is described in 
supplementary Figure S1.  Microarray data were normalised using the Rosetta 
Resolver ® system, as described in (Weng et al. 2006).  Weighted averages were 
calculated using log error data extracted for each probe set.  The error weight was 
calculated (log error / total log error of 4 hybridisations) and the average calculated 
integrating the error weight.  
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Supplementary Data
Supplementary Tables are found online http://www1.erasmusmc.nl/hematologie/
index.php?cId=73.
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ABSTRACT 
The 5’UTR of the nucleotide diphosphate kinase Nm23-M2 renders translation of 
Nm23-M2 dependent on PI3K-induced polysome recruitment. Nm23-M2 is also a 
common viral integration site in MLV-induced mouse leukaemia.  In this study we 
demonstrate that viral integrations 5’ of the AUG start codon can perturb factor 
dependent translation of the targeted gene. A virus integration in the 5’UTR of 
Nm23-M2 in the murine leukaemia cell line NFS61 results in a LTR-Nm23 fusion 
transcript that disrupts a predicted stem-loop structure. This is associated with 
growth factor-independent polysome recruitment of Nm23-M2. To identify the 
transcription start site of Nm23, 5’RACE experiments were conducted on cDNA 
generated at 60°C to overcome secondary structure. This approach characterised 
a longer 5’UTR containing high enthalpy structures, upstream open reading frames 
and putative signaling responsive elements.  To study the effect of these structures 
on control of mRNA translation, luciferase constructs flanked with Nm23-M2 UTR 
sequences were expressed in factor-dependent cell lines to compare contribution of 
putative regulatory elements to PI3K-dependent polysome recruitment.  Upstream 
ORFs in the distal part of the 5’UTR appeared to enhance polysome recruitment, 
while stem-loop elements in the proximal part of the 5’UTR inhibit translation. In 
contrast, upstream ORFs in the 5’UTR of the transcript mEd2, attenuate polysome 
recruitment. Thus, the position and interplay between regulatory elements within a 
UTR orchestrate translation control of a transcript. Proviral integration within complex 
5’UTRs resulting in deletion of regulatory elements constitutes a novel mechanism of 
constitutive expression of potential oncogenes.  
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Translation control of Nm23
INTRODUCTION
Retroviral insertion mutagenesis has proven to be a powerful method to identify 
genes involved in leukaemia, particularly now that insertion sites can be combined 
with expression profiling in human AML (Erkeland et al. 2006).  Various mechanisms 
may account for retrovirally induced malignancies (Jonkers and Berns 1996; Wolff 
1997). Retroviral insertion can activate transcription when its long terminal repeat 
(LTR) acts as a promoter or as an enhancer of neighbouring genes.  Insertion within 
the 3’ untranslated region (3’UTR) of a gene may result in removal of destabilising 
elements and hence promotes stabilisation of the transcript. In contrast, retroviral 
insertions within the coding sequence of the gene may silence expression.     A so 
far underestimated mechanism by which retroviral insertions may interfere with gene 
expression is through replacement of a structured 5’UTR that imposes translation 
control on the transcript. 
        Translation initiation requires binding of the eukaryotic translation initiation 
factor 4E (eIF4E) to the mRNA cap.  eIF4E is a limiting factor kept in check by eIF4E 
binding protein (4E-BP). Phosphorylation of 4E-BP releases eIF4E to associate with 
the scaffold protein eIF4G and the RNA helicase eIF4A to form the eIF4F scanning 
complex which associates with the 40S small ribosomal subunit to scan the 5’UTR 
for the first AUG codon in an appropriate context (Kozak 1989).  Another rate limiting 
factor in translation initiation is eIF2.  GTP-bound eIF2 associates with methionine 
loaded tRNA to form the the eIF2·GTP/Met-tRNAi
Met ternary complex (TC), which 
also associates with the 40S ribosomal subunit and serves to recognise the AUG 
initiation codon. At the initiation codon, the 40S and 60S subunits associate to start 
protein synthesis. 
          Secondary structures and upstream open reading frames (uORF) can inhibit 
scanning of the 5’UTR and silence translation (Manzella and Blackshear 1990). 
Overexpression of eIF4E can release inhibition of translation from structured mRNA 
(Manzella et al. 1991; Shantz et al. 1996; Koromilas et al. 1992; Blazquez-Domingo 
et al. 2005), most likely because the pre-initiation scanning complex supplies RNA 
helicase activity to melt complex 5’UTR sequences.  In addition to structures with 
high enthalpy other variables such as the relative distance of hairpin loop structures 
from the 5’ methyl G cap (Babendure et al. 2006), association of specific proteins 
with stem-loop structures (Cazzola and Skoda 2000) and the presence of upstream 
Open Reading Frames (uORFs), attenuate translation initiation (Morris and Geballe 
2000).  Translation of uORFs can attenuate translation of the proper ORF as a result 
of premature dissociation of ribosomes (Kozak 1987; Child et al. 1999), stalling of 
the scanning complex by interaction of the nascent peptide with components of 
the complex (Ruan et al. 1996) or due to the presence of rare codons (Meijer and 
Thomas 2003).  Conversely, uORFs can release translation silencing conferred by 
inhibitory elements within the 5’UTR.  Once the transcript is engaged in peptide 
production, secondary structures are more easily unfolded. 
         Polysome recruitment of Nm23-M2 is sensitive to growth factors and availability 
of the cap-binding translation initiation factor eIF4E (Blazquez-Domingo et al. 
2005). Interestingly, Nm23-M2 was found to be a common retroviral interation site 
in murine leukemia’s induced by the CasBr-M Murine Leukemia Virus (MuLV) 
(Joosten et al. 2002).  We here describe retroviral insertion within the 5’UTR of 
Nm23-M2 that replaces the structured 5’UTR by viral LTR sequences.  This fusion 
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transcript of proviral LTR-Nm23 has lost translation control (Figure 1C).  We studied 
regulatory elements in Nm23-M2 transcript that are lost upon retroviral insertion. 
Similar regulatory elements found in mEd2 transcript, previously identified as a 
translationally controlled gene, were studied as a comparison.  The elements in these 
two transcripts are differentially distributed along the 5’UTR.  Using in vitro systems 
we dissected the UTRs to identify potential regulatory elements.  Response to PI3K 
activity  is assessed using mouse pre-B cell line, Ba/F3 and chicken erythroblasts, 
HD3.  Surprisingly, the newly found uORFs in the distal part of the transcript relax 
translational control by the secondary structure in the proximal region of the Nm23-
M2 5’UTR.  The underlying mechanism is still unclear, although specific recognition 
and expression of uORFs might play a role in derepression of translation from the 
proper AUG.  Finally, a high enthalpy structure and a putative signalling responsive 
element in Nm23-M2 UTR have been assigned to the proximal region of the proper 
AUG.  These elements are missing in the transcript isolated from the tumour-derived 
cell line harbouring the retroviral integration in Nm23-M2.  
RESULTS
Viral integration results in a LTR-Nm23-M2 fusion transcript with simple 
5’UTR 
In CasBr-induced mouse leukemia, several retroviral integrations have been mapped 
5’ of the AUG start codon of Nm23-M2. (Joosten et al. 2002). Analysis of 20 cell 
lines derived from MLV-transformed murine leukemias indicated the presence 
of a retroviral integration 5’ of Nm23-M2 in the NF61 cell line. This offered the 
possibility to isolate RNA transcripts and identify a potential fusion transcript. Using 
oligonucleotide primers in the ORF of Nm23 and in the CasBr LTR, we amplified 
a LTR-Nm23 fusion transcript (Figure 1).  Interestingly, the integration is within the 
5’UTR of Nm23-M2 in between two inverted repeats and disrupts a high enthalpy 
stem-loop structure.  Similarly the Terminal OligoPyrimidine (TOP) tract previously 
identified by Rapid Amplification cDNA Extension (RACE) is lost.  Hence a complex 
5’UTR is changed into a simple one, disrupting translation control.  To test this 
possibility, we examined Nm23-M2 polysome association in NFS61 and NFS33, a 
related cell line in which the Nm23-M2 locus is intact, following factor deprivation 
and restimulation with IL-3.  The NFS61 line will express the LTR-Nm23-M2 fusion 
transcript from one allele and a normal Nm23-M2 from the other allele. Therefore, 
factor-deprivation and restimulation still affects the overall polysome recruitment 
of total Nm23-M2 transcripts. However, following factor deprivation, restimulation 
increases polysome association from 22 to 66% in a control cell line (NFS36), and 
from 61 to 73% in the NFS61 cell line (with LTR-Nm23 fusion transcript).
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Translation modulation of luciferase using Nm23-M2 UTRs
To address the effect of the lost regulatory elements on Nm23-M2 expression, we 
used reporter assays. As a model system we used Ba/F3 cells that are suitable 
for transient transfections and respond to factor deprivation and restimulation, as 
measured by phosphorylation status of 4EBP protein (Figure 2A). For the reporter 
construct we amplified the endogenous promoter including the 5’UTR of Nm23 up to 
the proper AUG and fused this to the ORF of the luciferase reporter. The 3’UTR of 
Translation control of Nm23
 
Figure 1   Viral integration results in a LTR-Nm23-M2 fusion transcript that lost translation control. 
A: Representation of genomic sequence and the alignment with the resulting endogenous Nm23-M2 
transcript.  The dotted line indicate the position of the 214bp intron starting from position –217 to –3 
relative to A of ATG.  The boxes indicate the untranslated exonic region.  The grey boxes show the position 
of an inverted repeat (IR) within the UTR.  The transcript starts with a tract of pyrimidines (TOP).  B: The 
proviral sequence in the cell line NFS61 was found to be inserted at position –263 in between the inverted 
repeats. C: Tumour derived cell lines NFS36 and NFS61 were factor-deprived (NF) and subsequently 
restimulated with IL3 (10ng/ml).   Polysome bound (pb) mRNA was isolated, and fractions were used 
for Northern analysis.  A radio-labeled Nm23-M2 probe was used to detect the Nm23-M2 transcript. 
Quantification by ImageQuant allowed to  measure the percentage of mRNA associated with polysomes 
(pb-mRNA).
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Regulatory elements in the 5’UTR of Nm23-M2
In previous studies we identified several transcripts subject to PI3K-dependent 
polysome recruitment in response to SCF restimulation of erythroid progenitors. 
Blast searches on EST-libraries identified 5’UTR sequences that extended beyond 
the 5’UTR of cDNA libraries available from the same sources (NCBI). RACE 
experiments to analyse the transcription start site and the most 5’ sequence of these 
transcripts failed under standard conditions, most likely because of the presence of 
structural elements (data not shown). However, using a mutant RT-enzyme active at 
60°C, we could resolve the 5’UTR of mEd2/ D12 that contains a predicted structure 
with an enthalpy of –21kcal/mol over 10nt (Figure 3).  Strikingly, also the RACE 
product for Nm23-M2 extended beyond the previously described TOP element. 
Instead of 170bp, we could establish that Nm23-M2 contains a 5’UTR of 439bp. 
RNA secondary structure analysis and scanning for consensus sequences of the 
5’UTR sequence of Nm23-M2 identified several putative regulatory elements, (i) 
A stretch of 76 nucleotides from -59 to -135 lacking adenosine, resulting in long 
stretches of GC and GU base pairing with UC-rich bulges in between (Figure 3). 
This high enthalpy structure is conserved between mouse and human transcripts, (ii) 
uORFs that are situated 5’ to the high enthalpy region, and (iii) signalling-sensitive 
structures denoted as a Gamma interferon activated inhibitor (GAIT) element.  This 
element was identified by RegRNA (http://regrna.mbc.nctu.edu.tw) and lies within 
the uORF initiating at an uAUG with perfect Kozak sequence.  These GAIT elements 
are conserved in human and rat.  Also the distribution of uORFs and secondary 
structures along the 5’UTR is conserved between human, rat and mouse. 
Effect of Regulatory elements on expression
To assay to what extent the different structures contribute to factor dependent 
transcript translation, we made use of reporter constructs. To facilitate rapid screening 
in both in vitro transcription translation assays and in transient transfections in PI3K-
dependent cell lines, we cloned a metallotheinine (MT)-T7 promoter combination in 
front of 5’UTR sequences of Nm23-M2 and mEd2, which, in turn, were fused to the 
AUG startcodon of the pGL2-derived luciferase gene. Compared to the full length 
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Nm23-M2 was fused to the stop codon of luciferase to retain all possible non-coding 
regulatory sequences.  Using a full length endogenous promoter ensured that the 
proper transcription start site is taken independent of the correct transcription start 
site prediction of previous RACE experiments.  To quantify reporter expression in 
response to factor deprivation and restimulation, a short half-life of the luciferase 
protein was imperative to ensure short depriviation time points prior to stimulation. 
Therefore we used the instable luciferase construct from pGL2 within Nm23-M2 
regulatory sequences and first measured luciferase activity following factor-
deprivation (Figure 2B).  Next, the luciferase activity of the Nm23-M2 construct was 
measured following 6h factor deprivation and restimulation in presence and absence 
of inhibitors of protein translation (rapamycin) or gene transcription (Actinomycin D). 
This indicated that factor restimulation induced reporter expression dependent on 
translation, but independent of transcription (Figure 2C).
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Figure 2   The untranslated regions (UTRs) of Nm23-M2 induce translation control when flanking 
the luciferase coding sequence.  A: BA/F3 cells were factor deprived for 6hours (NF) and stimulated 
with IL3 (10ng/ml) plus SCF (100ng/ml) for 2 hours in the absence or presence of rapamycin (inhibitor 
of mTOR).  Western blots with total cell lysates were stained with antibodies recognising total 4E-BP (α-
4E-BP).  The unphosphorylated, fast moving α-isoform, a partially phosphorylated β-isoform, and a fully 
phosphorylated, slow moving γ-isoform are indicated.  B:  A reporter construct with the luciferase coding 
sequence flanked with the UTRs of Nm23-M2 and the endogenous Nm23-M2 promoter, was transfected 
into BA/F3 cells.  The cells were factor deprived and the luciferase activity was measured at 2 hour 
time intervals, up to 8 hours.  C:  BA/F3 cells were transfected as in (B), factor deprived for 6 hours and 
restimulated with IL3 (10ng/ml) plus SCF (100ng/ml) for 2 hours in the presence of the translation inhibitor, 
rapamycin (10nM) or the transcription inhibitor, Actinomycin D (10µg/ml; ActinoD) or without inhibitors.   
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5’UTR, removal of the upstream ORFs in mEd2 UTR resulted in an increase in 
luciferase readout following in vitro transcription/translation indicating that the uORFs 
attenuate translation efficiency.  Surprisingly, the opposite effect was observed when 
the uORFs in Nm23-M2 were deleted (Figure 4A).   Transfection of the reporter 
constructs in HD3 or the murine BA/F3 cell line confirmed that the uORFs in Nm23-
M2 release the inhibitory effect in the proximal 5’UTR region. The presence of the 
uORFs increased the luciferase activity, whereas mRNA expression was similar for 
the full length and deletion construct (Figure 4B). Further mutational analysis will be 
designed to investigate the contribution of GAIT elements and uORFs.  In addition, it 
is important to investigate the distribution of these elements relative to the complex 
inverted repeat regions, known to inhibit translation initiation.
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Figure 3  Regulatory elements within extended Nm23-M2 5’UTR sequence as compared to elements 
in mEd2.  An open arrow indicates the proper AUG of Nm23-M2 transcript.  Black arrows indicate the 
upstream open reading frames (uORFs).  The region delimited by (*) do not contain A’s and harbours 
the oligo pyrimidine tract thought to be the transcription start site in previous experiments.  An inverted 
repeat with a high enthalpy (-20 kcal/mol) is indicated.  The secondary structure was predicted by Mfold 
software (http://www.bioinfo.rpi.edu/applications/mfold/rna/form1.cgi).  The uORFs and the “gait” structure 
were predicted using the scanning program regRNA (http://regrna.mbc.nctu.edu.tw).   The viral integration 
site occurs at the nucleotide denoted as NF61.  The smaller representation of the mEd2 5’ UTR structure 
shows the position of uAUGs and the high enthalpy inverted repeat.
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Figure 4  The uORF region contributes to translation efficiency in both Nm23-M2 and mEd2.  A: 
The 5’UTRs of Nm23-M2 and mEd2 were introduced between a T7 promoter and the coding sequence 
of the luciferase ORF.  The left panel indicates the primer positions for UTRs with [full length] or lacking 
the uORF region [del uAUGs]. The bold black arrow indicate uORFs; half arrows the position of the primer 
to amplify the UTR product; and G1/G2 the position of the Gait elements in Nm23-M2.  The right graphs 
show the kinetics of in vitro transcribed/ translated luciferase activity. Lysate was harvested at increasing 
incubation times, showing linear increase of luciferase activity. B: The same constructs for Nm23-M2 were 
transfected in BA/F3 cells and HD3 cells.  Signalling was abrogated by growth factor removel (NF) and the 
luciferase activity compared to steady state (ss) conditions.  The small graph inserts indicate the level of 
transcript in the cells quantified by Real Time PCR.  Error bars indicate the variance from 3 independent 
experiments.
123
Chapter 5
The role of growth factor sensitive structured UTR of Nm23-M2
Proviral integration within the Nm23-M2 locus was detected in 56% of the primary 
leukemias (Joosten, unpublished data).  The importance of Nm23-M2 as a common 
viral integration site is supported by association of high expression of the human 
homolog, NM23-H2 to a certain group of poor-risk myeloid leukemias (Yokoyama et 
al. 1996; Yokoyama et al. 1998). The growth factor-dependent expression of Nm23-
M2 may explain why we could not establish erythroid progenitor clones constitutively 
expressing this protein. Notably, we were unable to induce constitutive expression 
of most transcripts subject to growth factor-dependent translation (chapter 3).  This 
rendered the study of the oncogenic potential of Nm23-M2 in hematopoietic cells 
unconclusive.  
        Another approach to address the role of Nm23-M2 was a study on the loss of 
translation control by proviral integration.  The oligoclonal nature of the MLC-induced 
tumours rendered the assessment of protein levels compared to transcript levels 
difficult to interpret and polysome gradients from tumour material was not feasible 
either.  The NF61 cell line contains a proviral insertion within the 5’UTR of Nm23, 
resulting in a transcript without high enthalpy structures and lacking all the elements 
identified in this study.  In addition the elements are replaced by the viral sequence 
allowing easy scanning and efficient polysome recruitment of the modified UTR of 
Nm23-M2 fusion transcript and hence constitutive expression.  This suggest that 
deletion of regulatory elements within non-coding regions of complex transcripts 
permits a novel mechanism of constitutive expression of potential oncogenes that 
are otherwise sensitive to growth factor-dependent translation initiation.
Characterisation of regulatory elements within the Nm23-M2 UTR   
Despite all progress in the genome projects, it remains difficult to predict a 
transcriptional start site, leaving the identification of 5’UTR sequences to experimental 
approaches. Our own assays indicated that many structured 5’UTRs could only be 
reverse transcribed under conditions that destabilise secondary structures (e.g. RT 
at 65°C).  We used both databases and experimental approaches to identify the 
longest transcripts for Nm23-M2 and mEd2, in an effort to characterise regulatory 
elements within the UTR of Nm23-M2 that are disrupted by viral insertions.  mEd2 
was taken along since it was found to have similar elements in its 5’UTR, although 
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DISCUSSION
Nm23-M2 was identified as a common viral integration site in Cas-Br induced 
leukemias (Joosten et al. 2002). However, viral insertion upstream of the transcription 
start site did not result in enhanced expression.  Instead, disruption of regulatory 
elements within the 5’UTR of Nm23-M2 transcript permitted polysome recruitment 
and initiation of translation in the absence of growth factors (Joosten et al. 2004). 
Reanalysis of the 5’UTR of Nm23-M2 showed a much more complex structure than 
initially anticipated. Interestingly, upstream ORFs in the distal part of the 5’UTR 
appeared to enhance polysome recruitment, while stem-loop elements in the 
proximal part of the 5’UTR inhibit translation.  Together these regions are responsible 
for growth factor dependent polysome recruitment. 
Translation control of Nm23
the distribution was different.  A high enthalpy structure was found downstream 
of, or located within the uORFs in Nm23-M2 and mEd2 respectively (Figure 3). 
This presents an interesting interplay between selection of uAUGs and melting of 
structures.    
Translation initiation efficiency is governed by ribosome recruitment, scanning, 
and selection of the proper AUG.  Increased eIF4E availability upon growth factor 
signalling recruits the RNA helicase eIF4A to melt secondary structures (Koromilas 
et al. 1992). In addition, the availability of the ternary complex of GTP-bound eIF2 
associated with methionine-bound tRNA (eIF2:GTP-Met-tRNAi) determines the 
efficiency with which AUG startcodons are recognised (Morris and Geballe 2000). 
The uORF in the Nm23-M2 5’UTR starts with a perfect consensus sequence 
(AnnAUGG; -387) suggesting that regulation of eIF2 and differential selection of 
the uAUG is not the primary level of regulation. Instead, a first level of regulation 
may be the efficiency with which scanning continues beyond the uORF. It has been 
described before that an uORF with the uAUG before a stable secondary structure 
enhances scanning through that structure.  It is supposed that the bulgy ribosome 
and the process of translation destabilises secondary structure. The surprising 
condition in the 5’UTR of Nm2-M2 is that the high enthalpy secondary structure is not 
within the uORF, but separated by at least 207 nucleotides. This may mean that the 
peptide encoded by the uORF affects the stability of the secondary structure, or the 
efficiency with which the pre-initiation scanning complexes can unfold the structure. 
Although the presence of an uORF upstream of secondary structure is conserved, 
the sequence of the encoded peptide is not conserved between mouse and man, 
which renders a function for the peptide less likely.  The proximal structural element 
may be stabilised by proteins that are released following signalling. However, the 
fact that the structures block reverse transcription at 42°C on naked RNA indicates 
that their stability does not require protein binding. Instead signalling may stimulate 
protein-RNA interactions that destabilise the secondary structure.
       In addition to the high enthalpy structures and uORFs, the RegRNA RNA-
analysis program identified two GAIT elements. A GAIT element resembles the 
Iron Response element (Sampath et al. 2003), suggesting that such structures 
are candidates for protein/RNA interactions.  In Ceruloplasmin transcript the GAIT 
element is present in the 3’UTR and binds RpL13a, which is released from the 60S 
ribosomal subunit upon phosphorylation by IFNγ.  Binding results in a translationally 
inhibitory complex (Sampath et al. 2003) (Mazumder et al. 2003).  The GAIT element 
in Nm23-M2 may bind RpL13a, but it is also possible that other proteins are binding 
to control the pre-initiation scanning complex and polysome recruitment of NM23-
M2. The role of the GAIT elements awaits mutational analysis. 
MATERIALS AND METHODS
Cells
BA/F3 and tumour cell lines were cultured at a density of 0.2-1.0×106 cells per ml, in 
RPMI 1640 (Invitrogen) supplemented with 10% FCS (Hyclone, PerBio) and 10ng/ml 
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murine IL-3 (supernatant).  HD3 cells were cultured at a density of 1-2×106 per ml 
in S13 medium (ISCOVE medium supplemented with 12% Fetal Calf Serum; 0.05% 
chicken serum; 0.1% Bovine Serum Albumin; 0.02% bicarbonate and 1×10-4M β-
mercaptoethanol).  Genomic DNA was isolated as described previously (Joosten et 
al. 2002).  
RNA isolation, Northern blot and cDNA synthesis
Cell extracts were prepared by lysis at 4°C in extraction buffer (10 mM Tris-HCl, pH 
8, 140 mM NaCl, 1.5 mM MgCl2, 0.5% Nonidet-P40, 20 mM dithiothreitol, 150 _g/ml 
cycloheximide, 1 mM phenylmethylsulfonyl fluoride, and 500 units/ml RNasin), and 
nuclei were removed by centrifugation (1000 × g for 10 min at 4°C). The supernatant 
were centrifuged (12,000 × g for 5 min at 4 °C) to eliminate mitochondria.  The 
supernatant was either loaded on sucrose gradients to isolate polysome bound mRNA 
as described in (Joosten et al. 2004) or taken as total RNA.  The total supernatant 
was digested with 100 µg of proteinase K in 1% SDS and 10 mM EDTA (30 min 
at 37°C).  RNAs were recovered by phenol/chloroform/isoamyl alcohol extraction 
followed by ethanol precipitation.  Similarly the fractions from sucrose gradients were 
digested and RNA extracted.  RNA was quantified by UV-absorbance.  
For Northern blot analysis, RNAs were loaded on denaturing 1.2% 
formaldehyde agarose gels and subsequent blotted to Hybond-N membranes 
(Amersham Biosciences).  We used a 612-bp nm23-M2 cDNA fragment as a 
probe.  After hybridization, filters were scanned on a PhosphorImager (Amersham 
Biosciences), and signals were quantified by phosphorimaging.
cDNA for Real-time PCR was generated as described (Joosten et 
al. 2004).  For RACE experiments, 60ng of purified poly(A)+ mRNA and 5’-
TGAAGGTACGCTCGAGG-3’ for Nm23 and 5’-TGGATGCAAGATACAGATAGC -3’ 
for mEd2, were used to synthesise cDNA at 60oC in accordance to manufacturer’s 
protocol, using Roche Transcriptor Reverse Transcriptase (Roche 03531317001) 
supplied together with mRNA capture kit (Roche 117878960).  First stand cDNA 
was purified using High pure purification columns (Roche 11732668001) and dA-
tailed.  The first PCR (15s at 94oC, 30s at 59 oC, 72 oC for 10cycles followed by 25 
cycles of 15s at 94oC, 30s at 58 oC, 72 oC) was performed using the Nm23 primer (5’-
TGCCTGGTCTTGCCAGTCG-3’), the mEd2 primer (5’- TCACAGCGACAAAGCAGC-
3’) and the dT-linker forward primer supplied by the kit.  Nested PCR was performed 
using  the Nm23 primer (5’- TGCACGCCCTCTCCTTGCAG-3’), the mEd2 primer 
(5’-TGAAGCAGAGTCTCTGTAGTCC -3’) and the forward primer supplied in the kit. 
Subsequently, the final products were cloned directly into pCR2.1 (Invitrogen) 
according to the instructions of the manufacturer. Nucleotide sequencing was carried 
out using a binding domain sequencing kit according to instructions from the provider 
(PE Biosystems).  Sequencing was carried out on an ABI 310 automatic sequencer 
(PE Biosystems) using the M13 forward primer (5_-GTAAAACGACGGCCAGT-3_). 
All primers were obtained from Sigma-Genosys Ltd.
SDS-PAGE, western blotting and antibodies
For acute stimulation with growth factors and affect of rapamycin, proliferating 
BA/F3 cells were washed twice with phosphate-buffered saline (PBS) and seeded 
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at  4 x 106 cells/ml in plain RPMI (Invitrogen). After 6 h factor deprivation, cells 
were stimulated at 37°C with IL3 (10ng/ml) and SCF (100ng/ml) in the presence 
or absence of rapamycin (40ng/ml). Cells were harvested after the indicated time 
points by addition of ice-cold PBS.  Cell lysates, SDS-PAGE, immunoprecipitation 
and Western blotting were performed as described previously (van Dijk et al. 2000). 
10 µl of protein extract (≈1x106 cells) was loaded onto a 15% polyacrylamide gel. 
The antibodies used were: α-4E-BP1 (Cell Signaling Technology, Inc).
Cloning of Nm23 and mEd2 sequencies and Luciferase Reporter assays
The promoter including the 5’UTR of Nm23 was digested from a pGL3 construct 
described in (Joosten et al. 2004), and ligated into the pGl2 construct (Promega; 
NcoI site inserted at luciferase AUG and SnaBI site inserted 5’ to the polyA tail, 
using Quickchange Site Directed Mutagenesis kit from Stratagene).  The 3’UTR was 
amplified from a cDNA library and inserted to replace the poly tail of pGl2 vector by 
a SnaBI / BamHI digest.  The resulting luciferase with endogenous UTRs of Nm23, 
was used to investigate signalling-dependent translation control.
The mouse Nm23, mEd2 Untranslated regions (UTRs) were amplified 
from a cDNA library using the following primers, harbouring an XhoI site in 
the forward primer and an NcoI site in the reverse primer: forward Nm23 5’-
CCGCTCGAGCGGTTAATACGACTCACTATAGGGAGAGGGCTGAATTTCGGAGA
TAG-3’, reverse Nm23 5’-CATGCCATGGTCCGAAAGCCGGTGGGTCGGCTG-3’; 
forward mEd2 5’-CCGCTCGAGCGGTTAATACGACTCACTATAGGGCAGGTCAAG
GTTCCCGCTACAG-3’, reverse mEd2 5’- AACTGCAGAACCAATGCATTGGAGAAA
AGGGCGGAAGTGCCTGAGTGAGG -3’, and the Expand High Fidelity PCR System 
(Roche).  The transcription start site was taken at the 5’ end of the longest RACE 
product identified in this study.  The shorter forms of UTRs were amplified using 
the same reverse primers, and a forward primer downstream of the uAUGs 5’-
CCGCTCGAGCGGTTAATACGACTCACTATAGGGACAGAGACGACTGGCAAGAC
CAG-3’ in Nm23 and 5’- CCGCTCGAGCGGTTAATACGACTCACTATAGGGAAGGC
CAGGTATCAAGACCATC -3’ in mEd2.  The PCR products were ligated in pCR2.1 
vector (Invitrogen).  The fragment was digested out with XhoI and NcoI and cloned 
in pGL2-basic.  
For reporter assays, 10×106 Ba/F3 cells were electroporated (0.28kV, 
capacitance 960µFD) with maximum 20µg of DNA. After recovery for several hours 
in normal media, cells were washed and grown overnight in the presence or absence 
of IL-3 and SCF, or cells were IL-3 deprived for 6 hours and stimulated for 2hrs 
with IL-3 and SCF in the presence or absence of rapamycin (Alexis, Switzerland). 
Luciferase activity was measured using the Steady-Glo system (Promega). 
Transfection efficiency was determined by cotransfecting lacZ and analyzing β-
galactosidase activity.  For comparison of mutated UTRs with full length UTR, the 
cells were washed and grown overnight in the presence or absence of IL-3 and SCF, 
or cells were IL-3 deprived for 6hours.  
The luciferase assays were also performed in HD3 cells.  A DEAE protocol 
was used to efficiently transfect these cells.  In Brief, 20×106 cells were washed twice 
in 10ml TBS.  12.5µg DNA was dissolved in 50 µl TBS kept at 37oC.  75µl prewarmed 
DEAE-Dextran (5mg/ml) was mixed well and incubated for 30 min at room 
temperature (r.t.).  1.375 ml TBS were added to the DNA and mixed well, followed 
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by mixing the resulting DNA-solution to the cell pellet.  After 30minutes incubation 
at RT, mixing at intervals of 10 minutes, 9ml TBS and 2ml S13 medium were added. 
The cells were washed with 4 ml of S13 medium and seeded at a density of 1.4x106/ 
ml.  HD3 cells were straved at 42oC for 6hours followed by re-stimulation at 37oC for 
3 hours.  3×106 cells were lysed for luciferase assay and 20×106 cells were lysed to 
isolate cytoplasmic mRNA and quantitate luciferase transcript by Real-time PCR.  
Real-time PCR 
The real-time PCR assay involved TaqMan technology (PE Applied Biosystems Model 
7700 sequence detector), using the double stranded DNA-specific fluorescence dye 
SYBR green I to detect PCR product as previously described (Kolbus et al. 2003). 
The amplification program consisted of 1 cycle of 50°C with 2min hold (AmpErase 
UNG incubation), 1 cycle of 95°C with 10 min hold (AmpliTaq Gold Activation), 
followed by 40 cycles of denaturation at 95°C for 15s, annealing at 62°C for 30s 
and extension at 72°C for 30s. All the different primer pairs had similar optimal PCR 
annealing temperatures. Acquisition of the fluorescence signal from the samples was 
carried out at the end of the elongation step.  To confirm amplification specificity, the 
PCR products from each primer pair were subjected to agarose gel electrophoresis 
and the dissociation curve was checked at the end of each run. Gene-specific 
primers flanking a 300bp product within the luciferase coding sequence, forward 
5’-TCAGATTCTCGCATGCCAG-3’ and reverse 5’-TGGTACTAGCAACGCAC-3’ were 
obtained from Sigma-Genosys Ltd. 
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Erythroid progenitors undergo renewal divisions in the presence of Epo, SCF and 
glucorticoids, retaining the capacity to differentiate in culture with medium containing 
Epo alone.  The SCF driven renewal and repression of differentiation is PI3K 
dependent.  The cellular system used in this study proved to be extremely powerful 
to study the importance of signalling pathways in the decision between expansion 
and differentiation of erythroid progenitors.  The block of erythroid differentiation 
resulting from constitutive expression of eIF4E suggested an important role of 
SCF-driven availability of eIF4E in repression of differentiation.   Increased eIF4F 
activity enhances the translation efficiency of complex mRNA transcripts.  To 
identify transcripts that are recruited to polysomes upon SCF addition we hybridised 
polysome bound mRNA and total RNA from both factor deprived and re-stimulated 
erythroid progenitors to oligonucleotide arrays.   Subtraction of regulation at total and 
polysome bound fractions characterized a unique list of transcripts that are regulated 
at the level of polysome recruitment and hence initiation of protein synthesis. Among 
the most regulated genes, Nm23 was also found as a common virus integration site 
with insertions deleting a high enthalpy structure in the 5’ untranslated region of 
the mature transcript, suggesting a novel mechanism of proviral disruption of gene 
expression. Two genes, Igbp1/α4 and mEd2, repressed erythroid differentiation upon 
constitutive expression, indicating a critical role of these translationally controlled 
genes in the balance between expansion and differentiation.  Interestingly Igbp1/α4 
attenuates the negative regulation of mTOR targets by the S/T-phosphatase Pp2a. 
This prompted us to investigate the effect of constitutive Igbp1/α4 on the mTOR 
effectors 4EBP and S6K. Both were constitutively phosphorylated upon constitutive 
Igbp1/α4 expression.  Surprisingly, Epo stimulation resulted in S6K phosphorylation 
when Igbp1/α4 was constitutively expressed, suggesting that in these clones both 
increased translation efficiency of complex transcripts and enhanced ribogenesis 
might drive expansion and repress terminal differentiation.  The potential role of 
ribogenesis is supported by positive regulation of ribosomal factors and rDNA 
transcription regulation by SCF as shown in the profiling experiment. 
6.1 Structural RNA elements dictating translational control 
Translation regulation is one of the targets of constitutive active growth factor 
signalling.  Rate limiting eIF2 and eIF4E play a critical role in translation initiation of 
a subset of mRNAs that have cis-regulatory elements such as uORFs (Calkhoven 
et al. 2000; Morris and Geballe 2000; Dever 2002; Calkhoven et al. 2003) and 
secondary structures that impair ribosomal scanning for the proper AUG (Graff et al. 
1997; Clemens and Bommer 1999; Willis 1999; Graff and Zimmer 2003; De Benedetti 
and Graff 2004).  Inhibition of ribosomal scanning through structural hindrance can 
silence translation (Manzella and Blackshear 1990).  Release of translation block 
by removal of structural elements (Joosten et al. 2004) or overexpression of eIF4E 
(Manzella et al. 1991; Koromilas et al. 1992; Shantz et al. 1996; Blazquez-Domingo 
et al. 2005) implies a direct role of eIF4E in melting complex 5’UTR sequences. 
SCF signalling stimulates cap-dependent translation and is expected to enhance 
translation of transcripts that require increased levels of the eIF4F complex. These 
transcripts are generally characterized by structured 5’UTRs (Koromilas et al. 1992, 
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De Benedetti et al., 2004 or the presence of terminal oligopyrimidine tract (TOP) 
sequence (Jefferies et al. 1997). 
6.1.1 A unique list of translationally controlled genes.
We set out to identify polysome recruitment as a target of SCF.    Utilising polysome-
bound RNA for array hybridization increases the value of the data by including 
information on transcripts from which peptides are being synthesized, and also 
increases the sensitivity for low abundant transcripts.  This approach has been used 
previously to identify differential loading to polysomes upon inhibition of PI3K and ras 
pathway in glioma cells (Rajasekhar et al. 2003), and during hypoxia during which 
differential sensitivity to mRNA translation inhibition contribute to specific hypoxia-
induced protein expression (Koritzinsky et al. 2005; Wouters et al. 2005). 
A profiling study using polysome-bound mRNA derived from glioblastoma 
cells (Rajasekhar et al. 2003) identified hundreds of genes that were differentially 
expressed (>2-fold change) in cells upon transformation by v-Ras and/or v-Akt or 
in transformed cells treated with or without inhibitors of PI3K and MEK1. Instead, 
only 67 genes were found to be regulated >2-fold when total RNA was used for 
profiling (Rajasekhar et al. 2003). Taking the ratio of pb over total RNA into account 
343 known genes were found to be regulated at the level of polysome recruitment 
dependent on v-Ras/v-Akt signalling. This is in accordance with our observation that 
the number of genes selected as being differentially regulated in response to growth 
factors is at least 3-fold increased in polysome bound RNA compared to total RNA at 
any choosen threshold. However, the overlap in identified genes in the v-Ras/v-Akt 
glioblastoma cells and Epo/SCF-stimulated erythroid progenitors was small, which 
may have been caused by the use of a different cell type and a different experimental 
approach addressing quick responses to stimuli in our study as opposed to the effect 
of genetically perturbed pathways. In addition, the use of 4 independent replicates 
in our study and a different statistical analysis may have rendered our study more 
stringent in the selection of genes that are predominantly regulated by selective 
polysome recruitment.
 Both studies indicate that gene expression profiling using polysome-bound 
mRNA has major advantages. Polysome recruitment of specific transcripts responds 
to a wide variety of extracellular signals including growth factors but also nutrients 
and hypoxia, and intracellular signals including protein misfolding and apoptosis 
(Pain 1996; Gingras et al. 1999; Raught and Gingras 1999; Gingras et al. 2001; 
Lang et al. 2002; Stolovich et al. 2002; Rajasekhar et al. 2003; Blais et al. 2004; 
Blazquez-Domingo et al. 2005). This indicates that gene expression profiling of many 
different conditions including cancer could benefit from this approach. However, the 
advantage of using pb mRNA may depend on the conditions and samples used. 
Notably, different cellular processes are regulated at distinct levels, which is best 
exemplified by the observation that factor-dependent expression of genes involved 
in lipid metabolism were regulated at the level of gene transcription with concomitant 
polysome recruitment, whereas glucose metabolism was regulated largely at the 
level of polysome recruitment. Conventional profiling with total mRNA may be 
preferred to find targets of transcription factors, or when structural, noncoding RNAs 
have to be included in the targets.
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6.1.2  Regulatory elements in the 5’UTR of translationally controlled genes
We examined the 5’UTR of transcripts of which translation was regulated by 
SCF-induced polysome recruitment. This list contained many ribosomal proteins and 
some translation factors (chapter 3) known to contain a TOP sequence (Levy et al. 
1991). The difference between factor-induced expression (array data) in total versus 
polysome bound RNA of these genes, however, was mostly less than 1,5-fold.  To 
evaluate the most regulated transcripts, we selected genes that were at average at 
least 1.5-fold more regulated in pb RNA compared to total RNA. This selection was 
made in addition to the probability of differential expression as described in chapter 
4. This left us with 49 translationally controlled genes. 
The UTR sequence of these transcripts were downloaded from the NCBI 
database and blasted to mouse EST database. For 27 genes the UTR sequence 
could be extended based on novel EST sequences that corresponded to flanking 
regions in the genome.  We excluded 18 genes from our UTR analysis because the 
UTRs were too short or not unique in the genome. Transcripts with too short UTRs 
may possess structural elements that hinder extension using conventional cDNA 
synthesis, therefore further analysis is needed to ensure the proper length.  The 
remaining 31 UTRs were analysed for length, GC content, presence of upstream 
AUGs and upstream open reading frames (uORFs), inverted repeats that increase 
the enthalpy by at least -20kcal/mol (Babendure et al. 2006) and other structures 
such as pseudoknots.   The distance of such structures from the proper AUG and 
relative to uORFs was taken also in account (data not shown). 
Two of the 31 selected transcripts contained a TOP sequence, while the 
other structures that contribute to control of translation initiation are not easily 
discernable.  The bioinformatic tools, RegRNA (http://regrna.mbc.nctu.edu.tw) 
and UTRscan (http://bighost.area.ba.cnr.it/BIG/UTRScan/) were used to score 
for putative regulatory elements in the UTR sequences.  First, 11 genes contain 
a putative IRES sequence in the 5’UTR. Because structures functioning as an 
IRES are ill-defined, these structures must be interpreted as extensive secondary 
structures with multiple potential functions. 12 UTRs contained a single or multiple 
uORFs and interestingly 7 UTRs scored for structures that are recognised as GAIT 
elements (Gamma interferon activated inhibitor of Ceruloplasmin mRNA translation). 
These elements occur as single or multiple elements with a total of 12 elements 
distributed in the 7 UTRs.   Half of these elements were found within uORFs having 
a perfect Kozak sequence suggesting a regulation at the level of AUG selection. 
Interestingly, it has been shown in other studies that addition of IFNγ results in 
phosphorylation of ribosomal protein L13a which is released from the 60S ribosomal 
subunit and forms an inhibitory complex with the GAIT element (Mazumder et al. 
2003; Sampath et al. 2003).  The striking similarity to the Iron Responsive Element 
(IRE) suggests that such structures are candidates for protein/RNA interactions 
making them potentially responsive to signals.  Interestingly, the GAIT element in 
Nm23 transcript is conserved between mouse, rat and human and its position within 
the uORF is conserved in rat.
So far, we have not examined the role of the 3’UTR in selective polysome 
recruitment. However, protein complexes that associate with both the 5’ and 3’ UTR 
may be critical to control mRNA translation (Figure 6.1).  
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Figure 6.1  Stabilisation of mRNA scanning complex.  Upon phosphorylation of 4E-BP, eIF4E can 
bind the scaffold protein eIF4G that recruits several other proteins and protein complexes among which 
the 40S ribosomal subunit. This complex scans along the 5’UTR to the first AUG in a proper sequence 
context. EIF4G also binds PolyA binding protein (PABP) which brings 5’ and 3’ UTR in close proximity and 
facilitates recycling of translation complexes, which enhances translation efficiency. Proteins that bind 
AU-rich repeat-like sequences such as ELAV1 (HuR) can also bind PABP. The stabilization of scanning 
complexes by PABP may facilitate scanning past structural elements such as stem-loop structures 
or uORFs. Small ribonuclear proteins may further stabilise the complex of ELAV and PABP. Together 
with base-pairing between repeats in the 3’UTR and the 18S rRNA in the 40S ribosomal subunit these 
interactions may reposition the scanning complex on the 5’UTR.
The most studied RNP particles are the hnRNPs that recognize AU-rich 
elements (ARE) and coordinate expression of mRNAs at the level of nuclear-
cytoplasmic shuttling (Veyrune et al. 1996), cytoplasmic mRNA turnover (Shaw and 
Kamen 1986), and silencing of cell state- and type-specific mRNAs (Ostareck et 
al. 1997; Notari et al. 2006).    The ARE is located in the 3’ untranslated region of 
many short-lived transcripts from cytokines, proto-oncogenes, growth factors or cell 
cycle regulators (Bakheet et al. 2001).  Interestingly, the family members BRF1 and 
BRF2 known to promote ARE-dependent decay, are regulated by SCF signaling 
in an opposing way and there expression is reverted upon induction or erythroid 
differentiation. Collective expression of predisposed transcript subgroups (Keene 
and Lager 2005) underlines a relatively unexplored gene expression modulation 
that might drive cell fate in the same manner as regulation of the transcriptome by 
transcription factors.
Future Experiments
The elements identified in the UTRs offer a unique possibility to analyse the 
mechanisms of signalling-controlled polysome recruitment. Mutagenesis of identified 
regulatory elements will be investigated in reporter assays to assess the contribution 
to translation control.  
RNA-based electrophoretic mobility shift assays (RNA-EMSA) may prove useful 
to identify protein complexes on specific RNA molecules that shift in response to 
growth factor signaling. Affinity purification of protein complexes on RNA coupled to 
beads followed by mass spectroscopy is a powerful method to identify RNA-binding 
proteins that either stabilise or destabilise secondary structures. 
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An interesting additional experiment would be to immunoprecipitate specific mRNA 
binding proteins to identify mRNA subsets as described in (Tenenbaum et al. 2000).
In addition to structural elements also uORFs can have various functions 
in the regulation of polysome recruitment.  An uORF can be located upstream of 
the main ORF as seen in mEd2, but an uORF can also be out of frame overlapping 
with the main ORF and in that way block translation from the protein-coding start-
codon such as observed for Cnih. Interestingly, the uORF in the Cnih transcript 
encodes a cross species conserved peptide, which suggests that this peptide may 
have a particular function in the regulation of translation. In some transcripts, the 
encoded peptide of uORFs can interact with the 40S ribosomal subunit and cause 
stalling of the scanning complex. Such a mechanism has been extensively studied 
in the mRNA encoding S-adenosylmethionine decarboxylase (AdoMetDC).   The 
AdoMetDC uORF codes for the hexapeptide, MAGDIS, that suppresses translation 
of AdoMetDC by interacting with a component of the translation machinery (Hill and 
Morris 1993).  
Future Experiments
Reporter assays designed to investigate the effect of mutations directed to change 
amino acids within peptide of uORF in Cnih, would give indication of importance of 
the sequence.
6.1.3  Complexity and structures in Nm23, mEd2 and Igbp1/α4 mature transcripts
For further analysis we selected the transcripts of mEd2 and Igbp1/α4 because their 
constitutive expression impaired erythroid progenitor differentiation, and Nm23-M2 
because it was found as a common virus integration site.  Interestingly, a cell line 
derived from MLV induced tumours identified a proviral insertion that replaces the 
structured UTR of Nm23, with a simple sequence that looses translation control 
(Chapter 5).  
6.1.3.1 Regulatory elements in Igbp1/α4 transcript
Highly structured 5’UTRs of translationally controlled transcripts may not unfold 
at the  temperature used in standard reverse transcriptase reactions.  The RACE 
strategy was modified to synthesis first strand cDNA at 65oC starting from polyA+ 
mRNA.  Although we could extend the UTR sequence of other transcripts in our 
list, the RACE product of Igbp1/α4 indicated that the sequence is only 21bps. 
Interestingly, the human Igbp1/α4 5’ UTR is 297bp long, and this sequence shows 
regions of high homology with the mouse genomic sequence. Northern blot of total 
RNA prepared from mouse and human cell lines, showed clearly that the mouse 
Igbp1/α4 transcript is as long as the human (Figure 6.2 A).    Primers were designed 
within the homologous regions at position -161 to -192 relative to the mouse alpha4 
AUG and 92bp upstream of the longest alpha4 EST (DV65442).  PCR amplification 
yielded a 118bp product and sequencing confirmed the presence of a longer 5’UTR 
(Figure 6.2 B).   This suggests that a high enthalpy structure hinders nested PCRs 
designed for the RACE protocol.
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Future Experiments
RACE experiments will be done using nested primers designed upstream of the 
pseudoknot structure of alpha4, within the sequence that was confirmed present by 
PCR.
Figure 6.2  Identification of 5’UTR of alpha4.  A: Northern blot of total RNA prepared from mouse 
and human cell lines.  B: Alignment of different species with the mouse Igbp1/α4 cDNA and genomic 
sequence.  The homology between mouse genome and human cDNA is indicated.  In addition the position 
of the pseudoknot and the 118bp PCR product from mouse cDNA are annotated.  
6.1.3.2  The leader sequence of mEd2
RACE experiments consistently showed that the 5’ UTR of mEd2 corresponded to 
the sequence of the longest EST found in databases.  Amplification of the whole 
length UTR of mEd2 resulted in 2 products. Sequencing of these products show 
the presence of an alternatively spliced intron of 180bp. Q-PCR suggests that the 
spliced form is 5-fold more abundant compared to the unspliced form. The unspliced 
isoform is not regulated during differentiation of erythroid progenitors (Figure 6.3 
B), whereas the spliced isoform is downregulated (Figure 6.3 C)  Interestingly, the 
AG of the acceptor splice sequence is immediate upstream of the proper AUG and 
splicing of the intron results in the abolishment of the perfect Kozak sequence at this 
site (Figure 6.3 A). In addition, a consensus uAUG is located 5’ of the alternatively 
spliced intron. Splicing puts this upstream AUG in frame of the coding sequence. 
Thus the unspliced form contains a strong uAUG and associated uORF of 60nt that 
most likely affect  translation, whereas that same consensus uAUG may be used as 
main AUG to produce a protein with 14additional amino acids at the N-terminal side 
(Figure 6.3 A).  This intriguing result suggests that regulation of the splicing isoforms 
also controls translation initiation.
Notably, the first predicted protein was even much smaller and started at 
the an AUG at position +157.  This protein was described as MDS032. This protein 
was tested for an effect on signalling-controlled  promoter activity and enhanced 
Erk-dependent reporter activity. It is this protein that inhibits erythroid differentiation 
when constitutively expressed. Recently, mEd2 was reported as the D12 Q-SNARE 
protein with a translational start at AUG at position 0.  Despite several trials, we failed 
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to express this protein isoform in erythroid progenitors, suggesting that deregulated 
expression may be incompatible with proliferation of these cells. We have not yet 
tried to express the protein with an extended N-terminal part that is predicted to be 
encoded by the spliced transcript.   
Figure 6.3  Identification of 5’UTRs of mEd2.  A:  Loss of Kozak sequence in spliced mEd2 transcript 
isoform. B: Quantitative PCR showing fold increase by growth factor signaling using primers specifically 
amplifying mEd2 isoform with intron as compared to mEd2 transcript without intron in (C).  
6.1.3.3 The highly complex Nm23 UTR 
We extended further the 5’UTR of Nm23 by 40bp upstream of the longest 
EST.   Critical investigation of the newly identified UTR sequences of Nm23-M2 
and mEd2 showed the presence of high enthalpy structures that are distributed 
differently in relation to the region containing the uORFs.  Using luciferase assays 
we investigated the role of uORFs.  Interestingly, the uORFs of mEd2 attenuate 
translation initiation while the uORFs in Nm23 release inhibition of the high enthalpy 
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structure proximal to the proper AUG.   The mechanism responsible for this release 
is not easily discernable, and the possible explanation is that peptide synthesis at the 
uORFs change the conformation of the RNA transcript to allow opening of the high 
enthalpy structure.  In addition, the secondary structure predication software (Mfold; 
http://www.bioinfo.rpi.edu/applications/mfold/rna/form1.cgi) did not recognize 
the GAIT structure in the uORF of Nm23-M2, the sequence lies within a 
region of low enthalpy and hence conformation of this region is subject to 
change upon differential recruitment of RNA binding protein complexes. 
6.2 Role of Igbp1/α4 and mEd2 in translational feed-back control
As already briefly indicated in chapter 3, both alpha4 and mEd2 may be involved 
in positive feed-back control of mRNA translation. Igbp1/alpha4 associates with 
the phosphatase Pp2a, which dephosphorylates 4E-BP and p70S6K and thus acts 
as a direct antagonist of TOR activation. Igbp1/α4 modifies the target specificity of 
Pp2a and inhibits dephosphorylation of TOR-targets. We showed that constitutive 
expression of Igbp1/α4 in erythroid progenitors sustains proliferation and inhibits 
differentiation in absence of SCF, enhances Epo-dependent phosphorylation of 
4E-BP and p70S6K to levels that otherwise require Epo plus SCF, and enhances 
polysome recruitment of mRNAs, whose polysome association was previously 
shown to be strictly PI3K/mTOR dependent (Chapter 3). Thus, Igbp1/α4 acts in a 
positive feed-back loop on mTOR function, analogous to constitutive activation of 
kinase receptors.
The phosphatase Pp2a has been described to induce G1 arrest in epithelial 
cells by dephosphorylation of p70S6K upon TGFβ addition (Petritsch et al. 2000). 
Block of erythroid progenitor differentiation, by constitutive expression of alpha4, 
can be rescued by addition of TGFβ (Figure 6.4).   However, the action of TGFβ to 
rescue differentiation block is still unresolved and in addition to modulation of Pp2a 
activity, the Smad pathway may also play a role.  The release of differentiation block 
by TGFβ implies that Igbp1/α4-expressing cells are not clonal anomalies, but retain 
the capacity to differentiate if the strength of the differentiation signal is increased. 
Interestingly, another inhibitor of Pp2a, the putative oncogene SET [von Lindern et 
al., 1992 is induced in CML (Neviani et al. 2005).  Therapeutic activation and ectopic 
expression of Pp2a inhibits SET activation by BCR/ABL and resulted in reduced 
proliferation and leukemogenic capacity in transplantation murine models (Neviani 
et al. 2005).  
Future Experiments
Using a flag at an appropriate distance C-terminal of the start sites, we will first need 
to determine which AUG is really used in vivo in erythroid progenitors. Subsequently 
we will test how alternative splicing affects translation initiation.  
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Figure 6.4  TGFβ induces differentiation of clones constitutively expressing Igbp1/α4.  The addition 
of TGFβ to Epo plus SCF (ES) cultures induce differentiation of clones derived from I/11 cells transduced 
with an empty retroviral construct (eV) as shown by the peak of Hemoglobin at 72 hours.  Single cell 
derived clones constitutively expressing Igbp1/α4 proliferate in ES conditions and do not accumulate 
hemoglobin.  Upon addition of TGFβ the block in differentiation was released with a peak in hemoglobin 
at day 6 (144hrs).
Constitutive expression of the second gene, mEd2, also inhibited erythroid 
differentiation. Recently mEd2 was shown to be a SNARE protein (Q-SNARE 
protein D12) with quality control function in ER-lysosome trafficking. Interestingly, the 
expression level of mEd2/D12 correlated with eIF2 phosphorylation, suggesting that 
mEd2/D12 may act in a feedback loop signalling ER-stress to eIF2 phosphorylation, 
although the kinase responsible for the phosphorylation of eIF2 in response to 
unfolded proteins in the ER, PERK (Protein kinase R-like ER-localised eIF2α 
kinase), was not involved in this process (Figure 6.5). 
Interestingly, the translationally controlled genes attributed to a block of 
erythroid differentiation are directly involved in feedback mechanisms to maintain 
mTOR activity and recover eIF2 activity after stress, hence both promoting translation 
efficiency.  This suggest the importance of phosphatases in attenuation of signaling 
pathways in particular involved in cell fate decisions as in induction of differentiation. 
Comparison of polysome recruited transcripts using microarray analysis on 
RNA isolated from clones with constitutive expression of eIF4E or Igbp1/α4 under 
Epo conditions, would give insight on crucial effectors in erythroid differentiation delay. 
Including other model cell lines for other hematopoietic lineages would increase the 
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Figure 6.5  Restoring 
translation efficiency 
following stress release. 
Upon stress the eIF2α 
kinases PERK and Heme 
Regulated Inhibitor (HRI) 
phosphorylate eIF2α 
(eIF2-P).  Inactivation of 
eIF2 enhance expression 
of the activated-
trasncription factor 4 
(ATF4) and ATF6.  For 
ATF4 it has been shown 
that an inhibitory uORF 
is not selected at low 
eIF2 levels (Vattem and 
Wek 2004).  Growth 
Arrest and DNA Damage-
Inducible Protein, 
Gadd34 is a direct target 
of ATF4 and is involved 
in dephosphorylation 
of eIF2α.  Similarly 
mEd2/D12 is involved 
in restoration of PERK 
induced stress response.
potential to identify critical mechanisms involved in the balance between proliferation 
and differentiation of hematopoietic progenitors.  
In addition, to investigate if the block in erythroid differentiation can be rescued 
directly by interfering with pp2a activity, clones constitutively expressing Igbp1/α4 will 
be transduced with the active subunit of pp2a as in (Neviani et al. 2005).
6.3 Selective mRNA translation and cell fate determination
Pluripotent hematopoietic stem cells in the bone marrow of the adult renew to 
supply a pool of cells capable to diverge into different lineages. Extracellular factors 
play a critical role in lineage commitment, proliferation, survival and differentiation. 
Stem Cell Factor (SCF), interleukin 3 (IL3), and granulocyte-macrophage colony 
stimulating factor (GM-CSF) contribute to a wide range of lineages, while action of 
erythropoietin, G-CSF and thrombopoietin are confined to specific blood lineage. 
The issue of cytokine-controlled commitment being an instructive program as 
opposed to a stochastic event with a permissive role of cytokines is still a matter 
of debate.  The lack of specificity in signaling by cytokine receptors (Socolovsky et 
al. 1998) in the different hematopoietic lineages suggest that the principal function 
is the expansion and survival of committed progenitors, as opposed to instructive 
programs for lineage specific gene expression which is laid down by key transcription 
factors functioning in a network with multiple layers of feedback control.   
SCF-induced PI3K/PKB activity controls the level of eIF4E available 
for translation initiation and we show that overexpression of eIF4E in erythroid 
progenitors impairs their differentiation and enhances renewal divisions in absence 
of SCF.  Now we find that control of selective polysome recruitment of structured 
141
Chapter 6
transcripts is a major pathway downstream of SCF required to sustain renewal 
divisions. This implies that the intrinsic transcription program must provide the 
transcripts of which signalling determines whether or not they are translated. As 
such, transcription could be seen as instructive and translation as the permissive 
level of commitment and differentiation.  However, growth factors may control both 
levels. As discussed in Chapter 4, certain cellular mechanisms are controlled by 
signalling-induced gene transcription, whereas other mechanisms are largely 
regulated at the level of translation initiation.  Interestingly, preliminary results 
indicate that target genes of the erythroid transcription factors GATA and EKLF are 
subject to regulation at the level of polysome recruitment.  Hence signalling-induced 
enhanced polysome recruitment overlaps the transcriptional program of these key 
factors.  Further analysis is needed to understand the contribution of such target 
genes in terminal erythroid differentiation.
6.4 Control of protein synthesis: Igbp1/α4 regulates more than eIF4E 
release
Constitutive eIF4E expression impairs differentiation, but is not able to sustain 
renewal beyond 7 days in the absence of SCF. Upon moderate overexpression 
the cells undergo delayed differentiation but high levels of eIF4E eventually induce 
erythroid progenitors to die under differentiation conditions. 
Interestingly, constitutive expression of Igbp1/α4 results in maintained 
phosphorylation of both mTOR targets: 4EBP1 and S6K and it blocks erythroid 
differentiation (Chapter 3).  In contrast to eIF4E, alpha4 was able to sustain renewal 
in absence of SCF for at least 10 days.  Surprisingly, we observed that Epo addition, 
but not SCF was capable to phosphorylate S6K in the context of Igbp1/α4 constitutive 
expression.   This suggests that Igbp1/α4 acts at the level of mTOR activity resulting 
in simultaneous increase in ribosomal capacity that accommodates enhanced 
recruitment of non competitive mRNAs.  Although overexpression of eIF4E results 
in constitutive expression of Igbp1/α4, these levels of Igbp1/α4 may not reach the 
levels that are needed to attenuate phosphatase activity as in the case of constitutive 
activation of Igbp1/α4.  Hence eIF4E overexpression is expected to be limiting in 
transcriptional activation of ribosomal units.  In fact, the expression of Igbp1/α4 in 
eIF4E clones is comparable to Igbp1/α4 levels of Epo plus SCF stimulated erythroid 
progenitor cells, while in constitutive expressed Igbp1/α4 the ectopic protein is 
additional to normal expression (data not shown).  
S6K is a key factor in the regulation of ribosome biosynthesis and a 
prominent target of Igbp1/α4. Ribogenesis is considered to be particularly important 
for cell growth (cell mass production and cell size control), which is intimately linked 
to cell cycle progression (Jorgensen et al. 2004).  During hematopoietic differentiation 
induction cell growth and cell cycle are uncoupled to produce smaller mature blood 
cells.  Both IL3 and GCSF stimulate cell cycle, but GCSF-induce neutrophilic 
differentiation is accompanied by a significant decrease in ribosome abundance and 
rDNA transcription (Kroll et al. 2001).  A similar event occurs early in differentiation of 
murine erythroleukemic cells (Sherton and Kabat 1976) suggesting that ribosomal 
content is a common target of differentiation induction.  
Strikingly, defects in genes that are critically involved in ribogenesis in yeast 
contribute to the aetiology of several diseases that are congenital or acquired. 
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Diamond Blackfan Anemia (DBA) is characterised by mutations in ribosomal protein 
S19, which is involved in association of the 40S pre-ribosome (Draptchinskaia et al. 
1999; Ellis and Massey 2006).    Dkc1, the gene affected in X-linked Dyskeratosis 
congenita (DC) is a pseudouridine synthetase involved in 35S rRNA modification 
(Heiss et al. 1998; Ruggero et al. 2003; Liu and Ellis 2006). Although the enzyme 
also affects the RNA component of the telomerase complex, mice with deficient 
enzyme activity suffer from decreased ribosome capacity well before a telomeric 
defect becomes apparent (Ruggero et al. 2003).  Another inherited marrow failure 
syndrome, Shwachman-Diamond syndrome is associated with mutations in the 
SBDS gene encoding an RNA-binding protein localized throughout the cell and 
particularly in the nucleolus in a cell cycle dependent manner (Austin et al. 2005).  It 
is noteworthy that the above mentioned defects in genes involved in ribogenesis are 
associated with anaemia, suggesting that either proper function or proper synthesis 
rates of ribosomes is important to control renewal, survival or differentiation of 
erythroid progenitors.  Additional functions to supply of translational machinery have 
been attributed to ribosomes.  Interestingly, the ribosome components are subject 
to signalling modifications resulting in releasable factors that attenuate translation 
of specific transcript (Mazumder et al. 2003).  This suggests that modulation or loss 
of ribosomal constituents does not necessarily mean lowering of global protein 
synthesis rate, but might modulate specific RNA groups.  
The ribosome-associated diseases mentioned above, are all associated with 
bone marrow failure and to understand the disease mechanism it will be important to 
understand how ribosome synthesis affects normal hematopoiesis, which has hardly 
been studied. The results may yield important insight into anaemia in the elderly, 
which is an increasingly occurring condition in the aging populations of the Western 
world. 
Further investigation is required to examine whether ribogenesis only affects 
cell mass and cell cycle progression or whether it mainly affects the translation of 
selective mRNAs encoded by genes that control the balance between erythroid 
progenitor renewal and differentiation. It will be interesting to analyse whether 
transcripts regulated by eIF4E and eIF2 are also sensitive to the efficiency of 
ribosome biosynthesis.
6.5 Proliferation requires cell cycle progression and cell growth
Protein synthesis is generally perceived as an essential cellular process modulated 
in response to cell growth and cell cycle progression (Pardee 1989; Pyronnet and 
Sonenberg 2001) and its deregulation is a consequence rather than a cause of 
tumourogenesis.   This is challenged by increasing evidence.
Myc is known as a tumour gene promoting cell cycle progression but only a 
few genes have been identified as targets for regulation by c-Myc complexes (Niki 
et al. 2000).  Transcriptional upregulation of eIF4E is dependent on the transcription 
factor c-Myc (Jones et al. 1996).  We found c-Myc to be upregulated by SCF, while 
Mxi and Mad, two factors competing for the common heterodimerisation partner 
Max, are downregulated in response to SCF. Moreover, we validated Myc single 
strand binding protein (MSSP/Rbms1), a factor enhancing the transforming capacity 
of c-Myc (Niki et al. 2000), as a target specifically regulated by SCF- and eIF4E-
dependent translation initiation (polysome recruitment).   The importance of cMyc-
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regulated translation initiation factors has long been underestimated, while the 
search for targets that could explain the highly oncogenic potential of cMyc has been 
disappointing (Eisenman 2001).   In addition, transcription of ribosomal proteins, 
ribosome assembly factors (Kim et al. 2000), and nucleolar proteins are myc targets 
genes (Boon et al. 2001; Menssen and Hermeking 2002).   This suggests that the 
transforming capacity of myc could be attributed to enhanced translation initiation 
efficiency accompanied by enhanced translation machinery capacity.
Multiple tumour suppressors regulate ribosome production and translation 
initiation, underlining an important role in normal cell homeostasis (Fingar et al. 
2004; Inoki et al. 2005).  PTEN negatively regulates rpS6 phosphorylation and 
eIF4E availability by inhibiting the PI3K/mTOR pathway, directly effecting ribosome 
biosynthesis and translation initiation (Podsypanina et al. 2001; Backman et al. 
2002; Blazquez-Domingo et al. 2005).   Similarly, TSC1/2 and pp2a act at the level 
of mTOR activation (Inoki et al. 2002) and maintenance of active mTOR targets (Di 
Como and Arndt 1996; Gingras et al. 2001), respectively.   
6.6  Selective mRNA translation and AML
Our findings proved to be extremely difficult to correlate with existing AML patient 
information derived from extensive microarray data, since this has been derived from 
total RNA hybridisations (Valk et al. 2004).  For instance the expression of Igbp1/α4 
is constant in all patients in the cluster analysis, while the levels of the protein varied 
between samples as expected for a translationally controlled gene.  
 In yeast, the homologue of Igbp1/α4 is Tap42, which is required for the 
TOR pathway to be active. The TOR pathway in yeast is blocked when Tip41 binds 
and sequesters Tap42. The human homologue of Tip41 is MGC3794. Although this 
protein has not been studied it is expected –in analogy with yeast- that it suppresses 
the mTOR pathway and may act as a tumour suppressor gene. It is not known 
whether this gene is also regulated at the level of mRNA translation or at the level 
of gene transcription. Interestingly, gene expression profiling and clustering in  AML 
indicated that the Tip41 homologue MGC3794 is downregulated in a specific set 
of AML (cluster 5 in the study of Valk et al. 2004).  This suggests the interesting 
possibility that this cluster has an increased activity of the mTOR pathway. 
Preliminary trials were attempted using a number of approaches to quantify 
mTOR, S6K, eIF4E activity and alpha4 levels in patient material, but a high 
throughput investigation is needed to address the link between deregulation of 
Igbp1/α4 feedback and significance in disease.
Mechanisms that may control Pp2a activity in leukemia should be investigated. 
On the one hand, the role of deregulated Pp2a activity should be examined in 
leukemia models. In addition screening of AML samples for mutations deregulating 
Pp2a activity may shed light on the role of Pp2a in the regulation of proliferation 
and differentiation of hematopoietic progenitors. First, it is worth to study (i) the 
prognostic significance of the potential tumour suppressor Tip41 and (ii) specifically 
the activity of the mTOR pathway in these AML samples.  Second, it has been 
found that mutations of Tyr307 and Leu309 in the catalytic subunit of Pp2a, favour 
association with the alpha4 subunit and promote protein synthesis (Chung et al. 
1999). To investigate whether mutations in Pp2a are involved in leukemogenesis, it 
is important to screen at least for these mutations.
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Summary
The balance between proliferation and differentiation of committed 
hematopoietic progenitors is under tight control to maintain the progenitor pool and 
ensure maturation in response to physiological demand. Whereas development of the 
different hematopoietic lineages requires the coordinate expression of transcription 
factors, the balance between proliferation and differentiation is controlled by growth 
factors. These include cytokines such as erythropoietin (Epo) and granulocyte-colony 
stimulating factor (G-CSF) required for differentiation into specific lineages, as well 
as growth factors that enhance proliferation and delay differentiation of progenitors 
such as stem cell factor (SCF) and the ligand for FMS-like tyrosine kinase 3 (Flt3-
ligand). 
To investigate how the balance between expansion and differentiation of 
erythroid progenitors is controlled by growth factors, we used a model in which 
erythroid progenitors proliferate in the presence of Epo, SCF and glucocorticoids 
while they maintain the capacity to differentiate upon addition of Epo alone. SCF-
driven proliferation and inhibition of differentiation is dependent on phosphoinositide-
3-kinase (PI3K) activation. The main objective of the study described in this thesis is 
to understand how PI3K-controlled gene expression regulates the balance between 
proliferation and differentiation of erythroid progenitors. In particular, we studied the 
role of PI3K dependent control of mRNA translation. 
An extensive literature review of the importance of translation control in the 
regulation of hematopoiesis, is given in chapter 1. In general, translation of mRNA 
depends on the two major factors: (1) the availability and activity of the translation 
machinery and (2) the structure of a messenger. Structural elements in the mRNA 
render translation of the transcript sensitive to the availability of translation factors, 
which affect the translation of simple transcripts far less. 
The SCF-induced activation of PI3K controls the kinase mTOR (Target of 
Rapamycin), which releases eukaryote initiation factor 4E (eIF4E) from a repression 
complex to form an active pre-initiation scanning complex (eIF4F).  We could 
demonstrate that increased expression of eIF4E enhanced the formation of the 
eIF4F scanning complex and enhanced the recruitment of structured mRNAS into 
polyribosomes. Importantly, enhanced expression of eIF4E impaired differentiation 
of erythroid progenitors into mature erythrocytes, indicating an important role of this 
pathway in the regulation of proliferation versus maturation of erythroid progenitors 
(chapter 2). 
To identify transcripts that are subject to selective polysome recruitment in 
response to  growth factors, we compared SCF-dependent gene expression between 
total and polysome bound mRNA (chapter 3). This yielded a list of 115 genes subject 
to major regulation by translation initiation. The transcripts of nine out of ten genes 
tested in more detail required PI3K or increased eIF4E expression to be associated 
with polyribosomes. Among these genes is Igbp1 (Immunoglobulin binding protein-
1) that binds and inhibits the serine/threonine phosphatase Pp2a. This phosphatase 
functions as an mTOR antagonist in translation initiation. Constitutive expression 
of Igbp1 strongly impaired erythroid differentiation, maintained phosophorylation of 
two important mTOR targets, eIF4E binding protein (4EBP) and S6-kinase (p70Sk) 
phosphorylation and enhanced polysome recruitment of structured mRNAs. Thus, 
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we found that PI3K-dependent polysome recruitment of Igbp1 acts as a strong 
positive feedback mechanism on translation initiation, which underscores the 
important regulatory role of selective polysome recruitment for erythropoiesis.
Next, we evaluated the importance of growth factor-induced polysome 
recruitment versus transcriptional regulation of gene expression. In addition, we 
analysed to what extent growth factor-controlled genes are differentially regulated 
during differentiation and vice versa (chapter 4). Surprisingly, we found a 2,5-fold 
increase in growth factor-controlled genes upon analysis of polysome-bound mRNA 
compared to total RNA. The prominent, and so far underestimated effect of signalling 
on mRNA translation prompted us to evaluate signalling dependent expression 
of translation factors and proteins involved in ribosome biosynthesis. Together, 
ribosome synthesis regulation and polysome recruitment ensure enhanced 
translation efficiency in presence of mitogenic factors as discussed in chapter 4.
Next, we studied which elements in the 5’ untranslated region (5’UTR) of 
Nm23-M2 are responsible for growth factor dependent protein synthesis (chapter 
5). Nm23-M2 was not only found to be subject to translational control, it is also a 
common virus integration site in retrovirally induced murine leukaemia. A virus 
integration in the 5’UTR of Nm23-M2 in the murine leukaemia cell line NFS61 results 
in a LTR-Nm23 fusion transcript that disrupts a predicted stem-loop structure and 
perturbs factor dependent translation. The 5’UTR of Nm23-M2 contains high enthalpy 
structures, upstream open reading frames and putative signalling responsive 
elements.  To study the effect of these structures on growth factor dependent mRNA 
translation, luciferase constructs flanked with Nm23-M2 UTR sequences were 
expressed in factor-dependent cell lines.  Upstream ORFs in the distal part of the 
5’UTR appeared to enhance polysome recruitment, while stem-loop elements in the 
proximal part of the 5’UTR inhibit translation. A similar approach is being taken for 
two other translationally controlled genes that both impair erythroid differentiation 
when constitutively expressed: Igbp1 and mEd2. Both genes contain a complex 
5’UTR which we identified by homology searches and 5’RACE (chapter 6). 
In conclusion, the studies presented in this thesis demonstrated that polysome 
recruitment of structured mRNAs is a major target of SCF-induced PI3K activation, 
which is required for the expansion of the pool of erythroid progenitors. First, this 
mechanism of translational control involves the regulation of the cap-binding factor 
eIF4E. Also the growth factor dependent regulation of multiple other translation 
factors and ribosome synthesis factors is likely to contribute to enhanced mRNA 
translation, particular of highly structured transcripts. Second, we identified a number 
of genes that are subject to translational control. The analysis of their untranslated 
regions may shed light on the mechanism of transcript specific translational control. 
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Samenvatting
De balans tussen groei en uitrijping van bloedcelvoorlopers moet 
nauwkeurig gereguleerd worden om zowel de voorraad voorlopercellen als hun 
uitrijping aan te passen aan de vraag. Terwijl de ontwikkeling van de verschillende 
typen bloedcellen een gecoördineerde expressie van transcriptiefactoren vereist, 
wordt de vermeerdering van voorlopercellen vooral geregeld door groeifactoren. 
Hiertoe behoren cytokines die de uitrijping in specifieke celtypen controleren, 
zoals erythropoietine (Epo) en ‘granulocyte colony stimulating factor’ (G-CSF), en 
groeifactoren die celgroei stimuleren en de uitrijping remmen zoals stam cel factor 
(SCF) en de factor die de tyrosine kinase receptor Flt3 bindt (Flt3-ligand). 
Voor ons onderzoek hebben we een model systeem gebruikt waarin 
voorlopercellen kunnen uitgroeien in aanwezigheid van Epo, SCF and 
glucocorticoïden, terwijl de cellen uitrijpen tot rode bloedcellen in aanwezigheid van 
alleen Epo. SCF-geïnduceerde groei en remming van het uitrijpen is afhankelijk van 
phosphoinositide-3-kinase (PI3K) activiteit. Het doel van de studies beschreven in 
dit proefschrift is om te begrijpen hoe PI3K afhankelijke regulatie van gen expressie 
de balans tussen groei en uitrijping van rode bloedcelvoorlopers controleert. In het 
bijzonder hebben we de rol van PI3K in het vertalen van mRNA bestudeerd. 
Hoofdstuk 1 bevat een uitgebreid literatuur overzicht over de rol die 
controle van mRNA vertaling kan spelen in de bloedcelvorming. Het vertalen van 
een mRNA hangt af van twee factoren: (1) de beschikbaarheid en activiteit van 
de vertaalmachinerie, en (2) de structuur van het mRNA. Structuren in het mRNA 
kunnen ervoor zorgen dat het vertalen van een mRNA afhankelijk wordt van de 
beschikbaarheid van translatiefactoren, terwijl het vertalen van eenvoudige mRNAs 
hierdoor veel minder wordt bepaald.
PI3K reguleert het kinase mTOR (Target of rapamycin), waardoor de 
eukaryote translatie initiatie factor 4E (eIF4E) vrijkomt om een actief pre-initiatie 
scanning complex te vormen (eIF4F). Een matig verhoogde expressie van eIF4E 
bleek te resulteren in forse verhoging van het eIF4F scanning complex, en in het 
vertalen van transcripten met een complexe RNA structuur. Een verhoogde expressie 
van eIF4E blokkeerde ook de uitrijping van voorlopers tot rode bloedcellen  wat erop 
duidt dat eIF4E afhankelijk translatie van mRNAs van belang is om de balans tussen 
groei en uitrijping van voorlopercellen te reguleren (hoofdstuk 2).
Om de transcripten te identificeren waarvan de vertaling afhangt van de 
aanwezigheid van groeifactoren, hebben we een vergelijking gemaakt tussen 
SCF-geïnduceerde gen expressie op het niveau van totaal RNA versus ribosoom-
gebonden RNA (hoofdstuk 3). Zo vonden we 115 genen waarvan de expressie 
vooral gecontroleerd wordt door selectieve vertaling. Voor negen van de tien 
transcripten die we getest hebben, was de vertaling afhankelijk van PI3K activiteit en 
eIF4E expressie. Tot deze genen behoorde Igbp1 (Immunoglobulin binding protein 
1). Igbp1 bindt en remt het serine/treonine fosfatase Pp2a.  Dit fosfatase functioneert 
als een antagonist van mTOR in de vertaling van mRNAs en daardoor kan Igbp1 de 
mRNA vertaling juist stimuleren. Een constante expressie van Igbp1 blokkeerde de 
uitrijping van voorlopercellen tot rijpe rode bloedcellen, handhaafde de fosforylatie 
van 4EBP en p70S6kinase door mTOR, en liet transcripten met een complexe 
structuur beter met de ribosomen associëren. De PI3K afhankelijke vertaling van 
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Igbp1 functioneert dus als een sterk positief terugkoppelingseffect op de vertaling 
van complex gestructureerde transcripten, wat het belang van dit proces voor rode 
bloedcel ontwikkeling onderstreept.
Vervolgens hebben we geanalyseerd hoe groot het belang van groeifactor 
afhankelijk betrekken van mRNAs in polyribosomen is ten opzichte van groeifactor 
afhankelijke gentranscriptie. Daarbij hebben we ook bekeken in welke mate de 
expressie van genen die gereguleerd worden door groeifactoren verandert tijdens de 
uitrijping tot rode bloedcellen (hoofdstuk 4). Tot onze verrassing identificeerden we 
2,5 maal zoveel groeifactor gereguleerde genen in polysoomgebonden RNA als in 
totaal RNA. Het prominente en tot nu toe ondergewaardeerde effect van groeifactor-
geïnduceerde  vertaling van mRNAs was aanleiding om de factor afhankelijke 
expressie van translatie factoren en eiwitten betrokken bij ribosoom synthese nader 
te analyseren.
Vervolgens hebben we bestudeerd welke elementen in de 5’ onvertaalde 
regio (5’UTR) van het Nm23-M2 transcript groeifactor afhankelijke vertaling bepalen 
(hoofdstuk 5).  Nm23-M2 is niet alleen gevonden als een gen waarvan expressie 
wordt geregeld op het niveau van mRNA vertaling, het is ook doelwit van retrovirale 
integratie in muis leukemie.  Een virus integratie in de 5’UTR van Nm23-M2 in 
de leukemie cellijn NF61 resulteert in een fusietranscript van virale sequenties 
met Nm23-M2 waardoor een stabiele stem-loop structuur verloren gaat en de 
regulatie verstoord wordt. Om het effect van verschillende structurele elementen in 
de 5’UTR van Nm23-M2 op de vertaling van het transcript te bestuderen hebben 
we ze gefuseerd met sequenties die coderen voor luciferase en tot expressie 
gebracht in groeifactor afhankelijke cellijnen.  De uORFs bleken de vertaling van 
het fusietranscript te bevorderen, terwijl stem-loop elementen de vertaling remden. 
Eenzelfde aanpak wordt gevolgd voor twee andere genen die we geïdentificeerd 
hebben als zijnde gereguleerd op het niveau van mRNA vertaling, en in staat de 
uitrijping van rode bloedcelvoorlopers te remmen: Igbp1 en mEd2. Van beide genen 
hebben we de 5’UTR bepaald, die zeer complex blijkt te zijn (hoofdstuk 6). 
De studies die zijn beschreven in dit proefschrift laten zien dat de vertaling 
van transcripten met een complexe RNA structuur een belangrijke signaalfunctie 
is van SCF-geïnduceerde PI3K activiteit, die noodzakelijk is om het aantal rode 
bloedcelvoorlopers te laten groeien. Het mechanisme omvat de regulatie van de 
translatie initiatie factor eIF4E, maar ook de expressie van een groot aantal andere 
translatie factoren, en eiwitten die de ribosoom aanmaak reguleren. We hebben 
een groot aantal genen geïdentificeerd die gereguleerd worden door groeifactor 
afhankelijke vertaling. Analyse van de onvertaalde stukken van het transcript zal 
hopelijk het mechanisme van groeifactor afhankelijke mRNA vertaling onthullen. 
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4EBP eIF4E binding protein
ActD Actinomycin D
AML acute myeloid leukemia
ANOVA Analysis of Variance
ARE AU-rich element
BFUe Burst-forming unit erythroid
CFU-e Colony-forming unit erythroid
ChX cycloheximide
CLP Common lymphoid precursor
CML chronic myeloid leukemia
CMP Common myeloid precursor
Dex dexamethasone
eEF eukaryote elongation factor
eIF4E eukaryote initiation factor 4E
Epo Erythropoietin
EpoR Erythropoietin Receptor
Flt3 fetal liver tyrosine kinase-3
GAIT Gamma interfron activated inhibitor
GMP granulocytic/monocytic progenitor
hnRNP heterogenous nuclear ribonucleoprotein
HRI haeme regulated eIF2alpha kinase
HSCs Hematopoietic Stem Cells
Igbp1 Immunoglobulin binding protein 1
IRE Iron Responsive Element
IRES Internal Ribosome Entry Site
ITAF IRES trans-acting factor
LTR long terminal repeat
MDS myelodysplastic syndrome
mEd2 mouse embryonic differentiation factor 2
MEP Megakaryocytic/erythroid progenitor
miRNA micro RNA
MPD Myelo-Proliferative Disorder
mTOR mammalian Target of Rapamycin
NF No Factor added (depriviation)
ODC ornithine decarboxylase
p70SK S6 kinase (70kDa)
pbRNA polysome bound RNA
PI3K posphoinositide-3-kinase
PKB Protein Kinase B
PV polycythemia vera
RACE Rapid Amplification cDNA Extension
Rheb RAS-homologue enriched in brain
rRNA ribosomal RNA
RTK receptor tyrosine kinase
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SCF Stem Cell Factor
TGF transforming growth factor
TNF tumour necrosis factor
TOP terminal oligopyrimidine tract
TPO thrombopoeitin
Tsc tuberous sclerosis protein
uAUG upstream AUG
uORF upstream open reading frame
UTR untranslated region
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